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The prevalence of diabetes and obesity have continued to rise over the last 30 years. In 
New Zealand one in three adults have obesity and one in twenty have type 2 diabetes 
mellitus (T2DM). Thus, there is an urgent need to implement effective and scalable 
treatments for both diabetes and obesity. Bariatric surgery and low-calorie diets produce 
weight loss and reverse the disordered glucose metabolism associated with T2DM.  Both 
treatments create a state of negative energy balance in which the individual’s dietary 
energy intake is lower than their energy expenditure. However, maintaining a negative 
energy balance with low-calorie diets is challenging. This is partly due to a compensatory 
reduction in resting energy expenditure (REE), adaptive thermogenesis, that occurs 
during weight loss and is triggered by a period of sustained negative energy balance. 
Adaptive thermogenesis diminishes this negative energy balance, undermining weight 
loss. A better understanding of what influences adaptive thermogenesis and ways to 
mitigate it may inform more effective dietary interventions for the treatment of diabetes 
and obesity.  
Objectives:  
The overall aim of this thesis was to test the hypothesis that interrupting a low-calorie 
diet using an intermittent fast reduces adaptive thermogenesis during weight loss.  
To test this hypothesis, we first needed to develop an accurate and precise method for 
measuring REE using indirect calorimetry. Secondly, we needed to assess the 
relationship between REE and body composition in a local sample population. Thirdly, 
we needed to assess the safety of intermittent fasting in individuals with T2DM at risk of 
hypoglycaemia.  
Design:  
In-silico validity and precision testing of indirect calorimetry was conducted using 
ethanol combustion and nitrogen dilution. Having determined the quality of in-silico 
calorimetry measurements, the test-retest reliability was assessed in two repeated 





To assess the relationship between body composition and REE, a cross-sectional study 
of body composition and REE using indirect calorimetry was conducted, the Predictions 
of Resting Energy Expenditure in Māori and Pacific (PREEMPt) study. Next, the safety 
of intermittent fasting in individuals with T2DM was assessed in a 12-week prospective 
randomised control trial.  
Having completed these studies, the Changes in Resting Energy Expenditure with 
Different Schedules of Calorie Restriction (CREEDS) study was conducted to address 
the primary hypothesis that intermittent fasting attenuates adaptive thermogenesis during 
weight loss.  
Results:  
Following protocol refinement, high levels of precision and accuracy were observed 
during the nitrogen dilution studies and the second test-retest reliability study. 
The assessments of body composition and resting energy expenditure in the PREEMPt 
study were used to estimate the sample size required for the CREEDS study. We found 
that intermittent fasting increased the risk of hypoglycaemia on fasting days, this finding 
informed the design of the CREEDS study.  
In the CREEDS study, both intermittent fasting and continuous daily restriction resulted 
in adaptive thermogenesis, that was not mitigated by the intermittent fasting intervention.  
Of note, intermittent fasting was associated with a two-fold greater reduction in fat mass 
compared to continuous daily restriction.  
Conclusions 
Intermittent fasting does not mitigate adaptive thermogenesis seen during weight loss 
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1.1 Overview and Thesis Aims 
In the past 50 years, there has been a global rise in overweight, obesity and associated 
obesity-related co-morbidities such as Type 2 Diabetes (T2DM) (2, 3). In New Zealand 
in 2015/2016, 31.6% of all individuals over the age of 15 years were obese, compared to 
26.5% only five years previously, while 66.8% of all individuals were classed as either 
overweight or obese. Overweight and obesity are more prevalent in New Zealand Māori 
and Pacific ethnicities with rates of 78% and 89% respectively (4). The net result is 
increasing morbidity and mortality from obesity related complications and an associated 
increase in healthcare spending (5), (6), (7). 
Of the many complications of obesity, T2DM is one of the most important. Diabetes is 
associated with reduced life expectancy, poorer quality of life and considerable morbidity 
(8). The economic cost of T2DM is substantial, and accounted for an estimated $176 
billion US dollars in 2012 (9).  Between 2010 and 2017 the number of individuals with 
diabetes registered on the New Zealand Virtual Diabetes Registry increased from 
187,860 to 245,680 (10). Worldwide the global burden of T2DM is 422 million, nearly 
a quadrupling of the diabetes prevalence over the last 36 years. By 2030, it is estimated 
that diabetes will be the 7th leading cause of death (8).  
Weight loss through calorie restriction can be successfully used to induce diabetes 
remission and treat obesity (11). Unfortunately, successful weight loss can be difficult, 
and weight regain following a period of weight loss is common. Therefore, the question 
of how best we can implement weight loss and lifestyle modifications that result in 
durable resolution of both obesity and T2DM, is urgent and important. Weight loss 
requires a sustained negative energy balance; understanding the determinants of energy 
balance, and factors which influence these determinants, is central to developing a better 
understanding of how to achieve this goal.  
Therefore, the focus of this thesis is the study of human energy balance during weight 
loss. This introductory chapter begins with the physiology of energy balance and the 





remission of diabetes and successful weight loss are then discussed. The chapter 
concludes with a focus on the effects of diet interventions that alter schedules of energy 
intake. In the context of this thesis, ‘schedule’ refers to the temporal pattern of a 
prescribed calorie restriction. 
1.2 The Physiology of Energy Homeostasis  
‘Energy homeostasis’ describes biological processes that match dietary energy intake to 
energy expenditure (12). The goal of energy homeostasis is balance, an equal matching 
of dietary intake to energy expenditure (13). Conversely if energy homeostasis is not 
maintained, weight loss or weight gain will result. The use of the term energy 
homeostasis implies active regulation of body weight. An oft-cited argument for 
homeostatic control mechanisms is the observation that most individuals’ weight remains 
stable over prolonged periods despite variation in the myriad determinants of energy 
balance (14).   
To achieve energy balance dietary intake must be matched to the sum of the components 
of energy expenditure, or the total energy expenditure. These components are resting 
energy expenditure (REE), sleeping energy expenditure, physical activity energy 
expenditure and diet induced thermogenesis. Resting energy expenditure, also known as 
resting metabolic rate, may be defined as the amount of energy used by an organism at 
rest while in a state of complete muscular relaxation and awake. It is the largest 
component of energy expenditure, accounting for 50-75% of total energy expenditure. It 
differs from sleeping energy expenditure by about 5-10%, the energy cost of the awake 
state. If taken while fasting, REE is analogous to basal metabolic rate (15). All 
measurements of REE in this thesis are done while fasted. Physical activity energy 
expenditure usually accounts for 15-40% of total energy expenditure. Physical activity 
energy expenditure can be further subdivided into voluntary exercise energy expenditure 
and non-exercise activity thermogenesis. In many developed countries physical activity 
accounts for only a small proportion of total energy expenditure. Non-exercise activity 
thermogenesis is the energy expenditure of all occupation, leisure, sitting, standing and 
ambulation. Non-exercise activity thermogenesis is highly variable from person to person 





physically active jobs(16), (17). Diet-induced thermogenesis is the increase in energy 
expenditure that occurs after a meal. Diet-induced thermogenesis is also known as the 
specific dynamic activity or the thermogenic effect of feeding, and accounts for 
approximately 10% of total energy expenditure (18). The main value in breaking down 
energy balance in this way is that each component has a definition that allows them to be 
measured and summed. In this way the relative contribution of each component to a state 
of energy excess or deficiency can be determined experimentally. 
The partition of total energy expenditure in this way is useful for understanding the 
concept of energy homeostasis but does not offer adequate insight into how such 
homeostasis may be achieved. For this, a more detailed breakdown of the energy balance 
equation is required, that relates the components of energy balance to biological 
mechanisms of energy homeostasis. A proposed schema to consider energy homeostasis 
is presented in Fig. 1.1. 
 





In this schema, factors that influence dietary intake and dietary energy expenditure 
interact with each other to produce a state of energy homeostasis. It is unlikely that this 
state is regulated minute to minute, but day to day, or possibly over the course of weeks, 
in keeping with observational studies of weight fluctuation in healthy individuals (19). 
Which physiological systems are involved in energy homeostasis, where they are located, 
how they interrelate, and what the relative importance of each system is in regulating 
components of energy balance, are important questions that have only been partially 
answered.  
1.2.1 The Organisation of Energy Homoeostasis 
While all tissues require energy, the key players in the regulation of energy homeostasis 
are; the central and peripheral nervous systems, the gastrointestinal tract, pancreas and 
liver, white adipose tissue, brown adipose tissue, skeletal muscle, smooth muscle, the 
lungs and heart (20). The peripheral nervous system and endocrine systems relay signals 
to and from these organs.  
 The Nervous System 
The organisation of energy homeostasis in the central nervous system is comprised of 
anatomically and functionally related centres (Fig. 1.2)*. These centres are 
interconnected by inhibitory or excitatory neurons and receive feedback from outside the 
brain via sensory neurons or hormones that cross the blood brain barrier. Multiple inputs 
from the periphery and central nervous system are integrated and deliver a response 
directly or indirectly via efferent neurons (21-23).  
                                                          
* Reprinted from Cell, vol. 161, Gautron L., Elmquist JK, Williams KW. Neural control of energy 







The leptin-melanocortin pathway is one of the more completely understood pathways 
regulating components of energy balance (24). Following feeding, the hormone insulin 
is released from the pancreas and promotes leptin release from white adipocytes (25). 
Leptin travels via the blood stream to the blood brain barrier and is transported into the 
cerebrospinal fluid surrounding the brain (26, 27). From here it binds to pro-
opiomelanocortin (POMC) and Neuropeptide-Y/Agouti Related Peptide (NPY/AgRP) 
neurons in the arcuate nucleus of the hypothalamus (Fig. 1.2). The two sets of neurons 
have opposite effects on appetite. POMC neurons are anorexigenic, reducing hunger. 
POMC is cleaved to alpha- and beta-melanocyte stimulating hormone by prohormone 
convertase 1 (28). These cleaved products bind melanocortin receptors in the 
paraventricular nucleus of the hypothalamus. This activation results in a decrease in 
feeding (29). Conversely, NPY/AgRP neurons are orexigenic, hunger inducing. 
NPY = neuropeptide Y; Pomc = proopiomelanocortin; AgRP = Agouti gene-related 
peptide; Arc = arcuate nucleus; GLP-1= glucagon-like peptide 1. Reproduced with 
permission from Gautron et al.  





NPY/AgRP antagonises the POMC-melanocortin pathway leading to inhibition of the 
melanocortin receptors and an increase in feeding (22). Leptin exerts opposite effects on 
each system; stimulating POMC neurons and inhibiting the activity of NPY/AgRP 
neurons, resulting in a net inhibition of feeding.  
The leptin-melanocortin system is but one example of how the central nervous system 
co-ordinates components of energy homeostasis, in this case appetite. Other neural 
pathways outside of the hypothalamus that affect components of energy regulation have 
been described, but a detailed discussion of these is beyond the scope of this thesis. The 
sensory cortex conveys food-related sensory input. The functionally-defined hedonic 
areas of the brain; the central amygdala, ventral tegmental area, orbitofrontal cortex, 
insular cortex and ventral striatum play a role in food reward and are thought to be closely 
intertwined with regulation of appetitive behaviour (30),(31). The spinal cord mediates 
parasympathetic input from the gastrointestinal tract after feeding, decreases brown 
adipose tissue activity (section 1.2.1.3.2) and alters resting metabolic rate via the 
sympathetic nervous system (23, 32),(33).  
 The Gastrointestinal Tract 
Sitting at the entry point of dietary nutrients into the body, the gastrointestinal tract 
contains endocrine cells and afferent sensory nerves that relay information on nutrient 
intake centrally to influence meal termination and satiety. Hormones such as ghrelin, 
peptide YY (PYY), insulin and glucagon-like-peptide -1 (GLP-1) are released into the 
bloodstream or lumen of the gastrointestinal tract in response to nutrient stimulation and 
regulate several aspects of short term energy intake such as hunger and satiety. Though 
the gastrointestinal tract is home to many hormones, I will focus on those that appear to 
play a predominant role in energy homeostasis – the orexigenic hormone ghrelin, and the 
anorexigenic hormones PYY, and GLP-1.  
Ghrelin 
Ghrelin is a gut peptide secreted in an inactive, acylated form from the mucosa of the 
stomach (34). De-acylated ghrelin has an orexigenic effect when acting on the arcuate 
nucleus and other hypothalamic nuclei (35). It also activates hedonic or ‘pleasure/reward’ 





hedonic response to eating. Ghrelin levels rise with the duration of fasting and are 
suppressed following a meal, in proportion to the amount of calories consumed (36, 37). 
This suggests a role for ghrelin as a time-dependant regulator of energy intake that 
prevents negative calorie balance. This observation is supported by rodent and human 
studies demonstrating an increase in food intake with ghrelin administration and an 
increase in ghrelin during calorie restriction for weight loss in humans (38),(39),(40).   
GLP-1 
GLP-1 is produced by the L-cells of the small intestine in response to nutrient ingestion 
(41). GLP-1 enhances insulin secretion in response to an oral glucose load, known as the 
incretin effect, and is used in the treatment of T2DM. In addition to GLP-1’s effects on 
glucose homeostasis, it reduces feeding by acting on hedonic pathways and increases 
satiety by enhancing satiety signals conducted by the vagus nerve from stretch receptors 
in the stomach (42). In rodents, GLP-1 reduces feeding by decreasing gene expression of 
the orexigenic neurotransmitters NPY and AgRP in the arcuate nucleus during fasting 
(43). In humans, endogenous GLP-1 levels are associated with activation of hedonic 
reward pathways during fasting (44). Exogenous GLP-1 administration is associated with 
increased post-prandial satiety and decreased food intake and hunger (45).  
Peptide-YY 
Like GLP-1, PYY is also released from the L cells of the small intestine. Its active and 
most abundant metabolite, PYY 3-36 has been shown to be a regulator of food intake, 
producing both orexigenic and anorexigenic signals in mice when centrally administered. 
Despite this duality of function Pyy knockout mice exhibit decreased satiety and express 
an obese phenotype that was reversed by administration of PYY, suggesting a dominant 
role for PYY as a mediator of satiety (46). When infused in humans, PYY reduces caloric 
intake and increases satiety, changes that are associated with increased activity in the 
hedonic reward pathways in the brain (31). PYY levels are increased following bariatric 
surgery and may contribute to the beneficial weight loss seen following the procedure 






Insulin is secreted from the pancreas, primarily in response to glucose and sympathetic 
signals to the pancreas (49). Insulin has a direct effect on the POMC neurons of the 
arcuate nucleus of the hypothalamus stimulating appetite suppression, though its primary 
role is in glucose homeostasis rather than overall weight maintenance. Central nervous 
system administration of insulin acutely suppresses appetite (50). Insulin works in 
concert with other centrally acting regulators of energy intake. For example, central 
lesions that disrupt leptin signalling and insulin signalling produce greater metabolic 
derangements when they occur together compared with either individual lesions alone 
(51). In rat models, intracerebral insulin suppresses appetite and increases REE, though 
these results are limited by the non-physiologic route of insulin delivery (52), (53). In the 
human brain, insulin acts in the hypothalamus, prefrontal cortex and occipital regions 
(54). It is not yet clear how obesity alters the central activity of insulin, and what its 
overall effect on energy homeostasis might be.  
Glucose 
The other class of messengers emanating from the gastrointestinal tract are nutrients. 
Though this discussion is focused chiefly on energy homeostasis rather than lipid, 
glucose or protein homeostasis, there is evidence that nutrients may act directly to 
modulate aspects of energy metabolism. Arguably, given its critical role in brain 
metabolism glucose is amongst the best studied of these.  Ambient levels of glucose in 
the brain alter neuron firing rates in a positive, glucose excitatory, or negative, glucose-
inhibitory, fashion. Many anatomical regions critical to energy homeostasis contain these 
glucose sensing neurons, though it remains unclear what role glucose plays in central 
regulation of energy homeostasis (55). Glucose has also been shown to directly suppress 
appetite via the arcuate nucleus in rodent models though this finding has been 
contradicted by several studies (56), (57).  
 Adipose Tissue 
Adipose is both an energy storage tissue and a functionally active and adaptable 
endocrine tissue. Excess adiposity is the hallmark of obesity and is associated with an 





(FM) is associated with improvements in glycaemia. Adipose tissue may be white, brown 
or beige. Human fat stores are composed chiefly of white adipose tissue though depots 
of brown adipose tissue are present (58). The difference between these adipose tissue 
types is the quantity of uncoupling protein -1. Uncoupling protein-1 is a protein expressed 
on the inner mitochondrial membrane that “uncouples” substrate oxidation from ATP 
synthesis. Thus, rather than ATP production, energy is dissipated as heat (59, 60).  
White Adipose Tissue 
There is robust evidence for the role of white adipose tissue in energy homeostasis. 
Volumetrically white adipose tissue constitutes the majority of “fat mass”. Fat mass 
correlates with REE at weight neutrality, during weight loss, and overfeeding (61, 62). 
This is due to the metabolic activity of adipose tissue. Adipose tissue also secretes 
chemical messengers, ‘adipokines’, that act in an autocrine, paracrine or endocrine 
fashion (63). While over 600 adipokines have now been discovered, of these leptin and 
adiponectin have been the best described.  
Adiponectin is a 244-amino acid, 30 kDA protein secreted exclusively from adipose 
tissue. It was first discovered twenty years ago in mice and was soon isolated in human 
plasma (64), (65).  Adiponectin causes adipocyte differentiation in vivo, but it also 
regulates ectopic fat accumulation in the liver and beta oxidation of fatty acids in both 
skeletal muscle and liver (64), (66), (67). When injected intravenously adiponectin is 
detectable in cerebrospinal fluid. When injected into the ventricular cerebrospinal fluid 
of mice, adiponectin reduced weight in a dose-dependent manner over three to four days 
without altering energy intake. This suggests a central action of adiponectin on the 
regulation of energy expenditure (68). Adiponectin knockout mice models are unable to 
maintain their body temperature in cold environments, suggesting a central role in cold-
induced energy expenditure (69). Based chiefly on these animal models, adiponectin 
appears to be important in adipose-brain cross talk and energy expenditure regulation. 
Appropriately controlled studies in mice and humans will be needed to confirm these 
findings.  
Leptin, discovered in 1994, is the prototypic adipokine. The discovery of leptin was 





discovery of the melanocortin pathway and the characterisation of several leptin related 
disorders (70). Leptin is a 167-amino acid protein produced mainly by white adipose 
tissue. Its circulating levels reflect the size of individual adipocytes (71). Leptin binds to 
receptors located in several sites in the brain to regulate adiposity and weight gain. Leptin 
reduces appetite and feeding behaviour and increases in energy expenditure as a part of 
the leptin-melanocortin pathway (section1.2.1.1) (24). In studies of lean participants with 
low levels of leptin, the administration of leptin is effective in inducing satiety (72). 
Conversely, in the weight-stable obese, circulating levels of leptin are typically high and 
leptin administration is not effective (73, 74). This is thought to be due to the 
development of leptin resistance in the obese. Current approaches to leptin based 
treatments focus on the potential to enhance leptin sensitivity using a combination of 
leptin and a leptin sensitizer (75).  In the setting of weight loss, leptin may reduce 
adaptive thermogenesis normally seen in response to hypocaloric diets (76).  
Brown and Beige Adipose Tissue 
Brown adipose tissue was first discovered in non-human mammals and is important for 
adaptation to cold environments by facilitating heat production. In mice, control of brown 
and white adipose tissue thermogenesis is mediated by the sympathetic nervous system. 
This in turn is subject to regulation by the hypothalamus in response to hormones such 
as leptin, ghrelin, neuropeptide Y and insulin, forming a complete feedback loop (Fig. 
1.2) (77). Brown adipose tissue was identified in humans in 1986. Until recently it was 
thought to be important in non-shivering thermogenesis in infants, becoming inactive or 
vestigial by adulthood (78). In 2007, metabolically active brown adipose tissue depots 
were discovered in humans, and raised the possibility that brown adipose tissue may be 
important to energy homeostasis in adults (79).  
One of the chief arguments against a primary role of brown adipose tissue in energy 
homeostasis in human obesity is the very small volume of brown adipose tissue compared 
with total FM. In one study brown adipose tissue mass measured in five healthy 
individuals, were less than 67g (80). This represented less than 0.5% of total FM. 
Although brown adipose tissue is more metabolically active than white adipose tissue the 





Furthermore, in overfeeding studies in humans, brown adipose tissue was not activated 
again arguing against a primary role in energy homeostasis (82).  
Beige adipose tissue, which can be induced to become more “brown-like”, offers the 
possibility of a therapeutic role for ‘browning agents’ in the treatment of obesity (83, 84). 
These agents, could increase passive energy consumption by increasing metabolically 
active adipose tissue, thus facilitating weight loss. 
 The Thyroid Gland 
The thyroid gland produces the thyroid hormones tri-iodothyronine (T3) and thyroxine 
(T4) in response to signals from the hypothalamus, pituitary and the periphery. It has 
long been recognised that basal metabolic rate is elevated in conditions of thyroid 
hormone excess (85). By contrast the role of thyroid hormone in energy balance 
regulation of healthy individuals is a relatively recent finding. Though the precise 
mechanisms are unclear, thyroid hormone is thought to regulate REE by altering 
substrate availability and reducing the efficiency of heat generating oxidative 
phosphorylation in mitochondria. This results in greater oxygen consumption and heat 
energy generation and stimulates heat producing intracellular processes, such as calcium 
release, within skeletal muscle (86), (87, 88).  
1.2.2 Models of Energy Homeostasis: 
A detailed understanding of the biology of energy homeostasis, is useful in understanding 
obesity, the overlap between diabetes and obesity, potential mechanisms of action of 
obesity therapies and how energy balance is regulated. However, this decomposition of 
energy homeostasis into component parts is unwieldy for explaining scientific or clinical 
observations at the whole body or whole population level. Models of energy homeostasis 
provide a theoretical framework within which to consider the concept of energy balance. 
These models were developed from engineering models of complex control systems and 
are a prime example of how modelling can assist scientific enquiry (89).  
 Single Factor Set-point Models 
One of the most influential early models of energy homeostasis was the ‘lipostatic set-





indicating body ‘fatness’ was relayed to the hypothalamus and controlled dietary intake 
and thus body weight in a feedback loop. Kennedy’s model resembled several other 
single-factor set-point models that envisaged body weight and thus energy balance 
control systems as centred around a crucial physiologic parameter such as Mayer’s 
glucostatic model set-of food intake (91). Under this model, reductions in weight below 
a set-point trigger compensatory increase in energy intake and vice versa. One of the 
chief weaknesses of this hypothesis is its failure to account for environmental, social and 
psychological aspects of obesity (92),(93).  
 The Settling Point Hypothesis 
In the 1970’s, in response to these weaknesses, Wirtshafter and Davies proposed an 
alternative theory known as the ‘settling-point hypothesis’(92). This hypothesis provides 
a framework for explaining the effect of extrinsic factors on energy homeostasis. The 
settling point model proposes that weight proportionally affects energy intake. As dietary 
energy intake exceeds energy expenditure weight gain increases. It is this gain in weight 
that reduces energy intake by means of satiety signals initiated by feedback signals, such 
as leptin, from fat stores in the periphery. This proportional relationship between the 
controlled parameter, in this case weight, and energy intake, means the system eventually 
comes to a new equilibrium that compensates for the change in input to the system. In 
contrast to the set-point theory, the new settling point need not be the same as before. 
Thus, the model can account for changes in weight over time because of environmental 
influences, such as a change in food availability, that alter the equilibrium. This theory 
does not explain the role of known physiologic control systems on aspects of both energy 
intake and energy expenditure and this is one of its weaknesses.   
 The General Intake Model 
One objection to the set-point and settling point models is the assumption that all factors 
that alter energy homeostasis invoke a compensatory response to the perturbation. De 
Castro et al, 2002, argue that several factors relevant to energy balance, specifically to 
dietary energy intake, are not compensated for and thus are not reflected in these simpler 
models (94). Their assertion is based on detailed food diary records from twin studies 





the palatability of food, social facilitation of eating, and meal times (95). In response to 
the perceived shortcomings of these earlier models, Castro and Plunkett proposed the 
“general model of intake regulation”. The general intake model proposes that dietary 
intake is determined by a combination of genetically determined compensated and 
uncompensated factors, this latter being the main point of difference from the other 
models. The general nature of the model means it can be applied to any type of intake; 
fluid, macro or micronutrient etc, and the number of factors is not pre-specified. Each 
factor is given a weighting which affects intake and a weighting for how intake in turn 
affects the compensated factors. These weightings are presumed to vary individually 
based on heredity and can be experimentally determined. If there is a criticism of the 
application of the general intake model, it is that it is concerned chiefly with the question 
of dietary intake and ignores the role of energy expenditure except as a factor that may 
influence intake.  
 The Dual Set-Point Hypothesis 
A more flexible model is that of the ‘boundary model hypothesis’, also known as the 
‘dual set-point hypothesis’. This model was originally proposed by Herman and Janet in 
1984 and revisited by Speakman in 2007 (96). Briefly, they proposed that rather than a 
single set-point, body weight is regulated within certain “boundaries” with a lower 
boundary and an upper boundary. When body weight lies between these boundaries no 
compensatory mechanisms are active and body weight is primarily influenced by 
environmental factors and passive regulation as described in the settling point model. 
However, outside of these boundaries active regulation of energy intake and energy 
expenditure occurs to return body weight to a “normal” value. These boundaries may be 
differentially regulated, and demonstrate inter-individual variation (97),(93). 
There are several advantages to this hypothesis - it accounts for inter-individual variation 
in the width between upper and lower boundaries in keeping with a genetic predisposition 
to obesity (98). It also allows for differential regulation of an upper weight boundary and 
lower weight boundary which is consistent with far less vigorous defence against weight 
gain compared with weight loss and can thus explain weight gain over the life span (99), 
(62). It is also compatible with both environmental influence and physiological 





control loops that are centrally mediated. Finally, in contrast to the general intake model 
of energy expenditure, weight, and by implication energy balance, including both energy 
expenditure and energy intake, can be incorporated within the framework of the model.  
Thus, the dual set-point hypothesis provides the most useful framework when explaining 
observations about the aetiology of obesity in the context of the physiologic regulation 
of energy homeostasis. Were the regulation of energy expenditure completely 
understood, such a model would not be required. The model can be applied to adaptive 
thermogenesis, as a particular example of regulation of energy homeostasis that occurs 
during weight loss, which is itself incompletely understood.  
1.2.3 Adaptive Thermogenesis  
In its most general sense, adaptive thermogenesis refers to a compensatory change in 
energy expenditure in response to a change in some environmental factor (100). The term 
has been used to describe the increase in REE observed at colder temperatures or the 
change in physical activity related energy expenditure with imposed under- or over-
feeding. The previously described regulation of energy expenditure and models of energy 
homeostasis may apply just as readily to states of energy excess as they do to states of 
energy deficiency. However, as this thesis considers not just the problem of obesity, but 
interventions to treat obesity, the focus will be on energy homeostasis, and REE in 
particular, in the setting of imposed calorie restriction. In this context adaptive 
thermogenesis may be defined as: “the reduction in REE, beyond that which is expected 
for the change in body composition, occurring during a period of dietary energy 
restriction”. It is this definition that will be used from here on.  
In 1950 Ancel Keys published a landmark text in the field of nutrition. “The Biology of 
Human Starvation” is an account of semi-starvation experiments conducted from 1944-
1945. During the study 34 healthy male volunteers underwent 24 weeks of semi-
starvation and controlled re-feeding (101). Keys observed that during starvation, 
components of energy expenditure, REE, diet induced thermogenesis and physical 
activity energy expenditure, dropped to lower than predicted levels. This observation has 
been made in many subsequent studies.  Saltzman et al, 1995, reviewed studies of energy 





decrease in REE was greater than that predicted by the change in body composition, again 
supporting the existence of adaptive thermogenesis (102). Similarly, Prentice et al, 
performed a systematic review and meta-analysis of studies of adaptive thermogenesis 
published until 1991 (section 1.2.3.2.1) and estimated adaptive thermogenesis as an 
adaption of between 5-20% beyond that expected for the degree of weight loss (103). 
More recently Schwartz et al, 2010, performed a recent systematic review of changes in 
REE during weight loss in 90 publications involving 2977 participants, confirming the 
presence of adaptive thermogenesis in one of the largest systematic reviews on the topic 
(104).  
Despite having been widely studied, the assessment of adaptive thermogenesis can be 
challenging. The methodological requirements for assessing adaptive thermogenesis are 
discussed in detail in chapter 2 (section 2.3), and the characteristics of adaptive 
thermogenesis are presented in section 1.2.4.2. 
 The Purpose of Adaptive Thermogenesis 
Adaptive thermogenesis is regarded as an advantageous response to conditions of 
environmental deprivation. In animal studies, adaptive thermogenesis occurring during 
periods of food deprivation helps conserve energy stores and preserve life. A lower 
resting metabolic rate during periods of relative food scarcity can be viewed as a positive 
adaptation to an environmental threat, starvation (105). In humans, such a strategy, while 
relevant in conditions of variable food supply, is now less relevant in many parts of the 
world, where obesity rather than starvation is the main threat to health. Under these 
circumstances adaptive thermogenesis may be seen as a maladaptive trait (106).  
 Characterization of adaptive thermogenesis.  
Adaptive thermogenesis fits into the framework of the dual set-point hypothesis (section 
1.2.3.4) as the biological response that occurs when energy intake falls below a certain 
threshold. According to this hypothesis, the point at which adaptive thermogenesis occurs 
is likely to be genetically determined and variable between individuals. The tipping of 
energy balance from an uncompensated level beyond this point to a compensated level 
is driven by environmental or external influences. If these external factors persist, the 





Once alleviated, there is a gradual reversal of the adaptive mechanisms. The threshold 
for adaptive thermogenesis may be dynamic, i.e. not occurring at a fixed level of energy 
intake but because of the mismatch between energy intake and energy expenditure. 
This schema raises some questions in relation to adaptive thermogenesis, many of which 
remain unanswered. For example, what is the primary regulated parameter? I have used 
the term energy balance or homeostasis but what is the biological correlate of this 
concept? During a period of negative energy balance several physiological quantities 
change, all of which may be potentially subject to regulation; weight, FM, leptin, thyroid 
hormone, fat free mass (FFM), and substrate availability (107), (108), (109), (110), 
(111)). What determines the strength of the adaptive thermogenesis response? Does 
adaptive thermogenesis depend on the degree of weight lost, the change in body 
composition irrespective of weight lost, the degree of calorie deprivation, or the degree 
of energy imbalance? How much weight can be lost, and at what rate, before adaptive 
thermogenesis is triggered?  Finally, how is adaptive thermogenesis regulated during 
weight loss. 
Magnitude and Determinants of Adaptive Thermogenesis 
Rosenbaum et al, 2016, addressed some of these questions in a study of 17 obese 
individuals that underwent controlled underfeeding in an inpatient setting (108). Both 
total energy expenditure and REE were assessed after 10 and 20% weight loss from 
baseline weight. They found that the magnitude of the decline in REE, was proportional 
to weight loss. The decline in REE was greatest with the first 10% weight loss compared 
with the second 10%, providing evidence for a threshold phenomenon below which near-
maximal compensation started to occur and which was not greatly increased with 
additional weight loss in the 10-20% range. Adaptive thermogenesis was quantified as 
100 kJ per day at 10% weight loss. Finally, in this study the correlation between FM, and 
REE declined with weight loss but did not increase with weight gain. Apart from serving 
as an example of the usefulness of the dual set-point model as an inferential framework, 
Rosenbaum’s study adds considerably to quantifying several aspects of adaptive 
thermogenesis. The authors concluded that FM was a key predictor of REE but that the 





Prentice et al, 1991, performed a systematic review and meta-analysis of 29 studies of 
calorie restricted diets on metabolism up to 1991 (103). As outlined in section 1.2.3, 
adaptive thermogenesis was estimated to be an additional 5-20% reduction in REE 
beyond that expected for the degree of weight loss. Adaptive thermogenesis greater than 
20% occurred only in the context of “massive” weight loss.  There was a negative 
exponential relationship between the reduction in resting metabolic rate and percentage 
weight loss with most of the change occurring by 10% weight loss.  
Further supporting the observation that adaptive thermogenesis is proportional to weight 
loss and is near maximal at approximately 10% baseline body weight loss, Siervo et al, 
2015, found that the degree of adaptive thermogenesis was related to the rate of weight 
lost and that the severity of the diet prescription; either a six-day fast or very low-calorie 
diet. A more modest calorie reduction did not make a difference to the magnitude of 
adaptation observed. In this study adaptive thermogenesis was 7.7%. The degree of 
adaptation was related to the rate of weight loss only up until 10% of baseline weight but 
not beyond this, when the degree of adaptation plateaued (112). Knuth et al, 2014, also 
observed a proportional relationship between the rate of weight lost and the magnitude 
of adaptive thermogenesis (107).  
Schwartz et al, 2010, proposed that the reduction in REE was directly proportional to the 
degree of weight lost and, by pooling estimates from 900 studies, estimated an average 
reduction in REE of approximately -64.4 kJ/kg of weight lost. In addition, they found 
that adaptive thermogenesis was likely to be greater with interventions of less than 6 
weeks, -117 kJ/kg of weight lost, compared with those greater than 6 weeks, -54 kJ/kg 
of weight lost. 
Mechanisms of Adaptive Thermogenesis 
Tremblay et al, 1997, in a study of energy expenditure and body composition changes 
during underfeeding in monozygotic twin pairs, found a strong intrapair correlation in 
changes in REE after adjustment for body composition (113). REE was 9% lower than 
expected in the first half of the study and this decreased to 65% during the second half 
of the study, suggesting the attainment of a threshold level for adaptive thermogenesis 





noradrenaline levels with weight reduction of 5 kg, that showed a strong intrapair 
correlation (correlation coefficient 0.75). Weight loss in this study was almost entirely 
FM due to the exercise training protocol, there was no increase in lean mass. This study 
provides strong evidence for a genetically determined mechanism for adaptive 
thermogenesis, which may be mediated by sympathetic nervous system and thyroid 
hormone activity. It also suggests that loss of FM alone is sufficient to induce adaptive 
thermogenesis.  
In one of the earlier studies to investigate the mechanism by which weight loss may cause 
a reduction in REE, Bray studied glycerol-phosphate dehydrogenase levels in 
subcutaneous fat in addition to REE in fourteen obese subjects undergoing weight loss. 
Subjects lost a mean 6.8% of body weight over one week on a calorie restricted diet 
(114). A reduction in REE of 15%, beyond that expected for weight loss was observed 
and glycerol phosphate dehydrogenase in subcutaneous adipose tissue decreased with 
weight loss. Glycerol phosphate dehydrogenase is a key enzyme in the provision of 
substrates for aerobic metabolism in the adipocyte. The reduction in glycerol phosphate 
observed in this study suggests regulation of enzymes involved in carbohydrate or lipid 
metabolism in the cell may be a means of regulating REE during conditions of energy 
deficiency. 
In their systematic review, Prentice et al, 1991, a negative correlation between T3 and 
adaptive thermogenesis was noted, with a reduction in T3 of up to 70% of pre-dieting 
levels. This suggests that a reduction in T3 is associated with adaptive thermogenesis 
(103).  
A study of adaptive thermogenesis in severely obese participants in the “The Biggest 
Loser Competition”, identified a correlation between leptin, tri-iodothyronine and 
metabolic adaptation during weight loss of an average 35% baseline weight (107). This 
has also been documented during smaller bouts of weight loss of approximately 10% 
baseline body weight (115).  
The duration of adaptive thermogenesis 
The duration of adaptive thermogenesis likely relates to an ongoing state of weight loss. 





free living individuals with a dietary calorie restriction of 25% from estimated baseline 
requirements. Other authors have confirmed adaptive thermogenesis persists out to seven 
months if there continues to be weight loss (107, 116).  
By contrast, entering a phase of weight stability attenuates adaptive thermogenesis (117). 
Leibel et al, 1995, and Rosenbaum et al, 2000, performed a unique study of over and 
underfeeding in obese with non-obese men and women. Dynamic phases of weight 
change were interspersed with weight stabilisation periods over 16 months. During 
underfeeding to 90% of initial weight, a reduction in urine catecholamines, T3, and REE 
were identified (109, 117). The changes in REE, catecholamines and T3 were greater 
when measured during the dynamic phase of weight loss, compared to at the end of the 
eight-week weight-stabilisation period that followed weight loss. This suggests that 
measurements of REE or hormones relevant to adaptive thermogenesis are more sensitive 
if performed at the end of the dynamic phase of weight loss. 
 Is Dietary Intake the Primary Triggering Factor for Adaptive Thermogenesis 
Parameter 
It is still not clear what triggers the onset of adaptive thermogenesis. The weight loss 
studies that investigate adaptive thermogenesis all induce a negative calorie balance at 
the outset. Adaptive thermogenesis resolves after this negative calorie balance is 
removed. This raises the question whether it is the diet, or the consequences of the diet 
that trigger adaptive thermogenesis. The correlation between FM and leptin with adaptive 
thermogenesis is an example of the latter (108). However, diet, whether hypocaloric or 
isocaloric, is itself a potent physiologic stimulus. The ingestion of food is accompanied 
by activation of the autonomic nervous system, the release of hormones such as insulin 
and GLP-1, activation of brain centres resulting in food reward, diminution of hunger, 
and an increase in satiety.  It would be advantageous for adaptive response to a calorie 
deficit to trigger early, considering its obvious importance to survival. Dietary energy 
intake varies from hour to hour and day to day and so is subject to regulation on a shorter 






One way to investigate whether dietary energy intake triggers adaptive thermogenesis is 
to alter the schedule of calorie restriction without altering its overall magnitude. The use 
of different schedules of calorie restriction to investigate adaptive thermogenesis is the 
construct that forms the basis of the final study in this thesis, towards which the initial 
studies and chapters build.  A handful of studies to date have studied differences in 
adaptive thermogenesis with different schedules of energy intake. These are discussed in 
section 1.6.3.4.  
1.3 The Aetiology of Obesity  
The World Health Organisation has defined obesity as a body mass index (BMI), a 
person’s weight in kg divided by their height in metres squared, of 30 kg/m2 and above, 
and overweight as a BMI between 25 kg/m2 and 30kg/ m2 (118). BMI provides an easily 
measured clinical marker of excess weight, the physiologic hallmark of obesity, and is 
thus a useful screening tool. However, it does have limitations both as a complete 
definition of obesity and as a predictor of body composition in diverse ethnicities. 
Ethnicity specific BMI cut-offs may be a more appropriate indicator of cardiometabolic 
risk, were there sufficient evidence upon which to base new cut-offs (119). There is 
evidence to support the use of different BMI cut-offs to indicate body composition in NZ 
Māori & Pacific populations. However, at present there is not sufficient evidence to 
support the use of different BMI cut-offs to indicate cardiovascular risk, or other 
clinically meaningful complications of obesity, in NZ Māori & Pacific populations.   The 
diagnosis of obesity as a disease implies a greater risk of morbidity compared with the 
non-obese. However, measures of central or abdominal weight distribution such as waist 
to height ratio or hip to waist ratio are better predictors of obesity related complications 
such as diabetes, hypertension, dyslipidaemia and coronary heart disease (120, 121). This 
likely relates to the pathophysiology of metabolic complications of obesity. Sperrin et al, 
2014, propose an alternate definition of obesity as an increase in FM sufficient to 
adversely affect health, reflecting the fact that not all those who have an elevated BMI 
have obesity related illnesses, and that FM rather than FFM is associated with the 
metabolic complications of obesity (122). Having considered the physiology of energy 





1.3.1 The Genetics of Obesity 
 The Thrifty Gene and Drifty Gene Hypotheses of Obesity 
The evidence of a genetic basis for obesity is in keeping with current evolutionary 
perspectives on the emergence of obesity as one of today’s greatest epidemics. In 1962 
Neel originally proposed his ‘thrifty gene’ hypothesis to account for, not just obesity, but 
the increase in rates of T2DM that were noticed at the time (106). This hypothesis 
suggested that we evolved to store energy, as it was evolutionarily advantageous at times 
of privation. However, in the 20th century access to energy-dense food meant this was no 
longer the case and the trait became maladaptive. An alternative view is that of 
Speakman’s “drifty gene hypothesis”. Speakman argues that the thrifty gene hypothesis 
has several weaknesses’; the relatively low risk of famine, the low likelihood that famine 
would have a major impact on a population’s reproductive potential, the fact that 
contemporary hunter gatherers, such as the Namibian !Kung San, Cameroonian Pygmie 
and Australian Aborigine, do not become obese during periods of relative dietary excess 
and the partial prevalence of obesity in contemporary societies where food availability is 
ubiquitous (123). The alternative ‘drifty gene’ hypothesis is based on a theory of 
‘predation release’. This suggests that when our ancestors were subject to predation, 
obese phenotypes were at risk and selected out. With the removal of this threat, random 
genetic mutations have occurred over the millennia that predispose to obesity. These 
mutations would only result in an obese phenotype in a food abundant environment. The 
accumulation of several genetic mutations over time would explain a polygenetic 
predisposition that is present in only a proportion of the population (96). The drifty gene 
hypothesis is not incompatible with a genetically determined thrifty phenotype - any 
mutation that confers an increased risk of obesity can be incorporated into the hypothesis. 
However, it does provide a more plausible explanation for the emergence over multiple 
generations of such mutations. 
 Evidence from Monogenic Obesity Syndromes  
Until recently, evidence in favour of a genetic predisposition to obesity came largely 
from monogenic forms of obesity. Monogenic obesity syndromes are rare however, 





(124). Nonetheless, the syndromes reveal crucial pathways in the regulation of energy 
expenditure and the development of obesity. To date there have been 20-30 monogenic 
obesity syndromes described (125). These involve mutations that affect leptin, 
melanocortin, pro-hormone convertase and POMC signalling as part of the leptin central 
melanocortin pathway (24).  
 Evidence from Genome Wide Association Studies 
In contrast to the rare monogenic forms of obesity, heritability estimates from twin and 
sibling cohorts place the inherited predisposition to obesity at approximately 66% (126). 
Genome wide association studies (GWAS) enable whole-genome analysis for 
phenotype-genotype associations. In the last decade, over 50 gene loci have been 
identified in association with obese phenotypes (127). Two of the most significant 
findings from GWAS are that of the FTO and CREBRF genetic polymorphisms. While 
the function of the FTO gene is unclear, it is expressed in high concentrations in brain, 
as are many of the genetic polymorphisms implicated in obesity (98). Since its discovery 
in 2007, FTO has been studied in several ethnically diverse populations. Differences in 
the strength of the association with obesity in these groups are associated with different 
polymorphisms. FTO appears to be associated with increased dietary intake as its primary 
mechanism and is not associated with changes in physical activity, though how this effect 
is mediated is unclear (128). Polymorphisms of the FTO gene are common, with 43% of 
European populations carrying one risk allele and 20% carrying two. These FTO 
polymorphisms are the most prevalent globally and account for about 0.39% of the 
variance in BMI in European populations (129). This discrepancy between heritability 
estimates and variance explained by polymorphisms identified using GWAS is possibly 
explained by complex gene-environment interactions that are not identified by GWAS, 
or rare polymorphisms that have a large impact on heritability, as GWAS only identifies 
common polymorphisms associated with a common phenotype (126).  
By contrast, the CREBRF polymorphism rs373863828, discovered in 2016, is rare 
globally but has a high prevalence in Samoan populations. This polymorphism is 
important because of its phenotypic impact and putative functional role. In those that 
have the polymorphism, it accounts for 1.01-1.93% of the variance in BMI in the 





date. CREBRF polymorphisms in a mouse model increased fat accumulation and reduced 
energy utilization in adipocytes compared with the wild-type protein (130). Other loci 
identified by GWAS are located downstream from the melanocortin 4 receptor gene and 
others yet are associated with genes known to be expressed in the central nervous system 
(127). 
 Evidence from Epigenetic Studies 
Epigenetics describes the study of heritable changes in gene expression that are not due 
to changes in DNA sequence (131). Gene expression can be changed by the addition or 
removal of small carbon and hydrogen molecules, a process known as epigenetic 
regulation. For example, the addition of a methyl molecule, methylation, or removal of 
an acetyl molecule, de-acetylation, alters the epigenetic “marks” on DNA. Depending on 
the location of the mark, gene expression may be increased or decreased. Epigenetic 
marks have also been identified on histones, proteins that affect DNA’s folding structure 
and thus its accessibility to the cellular transcriptional machinery (132). In contrast to 
DNA, epigenetic modifications may vary over the life course, are altered by early life 
events and interventions for obesity, and may have a tissue specific distribution (127). 
This can make them challenging to study as epigenetic modification in prospective or 
cross-sectional studies, may be affected by events occurring many years earlier.  
Epigenetic studies can adopt a hypothesis-driven target gene approach, or a broader 
‘epigenome’ wide approach. The target or ‘candidate’ gene approach has identified 
methylation of the leptin gene (LEP) and pro-opiomelanocortin gene (POMC) in whole 
blood and PPAR coactivator 1 alpha (PGC1-α) in muscle (133),(134).  PPAR 
coactivator 1-alpha is involved in cellular respiration and increasing mitochondrial 
oxidative capacity. It has also been implicated in the development of T2DM (135, 136).  
The genome wide, ‘epigenome’ approach examines changes in whole genome 
methylation in several different regions that have been recently reviewed (24, 127, 137). 
Several thousand methylation sites may be identified in even one such study involving 
regions implicated in obesity, cellular metabolism, inflammation or indeed with no 





intervention have been conducted that similarly demonstrated epigenetic regulation 
occurring at multiple functionally diverse sites.  
The interpretation of such results is challenging. For any given epigenetic site, the normal 
variance must be known, so that the observed variance before and after an intervention 
can be interpreted. When an epigenetic modification is deemed significant, it is often not 
possible to demonstrate causality. Furthermore, interpreting the physiologic significance 
of tissue specific epigenetic regulation can be difficult. These significant challenges in 
the appropriate interpretation of epigenetic investigations notwithstanding, they remain 
a useful tool to supplement clinical intervention studies, develop novel hypotheses and 
identify new potential candidate genes in the pathogenesis of obesity.  
Taken together, monogenic forms of obesity and epigenetic studies support the 
importance of central regulation of energy homeostasis in the aetiology of obesity. A 
genetically determined predisposition to obesity is consistent with the dual threshold 
model of energy homeostasis, with lower thresholds for compensation of positive energy 
balance in individuals exhibiting an obesity related polymorphism. Finally, with only 
approximately 2% of variance currently explained by the most common single gene 
polymorphism, obesity is not just polygenetic, it is a multifactorial, environmentally 
determined phenotype in individuals with complex genetic predisposition.  
1.3.2 The Role of Environment 
Human society has changed significantly over the past 50 years. Some of these changes 
include; a switch from recreational activity to more sedentary pursuits, the availability of 
technology in the home, limited pedestrian and cycling access in cities and the food 
environment (138, Cooper, 2000 #39).  
An individual’s food environment refers to the available food that affects their diet and 
the systems and infrastructure through which they may obtain food. As society has 
changed, so have local food environments with; increased availability of cheap palatable 
energy dense foods such as sugar sweetened beverages, reduced access to healthy foods, 
the increased availability of low quality food near schools, changes in the cultural 





compounded by the increased availability of technology in the home (139), (140), (141), 
(142, 143).  
The impact of the environment on weight regulation can be considered as provoking or 
facilitating excess energy intake, or reducing energy expenditure rather than directly 
affecting the regulation of energy homeostasis per se. Therefore, while environmental 
influences are important to population levels of obesity, they don’t contribute to our 
understanding of energy homeostasis in the individual, which is the focus of this thesis.  
1.4 T2DM and Obesity as Overlapping Diseases  
Type 2 diabetes mellitus, is strongly associated with obesity. It is characterised by insulin 
resistance and relative insulin deficiency. Like obesity, it has a strong but incompletely 
understood genetic basis, possibly indicative of a heterogenous group of conditions 
resulting in a single common phenotype (144). Both conditions share similar 
predisposing factors; energy dense food, caloric excess and sedentary behaviour, though 
not all obese individuals will develop T2DM. It is not surprising that the rise in global 
obesity has been paralleled by a rise in global rates of type 2 diabetes over the past 30 
years (3 ) There is strong evidence that low-calorie diets and bariatric surgery are 
successful treatments for both conditions. To understand how we may leverage the 
benefits of bariatric surgery it is useful to consider the following questions: What are the 
core features of T2DM and why does it occur with obesity? What is ‘remission’ of 
T2DM, how does it occur? Finally, how can the beneficial effects of bariatric surgery be 
translated into effective scalable treatments for T2DM?  
1.5 Aetiology of Type 2 Diabetes in the Setting of Obesity  
1.5.1 A brief overview of normal glucose homeostasis  
The primary goal of glucose homeostasis is the provision of a steady supply of glucose 
to the tissues during both fed and fasting state. During the fasting state, blood glucose 
levels are largely maintained by a combination of hepatic (80%) and renal (20%) glucose 
production which is matched to whole body glucose uptake, resulting in a steady state 
concentration of blood glucose (145). Glucose production is achieved through 





production from precursors such as amino acids, lactate, pyruvate and glycerol, 
accounting for approximately the remaining (50%). Fasting gluconeogenesis is regulated 
by circulating glucose, insulin, substrate availability, and non-esterified free fatty acids 
produced during white adipose tissue lipolysis. These fatty acids are an indirect 
mechanism by which insulin can regulate endogenous glucose production during the 
fasted state. A fall in insulin promotes white adipose tissue lipolysis increasing glycerol 
availability and free fatty acids which in turn increase gluconeogenesis in a pyruvate 
carboxylase-dependent pathway (146, 147). In the fasted state the brain accounts for most 
glucose utilization followed by skeletal muscle, liver, the kidney, gut and heart (148).  
In the fed state, a rise in serum glucose promotes insulin release from pancreatic beta 
cells, which alters both glucose disposal and gluconeogenesis.  The first phase insulin 
response is the early response to glucose stimulation that occurs within minutes. The first 
phase response is impaired early in the course of T2DM and is thought to be related to a 
reduction in the readily releasable pool of insulin from pancreatic beta cells (149), (150). 
There is a net suppression of hepatic gluconeogenesis by approximately 80% as insulin 
suppresses adipose tissue lipolysis, and thus free fatty acid mediated gluconeogenesis, 
and promotes glucose storage in the form of glycogen (151). Insulin also promotes 
increased glucose uptake in the insulin sensitive muscle, heart and adipose tissues (148). 
The muscle is particularly good at increasing glucose uptake in response to insulin with 
an eight-fold increase over basal rates during insulin exposure (152).  
1.5.2 The Aetiology of T2DM 
While there still exists debate about the precise evolution of T2DM, epidemiological 
studies suggest that, despite large heritability estimates for the inheritance of T2DM, 
lifestyle factors, especially excess dietary energy intake and poor-quality diet have a large 
effect on the aetiology of T2DM (153).  
Molecular studies in animals and humans have characterised T2DM as a multi-organ 
disease with self-perpetuating deficits in nutrient handling. Hepatic, skeletal muscle, 
pancreatic, and adipose tissue insulin resistance have all been clearly documented in 
T2DM. The mechanistic basis for each of these observations is different and, in some 





excess lipid deposition and mitochondrial dysfunction which in turn lead to a cycle of 
worsening insulin resistance (154-159).  
Insulin resistance in the liver appears to be mediated by the accumulation of 
diacylglycerol. This causes translocation of activated protein kinase Cɛ, to the hepatocyte 
membrane where it phosphorylates and thus inactivates the insulin receptor (155, 156). 
The accumulation of diacylglycerol in liver and muscle can be induced in animals in 
response to lipid infusion and in humans in response to both lipid infusion and a 
hypercaloric diet. In obese individuals with fatty liver, intracellular diacylglycerol is 
associated with hepatic insulin resistance. Similarly, intracytosolic diacylglycerol in 
skeletal muscle impairs glucose oxidation, glycogen synthesis and whole-body glucose 
disposal (157), (158), (154). In mouse models of diabetes, the development of diabetes 
is preceded by a progressive rise in free fatty acids, pancreatic lipid deposition and 
impaired glucose-stimulated insulin secretion (160). Accumulation of long chain fatty 
acids within the pancreatic beta cell; increases reactive oxygen species production, 
depletes intracellular calcium and triggers cell death (161-163). Gastaldelli et al, 2017, 
have examined the development of altered metabolism in the adipocyte with the onset of 
impaired glucose homeostasis and found a correlation between circulating free fatty acids 
and adipocyte insulin resistance (164). Fatty acid handling is altered in adipocytes in 
obese individuals, a phenomenon which is worsened by insulin resistance. Oxidation of 
fatty acids is downregulated, uptake of fatty acids by the adipocyte is impaired and 
lipolysis of storage forms of free fatty acids is increased. This is exacerbated by insulin 
resistance and leads to an increase in plasma free fatty acids which are taken up by the 
pancreas, liver and skeletal muscle (159).   
Taken together, this suggests a role for intracellular lipid accumulation in non-adipose 
tissues during a state of energy excess as one of the key pathogenic events in the 
development of T2DM. Impaired storage of lipid in adipocytes and ectopic fat deposition 
in three of the main organs involved in glucose homeostasis leads to worsening insulin 
resistance and greater dysfunction of lipid handling in an ever-worsening cycle. Frayn 
proposed excess lipid deposition in non-adipose tissues as a key factor in the 
development of insulin resistance due to saturation of the storage capacity of adipocytes 





hypothesis outlines the mechanisms by which a state of calorie excess leads to the 
development of T2DM (166). As adiposity and whole-body insulin resistance increase, 
blood glucose levels rise. Excess glucose taken up by the liver is converted to lipids 
which are either stored in the liver, further impairing insulin sensitivity, or exported to 
the peripheral circulation where they contribute to intrapancreatic lipid accumulation. 
Increased intrapancreatic lipid impairs the beta cell response to glucose ingestion thus 
worsening post-prandial glycaemia and further adding to de novo lipogenesis in the liver. 
This hypothesis fits well with the cellular model of T2DM as a disease of disordered fatty 
acid metabolism leading to progressive multi-organ insulin resistance in response to 
maladaptive fatty acid oxidation and trafficking. 
Additional evidence at the organ level for the Twin Cycle hypothesis comes from studies 
of weight loss with low-calorie diet or bariatric surgery. Reversal of dysglycaemia has 
been associated with a reduction in intrapancreatic and intrahepatic fat content visualised 
by MRI (167), (168). During an eight-week dietary weight-loss program in participants 
with diabetes, the first phase insulin response (section 1.5.1) to a glucose infusion 
normalised to those of the control participants without diabetes. This was associated with 
a reduction in intrapancreatic triglycerides (167). The observation that intrapancreatic fat 
decreases with weight loss, is specific to T2DM, and not simply a reflection of decreases 
in whole body fat generally. Obese T2DM participants who underwent bariatric surgery 
again demonstrated a reduction intrapancreatic fat with improvements in glucose 
homeostasis, that was not observed in non-diabetic controls who also underweight 
bariatric surgery with comparable weight loss (168). These studies provide evidence that 
specific deficits of glucose-stimulated insulin secretion and insulin-mediated suppression 
of hepatic gluconeogenesis are associated with ectopic fat deposition in the pancreas and 
liver respectively. They also illustrate the mechanism by which low calorie interventions 
may be used to improve T2DM.  
1.6 Treatment of Obesity and Diabetes   
The rise in prevalence of obesity and T2DM over the past few decades is testament to 
the limited efficacy of efforts to prevent and treat obesity and its complications (3). 





established. Nevertheless, for the 33% of New Zealanders with established obesity, and 
for the 5% of New Zealanders with T2DM, weight loss represents the main way of 
reducing morbidity and extending life (4),(3). 
Treatment of obesity amounts to induction of a sustained negative energy balance and 
thus weight loss. This can be induced pharmacologically, surgically or by means of a 
dietary intervention. The range of past and current pharmacotherapies and dietary 
therapies for weight loss is beyond the scope of this thesis. What follows is an overview 
of the two treatments for obesity that induce diabetes remission, bariatric surgery and 
calorie restriction, and a discussion of their possible mechanisms of action.  
Bariatric surgery and very low-calorie diet (VLCD) interventions can produce substantial 
reductions in weight and improvements in glycaemia. This is in marked contrast to 
pharmacological treatments for T2DM which at best produce mild weight loss and at 
worst induce further weight gain (169). Studying how these treatments work, how they 
can be optimized and how they integrate with our current understanding of existing 
models of obesity and T2DM is a critical step in advancing treatments for obesity and 
diabetes.  
1.6.1 The Surgical Treatment of Obesity: Bariatric Surgery 
In 1967, Edward Mason proposed a gastric bypass procedure for the treatment of obesity. 
Surgeries which have the primary intention of promoting weight loss, are termed 
‘bariatric’ surgery (170). Nowadays, the most commonly performed bariatric procedures 
can be grouped as purely restrictive: laparoscopic gastric banding (LGB) and 
laparoscopic sleeve gastrectomy (LSG), or malabsorptive: roux-en-y gastric bypass 
(RYGB) and biliopancreatic diversion (BPD) (Fig. 1.3)(171, 172). The anatomical and 
functional distinction between the procedures is relevant to the difference in efficacy and 










Banding procedures involve placement of an inflatable adjustable band that encircles the 
stomach, thus restricting passage of food through the stomach by external 
compression(Fig 1.3, panel A). A sleeve gastrectomy is usually done laparoscopically 
(LSG) and involves surgical closure of most of the stomach volume to leave a low 
Figure 1.3: Common Bariatric Surgery Procedures 
A) Gastric banding, B) Sleeve gastrectomy, C) Roux-en-Y gastric bypass 





volume vertical sleeve(Fig 1.3, panel B). The vertical banded gastroplasty (VBG) 
involves closure of the stomach with vertical anastomosis, like LSG, followed by 
placement of a cuff around the residual patent portion of the stomach. Malabsorptive 
procedures involve anastomosing the small bowel directly to the proximal stomach to 
bypass the distal stomach and proximal small bowel. The Roux-en-y gastric bypass 
procedure (Fig 1.3, panel C), and biliopancreatic diversion (Fig 1.3, panel D) are the two 
most commonly performed malabsorptive procedures. The duodenal switch procedure is 
a variation on BPD that involves anastomosing the first portion of the duodenum to the 
distal small bowel.  
In 1995 Walter Pories reported the normalisation of blood glucose in a cohort of 271 
patients with either T2DM or impaired glucose tolerance following bariatric surgery 
(173). Though the effect of bariatric surgery on glucose homeostasis had been recognised 
much earlier, Pories’ paper was considered a landmark and stimulated research into 
mechanisms of diabetes remission following bariatric surgery (174). Modern bariatric 
surgery is now regarded as the single most effective treatment for both obesity and T2DM 
(175, 176). Weight loss and diabetes outcomes following either RYGB or LSG, surpass 
intensive medical management up to five years post-operatively (177, 178).  
Bariatric procedures differ in their weight loss outcomes, the occurrence of side effects, 
their ability to improve glucose homeostasis and the degree of malabsorption (1, 171, 
172, 179).  These differences have informed the investigation of the underlying causes 
of diabetes remission. Comparisons between surgery types have identified which 
procedures are most effective at inducing weight loss and effecting diabetes remission 
(Table 1.1). To facilitate comparison between different bariatric procedures with respect 
to weight loss and diabetes outcomes, there has been a move to separating effects from 
different types of surgeries, standardising a definition of diabetes remission following 
bariatric surgery and to consider the impact of different surgical techniques for a given 







1.6.2 Bariatric Models of Diabetes Remission 
The definitions of diabetes remission endorsed by the American Diabetes Association 
are:  
“Partial remission is sub-diabetic hyperglycaemia (A1C not diagnostic of 
diabetes [<6.5%], fasting glucose, fasting glucose 100-125mg/dl [5.6-6.9 
mmol/l] or at least one year’s duration in the absence of active 
pharmacologic therapy or ongoing procedures.  
Complete remission is a return to “normal” measures of glucose 
metabolism (A1C in the normal range, fasting glucose <100mg/dl [5.6 
mmol/l] of at least 1 year’s duration in the absence of active pharmacologic 









%EBWL 55.9 46.2 55.5 59.7 63.6 
%Remission 
Overall 
78.1 56.7 79.7 80.3 95.1 
%Remission 
< 2 years 
80.3 55.0 81.4 81.6 94.0 
%Remission 
> 2 years 
74.6 58.3 77.5 70.9 95.9 
Table 1.1. Weight loss and diabetes resolution following bariatric surgery (1).  
 
% EBWL: Percent excess body weight loss; BPD: Biliopancreatic diversion; DS: 






A comparison of diabetes remission rates between bariatric procedures have been 
documented in several large meta-analyses (172), (182), (1). Limitations of these meta-
analyses include; the inclusion of heterogeneous studies - particularly with respect to 
different definitions of remission, the paucity of RCTs, relatively few head-to-head 
studies comparing treatments, incomplete reporting of the ascertainment of diabetes 
status and incomplete descriptions of diabetes outcome assessments(182, 183). 
Nonetheless, they provide a useful insight into the prevalence of diabetes remission 
following different surgery types. 
Diabetes remission occurs most commonly following biliopancreatic diversion with 
duodenal switch, followed by, gastric bypass (80.3%), and gastric banding (56.7%) 
(Table 1.1). The likelihood of long-term remission correlates with the degree of weight 
loss (1). Other than weight loss, predictors of remission include: young age, absence of 
insulin use, the surgery type and good glycaemic control (184),(25) ,(185) ,(186). Apart 
from differences in the incidence of remission following different surgery, the 
components of glucose homeostasis that improve as well as the timing and magnitude of 
these changes vary between RYGB, BPD, VSG and LGB (187).  
Within the first week following RYGB, before any significant weight loss, fasting plasma 
glucose, endogenous hepatic glucose production and fasting serum insulin decrease, and 
fasting insulin clearance and hepatic insulin sensitivity increase compared with 
preoperative levels. By three months these changes have progressed and continue to do 
so out to one year with ongoing weight loss (188). There are conflicting data in relation 
to improvements in insulin secretion following RYGB. After RYGB, some studies 
indicating no improvement in first phase insulin response within the first four weeks 
while others report the opposite (189), (190), (191, 192).  
Within four weeks following BPD, reductions in fasting plasma glucose and 
improvements in oral but not intravenous glucose tolerance are seen (193). In one study, 
BPD was associated with improvements in glucose disposal, post-prandial glucose and 
insulin resistance by as early as day three post-operatively (194).  
LSG is also associated with reductions in fasting plasma glucose and oral glucose 





improve within five days, though this has not been replicated in all studies (195). 
Improvements in insulin secretion following an intravenous glucose load has been 
reported following LSG within 72 hours (196). However, the method used for assessing 
this, plasma insulin concentration in response to an intravenous glucose load, is not a 
direct measure of assessing pancreatic beta cell function as it is a product of both insulin 
secretion and insulin clearance by the liver, which is altered in individuals with T2DM 
(197). 
 In one of the few studies where LGB’s effects on glucose and insulin levels in the 
immediate post-operative period were assessed, no significant decrease in fasting glucose 
was observed and none of the patients achieved diabetes remission (198). This study was 
chiefly limited by a very small sample size for the LGB group. By one year following 
LGB hepatic insulin sensitivity, measured by the surrogate marker HOMA-IR, improves 
modestly, though not back to a normal value (199, 200). 
Together these data illustrate a common theme: early improvements in fasting glucose 
because of decreased endogenous hepatic glucose production and increased hepatic 
insulin sensitivity with resulting lowering of fasting glucose and insulin.  There are also 
improvements in oral glucose tolerance following bypass procedures and VSG thought 
to be due to the incretin effect, particularly that of GLP-1 (201). There is no evidence 
that this occurs following LGB.  
Efforts to explain the improvements in glucose homeostasis following bariatric surgery 
have focussed chiefly on four models; calorie restriction, alteration in gut peptides, 
alterations in gut microbiota and changes in bile acid metabolism (168), (202), (203), 
(204), (205), (206).  
 Calorie Restriction Improves Glucose Homeostasis Following Bariatric 
Surgery.  
VLCD Prior to Bariatric Surgery 
A low-calorie diet is simply the habitual intake of an energy content lower than the 
requirements of the individual. Very low-calorie diets (VLCD’s) have been defined by 





providing fewer than 3350 kJ/day (207). Still more restrictive, are ‘complete’ fasts, such 
as religious fasting that involves a total abstinence from food for a specified period.   
Calorie restriction occurring in the setting of bariatric surgery usually begins pre-
operatively with a VLCD (208), (209, 210). This is advocated to reduce liver volume 
prior to the procedure. A recent systematic review of pre-operative VLCDs highlights 
the variation in calorie content, macronutrient composition and duration (211). Despite 
this heterogeneity VLCD consistently reduces liver size, due to a reduction in liver fat 
content, water and glycogen (167, 212). 
The Contribution of VLCD to Improvements in Glucose Homeostasis 
When considering the cause of diabetes remission with VLCD alone versus bariatric 
surgery, the preoperative VLCD is a significant confounding variable. To what extent is 
the post-operative improvement in glycaemia attributable to the pre-operative 
intervention? The argument that glycaemia improves prior to significant weight loss post-
operatively is worth considering. The inherent assumption is that weight lost, as distinct 
from the induction of a negative calorie balance, is primarily responsible for 
improvements in glycaemia seen with VLCD. VLCD induces approximately 4-5kg 
weight loss over two weeks (213, 214). This degree of weight loss, in patients with 
diabetes, is sufficient to normalise fasting plasma glucose, restore hepatic insulin 
sensitivity to those of non-diabetic controls, reduce hepatic triglyceride content by 30%, 
reduce plasma triglycerides by 50% and decrease insulin secretion by 40% all within the 
first week (167). Thus, by post-operative day one, if a perioperative VLCD has been 
employed, the patient has already experienced an intervention associated with clinically 
relevant improvements in glucose homeostasis.  
Improvements in glucose homeostasis can be accounted for by the effect of 
calorie restriction: The evidence in favour.  
In many studies GLP-1 secretion (section 1.2.1.2.2), measured at four days, one or three 
weeks post-op is clearly increased with RYGB compared with VLCD (168, 202, 215, 
216). Despite the rise in GLP-1 with RYGB, many studies have failed to demonstrate a 
clinically meaningful difference in post-prandial glucose concentration compared with 





to failure to match calorie intake between the VLCD and post-RYGB days.  In a more 
recent study, Pop et al, 2018, addressed this by measuring intake during a ten-day VLCD 
and providing the same intake exactly for each participant during the 10-day post RYGB 
period. While GLP-1 was elevated post RYGB there was no difference in glucose 
clearance or insulin sensitivity between treatments by post-operative day seven. 
Endogenous glucose production was lower in the diet-only group (217). Thus, it seems 
that when equivalent calorie matching within individuals is achieved, RYGB does not 
confer additional advantages on glucose homeostasis compared with VLCD, particularly 
with respect to post prandial glycaemia, the aspect of glucose homeostasis that may be 
expected to benefit from enhanced GLP-1 secretion.  
Improvements in glucose homeostasis can be accounted for by the effect of 
calorie restriction: The evidence against.  
Foo et al, 2011, studied changes in insulin resistance; six days following VLCD, six days 
following subsequent RYGB; and six days following a control RYGB-only group (219). 
Improvements in HOMA-IR attributed to improved hepatic insulin sensitivity were 
observed in all groups. The total reduction in HOMA-IR with VLCD and sequential 
RYGB was equivalent to the reduction in HOMA-IR achieved by RYGB alone in the 
control group. One potential explanation for this may be differing weight loss or greater 
calorie restriction in the RYGB-only group or a ‘saturable’ effect of calorie restriction 
mediated by VLCD or RYGB on HOMA-IR. The observed deterioration in whole body 
insulin sensitivity, measured by an insulin tolerance test in this study, may have been 
related to perioperative physiological stress. This has been shown to worsen peripheral 
insulin resistance for up to three weeks post-operatively (220). 
Pournaras et al, 2016, also studied the relative contribution of VLCD, altered nutrient 
delivery and weight lost to diabetes remission following RYGB. Measurements were 
performed pre-VLCD, two weeks post-VLCD, two weeks post-operatively and at 52 
weeks post-operatively. They found that the improvements in whole body insulin 
sensitivity were the same after two weeks of VLCD as they were two weeks after RYGB. 
In the same study RYGB was associated with improvements in postprandial 
hyperglycaemia not attributable to VLCD, while weight lost at 52 weeks was responsible 





early improvements in peripheral insulin sensitivity, has not been observed in other 
studies at a similar timepoint (222). However, peripheral insulin sensitivity several 
months following RYGB, has been consistently shown to improve in proportion to 
weight lost.  
Improvements in glucose homeostasis can be accounted for by the effect of 
calorie restriction: Resolving the discrepancies.  
Pop et al, (section 1.6.2.1.3) addressed two aspects of matching calorie intake in the 
design of studies of VLCD versus RYGB in their study. First, for individuals of different 
sizes and activity levels, a uniform calorie prescription, will represent a different 
proportion of their total energy requirements, thus calorie prescriptions should be 
individually tailored. Secondly, the degree of calorie restriction following RYGB cannot 
be assumed to be the same as the protocol specified VLCD by default. Confounding 
factors that may alter energy intake or energy balance following RYGB include; post-
operative complications such as infections or constipation, variable tolerance of a 
hospital diet and medication-related nausea. A third challenge in accurately calorie 
matching which has yet to be appropriately addressed in studies comparing VLCD and 
RYGB, is the increase in energy requirements caused by major abdominal surgery and 
the ensuing convalescence.  
Basal metabolic rate is increased by at least 15-20% from the time of abdominal surgery 
for at least 72 hours post-operatively (223). In a 40 yr old 140 kg male with a height of 
170cm, a 20% difference in REE accounts for 2150 kJ increase in daily calorie 
requirements approximately†. The failure to incorporate total calorie requirements is 
common-place in head-to-head studies of RYGB and VLCD. Determining what the 
calorie requirements would be for a matched VLCD is challenging given the earliest 
published data regarding changes in energy expenditure following RYGB are at 14 days 
post-operatively (224).  
Laferrere et al, 2008, studied RYGB versus matched weight loss with a VLCD.  
Compared to VLCD, RYGB was associated with higher GLP-1 and insulin levels, a 
lower glycaemic response to an oral glucose challenge, and a lower fasting glucose (225). 
                                                          





A significant limitation of this study was that equivalent weight loss took three weeks 
longer to achieve in the RYGB group, as the calorie intake in the VLCD group was not 
well matched. To address this confounder, Jackness et al, 2013, performed a similar study 
using a 2100 kJ VLCD that produced similar weight loss in similar time. There was no 
difference in glycaemic outcomes in this study (226). The use of calorimetry methods 
pre- and post-operatively to determine daily energy requirements would provide more 
accurate calorie prescription for both VLCD and post RYGB, and address standardisation 
of proportional calorie deficit and changing energy expenditure post-operatively.  
In summary, inadequate matching of induced calorie deficit in head to head studies of 
RYGB and VLCD has confused the relative contribution of VLCD to diabetes remission 
following RYGB. While a definitive study is required, those studies that have come 
closest to appropriate calorie matching have not demonstrated a benefit from RYGB that 
isn’t explained by the degree of calorie deficit. Changes in gut peptides, bile acid 
metabolism and gut microbiota have also been suggested to have role in diabetes 
remission following bariatric surgery.  
 Gut Peptides: GLP-1  
The profile of hormones released in response to a meal changes dramatically with 
bariatric surgery due to more rapid nutrient delivery through the gastrointestinal tract. 
This is particularly true of RYGB and BPD procedures which involve bypass of the 
proximal small bowel, unlike LSG (227). Glucagon-like peptide 1 has been proposed as 
key mediators of diabetes remission following bariatric surgery(228),(229).  
Relative to bile acid metabolism and gut microbiota, more is known regarding the 
physiologic function of the incretins in humans, and their contribution to diabetes 
remission following bariatric surgery. Jorgenson et al, 2012, demonstrated a ten-fold 
increase in GLP-1 five days following RYGB. This coincided with increased insulin 
secretion in response to a meal, and was sustained out to one year (230). Studies using 
GLP-1 blockade following RYGB demonstrate deterioration in postprandial insulin 
responses, providing strong evidence for a contribution of GLP-1 to improvements in 





 Altered Enterohepatic Cycling of Bile Acids 
In obese subjects, systemic bile acids are reduced compared with their lean counterparts. 
Following bariatric surgery however, bile acid concentrations in the blood increase as 
early as six weeks post-operatively (231). This is thought to be due to disruption of 
enterohepatic cycling that occurs because of bypass procedures such as RYGB, VSG, 
duodenal-endoluminal sleeve and ileal transposition.  
Bile acids have been shown in mice to; regulate the production of bile acids from 
cholesterol, improve glucose homeostasis, reduces lipids by increasing lipoprotein lipase, 
inhibiting lipogenesis, and influence GLP-1, PYY and energy metabolism (232, 233), 
(234),(235).  
Human trials are limited to observational studies that have investigated the association 
between elevated bile acids and diabetes remission or weight loss. These studies have 
produced conflicting results and are confounded by inter-individual variation in bile acid 
metabolism pre-operatively. Gerhardt et al, 2013, examined over 100 patients before and 
after-RYGB and found no association between total bile acid concentrations and the 
occurrence of diabetes remission (236). Other studies have found an association between 
total bile acids and improved glycaemia (237),(238). Though the improvements in 
glycaemia occurred before the change in total bile acid concentration in one of these 
studies (238).   
Bariatric surgery has stimulated a greater understanding of bile acid metabolism and its 
possible role in the resolution of obesity and diabetes. However, more work needs to be 
done to confirm the physiological role of bile acids in humans, determine causation and 
quantify the clinical significance of observed changes in bile acids following-bariatric 
surgery.   
 Gut Microbiota  
The human gastrointestinal tract normally plays host to millions of bacteria. These 
become established in early life and remain relatively stable in most healthy individuals 
through adulthood. One theory by which gut microbiota may influence obesity and 





propose that the post-operative gut microbiota may act indirectly to improve glycaemia 
by; altering bile salt metabolism, reducing inflammation and influencing central energy-
homeostasis. 
In mouse models of obesity, there is an observed reduction in the microbial diversity, and 
a reduction in some families of bacteria such as Bacteroidetes and Firmacutes (239). A 
comparison of lean and leptin deficient obese mouse models showed an increased 
extraction of short chain fatty acids from the diet, changes in whole microbiome gene 
expression and change in total energy extraction from the diet (240). This latter is thought 
to be due to more efficient extraction of energy from complex carbohydrates. In human 
studies, changes in the bacterial composition of the gut, including an increase in bacterial 
diversity, have been observed following bariatric surgery. The interpretation of these 
studies is challenging, as dietary intake, living environment and physical fitness, all have 
a bearing on the gut microbiome and are not often controlled for (205).  
At this point it is not possible to draw firm conclusions in relation to the role of gut 
microbiota in the pathogenesis of obesity or resolution of T2DM beyond simple 
association. Prospective observational studies, adequately powered and controlled with 
a clear mechanistic basis are required before this will be possible.   
In summary, there is robust evidence for the effect of calorie restriction on improvements 
in glycaemia. While GLP-1 may be an important contributor to early improvements in 
glycaemia following bariatric surgery, GLP-1 in the absence of weight loss has not been 
to induce diabetes remission, unlike calorie restriction. The investigation of bile acid 
metabolism and gut microbiota following bariatric surgery has been valuable, but to date 
has not been clearly shown to mediate improvements in glycaemia or diabetes remission. 
1.6.3 Low-Calorie Diets in the Treatment of Obesity  
Low calorie diets have been used as a treatment of obesity long-before the advent of 
bariatric surgery. The Greek physician Galen was one of the first to suggest low calorie 
foods for the treatment of obesity with his treatise: On the Slimming Diet, c.180 AD 
(241). This has continued through the 20th century with the development of VLCD’s as 





 Features of a Calorie Restricted Diet 
Apart from the degree of calorie restriction, additional characteristics of a low-calorie 
diet or VLCD are the schedule of dieting and the macronutrient composition. Broadly, 
schedules can be considered continuous or intermittent. A continuous low-calorie diet, 
also known as continuous daily restriction (CDR), involves prescribed calorie restriction 
by the same degree every day of the week. In practice this can only be approximated, as 
the physical activity component of total daily requirements will vary daily, outside of a 
supervised inpatient stay. Conversely, an intermittent fast (IF) involves a hypocaloric diet 
that is interrupted with days of ad libitum, isocaloric or hypercaloric intake. An example 
of this is alternate day fasting (ADF) which may involve VLCD’s or complete fasts on 
alternate days with an isocaloric or hypercaloric diet otherwise(243, 244). Another 
example of an IF is two days of VLCD diet per week compared with isocaloric intake 
otherwise, this form of IF is the intervention used in chapters six and seven. When dietary 
restriction is imposed over a period of hours, the schedule is known as “time-restricted 
feeding” (245, 246). Studies of the effect of fasting between sunrise and sundown during 
Ramadan, a type of religious fast, are another example of time restricted feeding.  
The macronutrient composition of a diet refers to the proportion of fat, carbohydrate or 
protein in a diet. Macronutrient composition is conventionally expressed as the 
proportion of a given macronutrient, often in percent, that comprises the energy content 
of the diet. Each of these dietary characteristics may have a bearing on weight loss 
achieved or glucose homeostasis.  
The roles that the magnitude of calorie restriction, macronutrient composition and 
schedule of calorie restriction play in treating diabetes and obesity will be examined in 
turn.  The addition of supplements to the diet or exclusion/inclusion of specific foodstuffs 
represent other ways to prescribe a diet. However, the scope of the following discussion 
will be limited to features of a diet prescription for which there is some evidence of a role 





 Magnitude of Calorie Restriction   
The Effect of Magnitude of Calorie Restriction on Weight Loss 
In highly controlled inpatient studies of calorie restriction, the degree of weight loss 
proceeds in close alignment with the degree of caloric deficiency (247). Reinhardt et al, 
2015, monitored weight loss and energy balance in response to calculated dietary energy 
deficiency of 50% in 12 individuals weekly for six weeks. There was a strong correlation 
between weight loss and calculated energy deficit, r = 0.75, though the degree of weight 
lost was not entirely explained by the imposed calorie deficit (247). Proportionality 
between the calculated energy deficit provided by a diet and the weight loss incurred has 
been shown elsewhere (117, 248). While the magnitude of the association in weight loss 
due to calorie deficit is variable between studies, this may be attributable to differences 
in body composition assessment methods (section 2.3.1), assumptions in relation to 
estimation of energy deficit, ascertainment of measures of energy expenditure, changing 
energy requirements during a period of sustained calorie restriction, or adherence. In a 
meta-analysis of six head-to-head studies of low-calorie diet (4184-6694 kJ/day) versus 
VLCD (1673 – 1907 kJ/day), VLCD was shown to induce greater short-term weight loss 
between 6-18 weeks, compared with low-calorie diet. At long-term follow-up between 
one and five years there was no difference in sustained weight loss between low-calorie 
diet and VLCD (249). This is quite likely due to changes in adherence or energy 
expenditure in the medium to longer term. In summary, while accurate prediction of 
weight loss is complex, the magnitude of weight loss is quite clearly proportional to the 
degree of calorie restriction. 
The Effect of Magnitude of Calorie Restriction on Glucose Homeostasis 
How VLCDs improve glucose homeostasis, particularly prior to bariatric surgery 
(section 1.6.2.1), has previously been discussed. That calorie restriction improves 
glucose homeostasis is clear. However, what is the evidence that the magnitude of such 
restriction influences glucose metabolism?  
With respect to improved glucose homeostasis with low-calorie diets, it had been 
identified by Henry et al, 1986, that low-calorie diets were beneficial in individuals with 





of an energy intake target of 4200-6300 kJ (low-calorie diet group) versus a very low-
calorie diet of 1680 kJ (252). Both interventions lasted 20 weeks. The energy intake 
targets in the VLCD group were matched to those of the low-calorie diet group in the 
first month. This was followed by eight weeks of VLCD or low-calorie diet followed by 
weight maintenance again matched to the low-calorie diet group. Compared with the low-
calorie diet group, VLCD was associated with a higher proportion of individuals stopping 
and remaining off hypoglycaemic medication, significant improvements in fasting and 
post prandial glucose, and insulin response to a meal test. This was despite no significant 
difference in weight between treatment groups by one year. The study again highlighted 
that weight loss between groups differed in proportion to the degree of calorie restriction. 
During matched dietary intake, weight loss was the same in both groups. A second study 
by Wing’s group compared low-calorie diet with VLCD and behavioural therapy for one 
year. Two periods of 12-week VLCD with a 12-week low-calorie diet between them were 
followed by weight maintenance with a low-calorie diet. Improvements in glycated 
haemoglobin in the first 12 weeks were strongly associated with the degree of weight 
loss, and those in the VLCD group remained off medications for longer, with a lower 
fasting plasma glucose. By six months, three months into the weight maintenance phase, 
there was no difference between low-calorie diet and VLCD in fasting insulin or fasting 
glucose (253), possibly due to a reduction in weight difference between both groups at 
this timepoint. To date, these two studies by the same group remain the only RCT’s of 
VLCD vs low-calorie diet on glycaemic outcomes in individuals with T2DM (254).  
Based on the studies of Wing et al, it is interesting to consider whether the effect of a 
VLCD extends beyond simply the degree of calorie restriction. For example, do 
difference in food type, meal density, or meal schedule provide additional benefits on 
glycaemia with a VLCD compared to a low-calorie diet. While there is currently 
insufficient evidence to address these questions, the work of Wing et al is strong evidence 
that the magnitude of calorie deficiency is the primary determinant of glycaemic 
outcomes after a calorie restricted diet.  
 Macronutrient Composition 
The macronutrient composition of a diet, in contrast to the schedule of dietary restriction, 





reviewed. There are a great many permutations of macronutrient composition in 
existence (255). When considering weight loss and glycaemic outcomes three types of 
macronutrient-controlled diets have been most closely studied; Low carbohydrate, low 
fat or high protein diets. Because fixed macronutrient diets are defined as the proportion 
of the energy intake that comes from a certain macronutrient, it is not possible to alter 
one macronutrient without reciprocal alteration of another. If changes in absolute 
quantities of a single macronutrient are altered in isolation, this results in change in total 
energy intake, which will obviously confound interpretation of the results.  
There are many possible reasons why different macronutrient content may alter weight 
loss or glycaemic outcomes in the context of obesity and/or T2DM. These have been 
summarised in a recent review (256) and include both behavioural and physiological 
factors such as; adherence, cost, side effects, substrate utilisation, energy density and 
satiety.  
The Effect of Carbohydrate on Weight Loss and Glucose Homeostasis  
Foster et al,2010, conducted one of the largest and longest studies of low carbohydrate-
high fat diets versus high carbohydrate-low fat diets in 307 overweight and obese men 
and women over two years (257). The low carbohydrate diet intervention contained less 
than 20% intake as carbohydrates, while the high carbohydrate diet intervention was 55% 
or more. The maximum weight lost was 12 kg at six months with 7 kg net weight loss by 
two years. There were no differences in weight loss between treatment groups at any 
timepoint. Glycaemic outcomes were not assessed. There was an emphasis on 
carbohydrate restriction in the low carbohydrate group and calorie restriction in the 
control group during dietary education, without strict energy intake targets in either 
group. No measures of adherence to dietary energy intake or macronutrient targets were 
reported in this study. It is thus unclear whether the planned between group difference in 
intake occurred.  
Over fifty studies have been performed examining the effect of low carbohydrate diet 
interventions in individuals with T2DM. Nine separate meta-analyses of these studies 
have failed to reach a consensus in relation to whether low carbohydrate diets improve 





0.28% (95% CI: -0.53 to -0.02%) or 3.3 mmol/mol (95%CI: -5.8 to -0.2 mmol/mol) in 
glycated haemoglobin (HbA1C) (258). By contrast Castañeda-González et al,2011, 
found no consistent differences in HbA1C or fasting glucose in individuals with T2DM 
in studies of greater than 12 weeks duration (259).  
In order to reconcile the disparities between the results of these and other meta-analyses 
of the effect of low carbohydrate diets on glycaemia, Van Wyk et al, 2016, performed a 
systematic review of ninety-two studies comprising the nine meta-analyses (260). Only 
randomised controlled trials in adults with T2DM were reviewed. Most studies were 
excluded due to; a study duration of four weeks or less, a carbohydrate content of 45% 
total energy intake or more in the low-carbohydrate intervention group, or no record of 
dietary intake during the study. Eleven of the remaining studies demonstrated no weight 
loss difference between a high and low carbohydrate diet. With respect to glycaemia, 
there were no differences in insulin sensitivity, insulin secretion or fasting plasma 
glucose in any of the studies. Eleven of the twelve studies demonstrated no difference in 
HbA1C. The assessment of glycaemia was complicated in most studies by variable 
medication titration protocols, and failure to incorporate changes in medication in the 
analysis of glycaemic outcomes.  
Thus, in well-controlled RCT’s of low carbohydrate interventions longer than four 
weeks, there is consistency in failing to demonstrate a significant effect of a low 
carbohydrate diet on weight loss or glycaemia. This is in keeping with the American 
Diabetes Association’s emphasis on usual macronutrient distribution, rather than a focus 
on low carbohydrate diets, acknowledging the effects of low carbohydrate diets on 
glycaemia are currently unclear (261). 
The Effect of Protein on Weight Loss and Glucose Homeostasis  
Santesso et al performed a meta-analysis of 74 RCT’s of high versus low protein diets, 
73 of these studies were in overweight or obese individuals without diabetes. While 
weight loss appeared to be greater with a high protein diet, this was associated with a 
higher baseline BMI in the high protein groups. If a fixed calorie prescription rather than 
proportion of intake was used, imbalance in the baseline BMI of participants may have 





fasting glucose or HbA1C was detected. The level of evidence was graded moderate or 
low, and there was a high degree of heterogeneity, I2>60%, for most outcomes (262).  
Krebs et al, 2012, conducted the largest study of high protein diet in overweight adults 
with T2DM. The DEWL study ran for two years and compared a high protein low carb 
diet containing 30% protein, 40% carbohydrate and 30% fat with a low protein high 
carbohydrate diet containing 15% protein, 55% carbohydrate and 30% fat. There was no 
difference in weight loss or HbA1C between groups. Adherence to the protein and 
carbohydrate targets was challenging for participants in the study, with negligible 
difference in macronutrient intake between treatment groups from six months onwards, 
emphasising the value of having incorporated a measure of dietary adherence in the study 
design (263).  
Larsen et al, 2011, conducted a shorter study of ninety-nine overweight or obese 
individuals with T2DM. A three-month 30% energy restriction period was followed by 
a nine-month weight maintenance phase. The high protein diet contained 30% protein 
and the low protein diet, 15%. While there were significant differences in protein intake 
this amount to a difference of 7.5% between groups rather than the planned 15%. There 
was no difference in weight loss or HbA1C between treatments (264). 
As with carbohydrate content of diet, the wide variety of study designs and variable 
quality limits the usefulness of meta-analyses for studies of macronutrient composition. 
Two of the largest well controlled RCT’s examining high protein diets have demonstrated 
no significant effect on weight loss or on HbA1C.  
The Effect of Fat on Weight Loss and Glycaemia 
McAuley et al, 2006, compared the effect of three diets; high carbohydrate, high fat and 
high protein, in insulin resistant obese women over 12 months (265, 266). Both the high 
protein and high carbohydrate groups had a fat content of 30% while the high fat group 
were prescribed a low carbohydrate diet aiming for under 20g/day for two weeks and 
increasing to 50g/day thereafter. The study was remarkable for the assessment of 
adherence, the inclusion of measures of glucose homeostasis, a low dropout rate and two 
lower fat dietary controls.  Though the high carbohydrate diet appeared to produce more 





concluded that underreporting of energy intake was the likely explanation for this result. 
Adherence to the diet prescription was maintained at six months, but by 12 months, it 
had declined. There was no difference in weight between groups over the 12 months 
interval. There was no difference in fasting insulin, fasting glucose or two-hour post 
OGTT glucose at any time point.  
Tobias et al, 2015, performed a meta-analysis and systematic review of 53 studies of 
RCT’s of low fat diet interventions (267). Pooled estimated for weight loss appeared to 
be greater with high fat interventions. As with meta-analyses of protein and carbohydrate 
intake, the heterogeneity was high. However, when only studies that included calorie 
prescriptions in both intervention and comparator groups were included there was no 
difference between low fat and control diets.  
In conclusion, the evidence to date does not suggest an effect of macronutrient 
composition of a diet on weight loss or glycaemic outcomes, independent of calorie 
restriction. Differences in adherence to diets of differing macronutrient composition may 
be due to the palatability, feasibility of implementing the diet, and the cost of a diet. 
However, when adherence to a dietary energy prescription is achieved, the macronutrient 
content of a diet does not alter weight loss or glycaemia.  
 The Schedule of Calorie Restriction  
There are many examples of diets that vary in schedule. Religious fasts, such as once 
weekly food abstinence or fasting during the month of Ramadan, have been around for 
hundreds of years. Scheduled intermittent diets have recently become more popular with 
the lay public. What evidence is there to support the use of diets that vary in schedule 
over and above a calorie restriction?  Much of the evidence in favour of schedule-specific 
effects of dieting come from animal studies. The most studied schedules of calorie 
restriction are; complete ADF, IF, and time-restricted feeding.  
The study of different schedules of restriction may be fruitful in two ways; first to 
evaluate if adaptive thermogenesis is diminished by brief periods of fasting interspersed 
with adequate energy intake for requirements. Secondly, interrupting fasting may 
improve glycaemia, lipid profile and FM loss compared to equivalent weight loss with 





 Animal Studies of Scheduled Calorie Restriction 
Animal studies enable more detailed and invasive studies than are possible in humans. In 
this respect they are essential and complementary to human dietary intervention studies, 
if done well. Unfortunately, there are serious limitations with the study of different 
schedules of dietary intervention in the animal literature. A detailed table of 15 RCT 
investigating the effect of altered feeding schedule on diverse outcomes is available in 
appendix A. The most pervasive methodological limitations relate to the statistical 
analysis, biological heterogeneity and the diet intervention.  
Time Restricted Feeding Studies 
Some interesting insights into possible beneficial effects of a specific schedule of 
feeding/fasting come from studies of time-restricted feeding in rodents. Hatori et al, 
2012, studied mice for 100 days that were allowed access to food either ad libitum or 
only during an 8-hour light phase (245). Food intake over 24 hours was the same in the 
time restricted versus the ad libitum group. Time restricted feeding was associated with 
widespread alteration in the expression of enzymes that regulate gluconeogenesis, 
glycolysis, fatty acid oxidation, fatty acid desaturation, fatty acid synthesis and 
nucleotide biosynthesis was seen in the liver. There was also increased expression of 
uncoupling protein in brown adipose tissue in the time restricted mice.  These changes 
were associated with improved glucose tolerance, reduced hepatic steatosis and less 
weight gain in the time restricted mice despite similar food consumption. In addition, 
there was an increase in nocturnal energy expenditure in the time restricted mice related 
to increased physical activity. Thus, it is possible that the relative difference in energy 
balance rather than feeding schedule may account for the difference observed above. 
Nonetheless, the finding that known circadian regulators of cellular metabolism were 
significantly altered with different schedules of feeding in mice is an important one. This 
provides a mechanistic basis for regulation of intermediary metabolism and energy 
expenditure on a circadian timescale. These findings have yet to be replicated in humans 





Intermittent Fasting in Animal Studies:  
Complete ADF, involving alternating ad libitum intake and a complete fast daily, have 
been assessment in thirteen rodent studies (268-270),(271-278).  
Weight  
All thirteen studies reported on weight change during the diet intervention. Weight loss 
increased in both the ad libitum controls and intervention groups in eleven studies (268-
272, 274-277, 279, 280). Of the other two, weight decreased by 5% from baseline in the 
ADF groups over a four-week period in one and by 6% in the ADF group with 33% 
calorie restriction on feeding days over a four-week period (273). Changes in weight 
were consistent with the calories provided across all studies (appendix A). In the only 
study that demonstrated a matched calorie intake between a CDR an IF group, weight 
gain of 68% was observed in both IF and CDR groups (279).  Several studies noted 
gorging with ADF on feeding days, thus the calorie intake in an ADF group was often 
greater than half that of the ad libitum group and in two studies exceeded the intake in 
the ad libitum group (271-274, 276),(272, 274).  
Body Composition 
Body composition was assessed in three studies using MRI (273-275). Intermittent 
fasting was associated with a reduction in FM compared with an ad libitum control by 
Boutant et al, 2016. Gotthart et al, 2016, found lower FM and lean mass with low-fat 
ADF compared to high-fat ad libitum intake, but no difference low-fat ADF and a low-
fat continuously restricted control. Thus, body composition changes relate more to 
calorie intake rather than schedule of feeding during weight loss.  
Assessment of Glucose Homeostasis 
Nine studies examined some aspect of glucose homeostasis(268, 270-275, 279, 280). 
Methods of assessment varied widely, from urine glucose measurement to intraperitoneal 
glucose tolerance tests (268, 270-272), (275, 279, 280), (274),(273).  
Fasting insulin was no different in the ADF group compared to the ad libitum control in 
three studies and higher in one study (271, 275, 280),(279). In this study, ADF resulted 





compared with continuously fed controls in three studies and no different in one study, 
where the IF group gained the same weight as the control group (270-272),(268).  
Oral glucose tolerance tests and insulin tolerance tests were performed in the same two 
studies and produced discordant results (273),(275).  
A hyperglycaemic euglycaemic clamp was performed by Boutant et al, 2016, after 12 
weeks of either ADF or ad libitum intake and demonstrated significantly increased 
glucose disposal with ADF. The ad libitum mice in this study gained approximately three 
times more weight than the ADF group. The additional weight gain, and thus insulin 
resistance, in the ad libitum arm is the most likely explanation for these findings(274).  
Thus, the apparent superiority of ADF over CDR could be reconciled by excessive weight 
gain in the control group, irrespective of the assessment method used.  
Central Regulation of Energy Metabolism  
Three studies measured endogenous leptin concentrations in response to different 
schedules of fasting (269, 273, 279). Two studies found leptin levels that were no 
different than continuously fasted controls with weight gain of 10% (273, 277). Bonorden 
et al, 2009, demonstrated that leptin was lower with intermittent fasting but weight gain 
and FM change was greater in this study which may accounts for the discrepant findings. 
Chausse et al, 2014, studied the effect of a leptin injection on food intake, and 
hypothalamic signalling following an ADF compared with an ad libitum fast (276). ADF 
rats were much more sensitive to the appetite suppressant effect of leptin and had 
increased expression of orixegenic neurotransmitters in the hypothalamus. Poor weight 
gain matching was a notable limitation of this study.  
Gotthardt et al, 2016, also studied hypothalamic neurotransmitter expression in response 
to ADF or ad libitum diets (273). They found increased expression of orexigenic NPY, 
lower levels of anorexigenic POMC and no difference in AgRP in response to ADF 
compared with ad libitum intake. Weight gain was not matched between ADF and ad 
libitum groups in this study either. Nonetheless, these studies are an illustration of how 
animal models may further an integrated understanding of central energy homeostasis in 





Taken together, the existing data from animal studies of ADF supports the importance of 
the magnitude of calorie restriction but, because of study design, has not adequately 
addressed the question of whether differences in dietary schedule independent of calorie 
restriction offer any unique advantage.  As a result, the metabolic differences between 
feeding regimens such as glycaemic responses to a glucose tolerance test, weight change, 
serum triglyceride content, oxidative metabolism or regulation of hepatic diacylglycerol 
content may be due to differences in energy intake rather than the dietary schedule(276-
280),(276),(275),(278). A small number of human studies have explored the effects of 
different dietary feeding schedules 
Limitations of Animal Studies  
Statistical Analysis 
Despite a well-developed hypothesis, and the prior publication of methods used to 
evaluate the pre-specified outcomes, no study provided either an a priori or post-hoc 
power-calculation for their study outcomes (245, 268-272, 274-281). Many studies assess 
multiple outcomes between multiple groups, without a pre-specified primary outcome or 
any adjustment for multiple outcomes (245, 273, 275, 277, 279, 280, 282). This increases 
the risk of type I error, especially without power calculations to temper confidence in the 
conclusions drawn. Some of the studies involved complex factorial designs (277, 278, 
281), but the statistical analysis did not reflect this design. Descriptive analyses of 
between group differences without statistical testing of these observations is common. 
Rather, authors present statistics for within group change with time or between group 
comparisons at the end of the intervention. This method does not assess between-group 
difference in change from baseline (277, 278, 280).  
Biological Heterogeneity 
There is considerable heterogeneity in the biology of the animals being studied. All 
studies involved either mice or rats. Across the thirteen studies, seven genetically 
different rodent models were used. The age of the rodents at the start of the dietary 
intervention varied from 3 weeks to 12 weeks. As the dietary interventions lasted up to 
43 weeks, the age, growth trajectory and physiology of the rodents simultaneously 





the primary outcome, e.g. weight gain, prostate cancer, or the energy requirements of the 
rats and may lead to discordant findings between studies exploring the same intervention.  
Dietary Intervention 
The chief limitation in inferring an effect of schedule as distinct from the calorie 
restriction is in the design of the dietary interventions. No rodent studies based calorie 
prescription on an assessment of energy expenditure or other surrogate of energy 
expenditure, despite the availability of sophisticated indirect calorimetry methods for 
rodents. Instead prescriptions were commonly based on mean unrestricted or ad libitum 
intake in a control group. In every study, ad libitum intake caused weight gain. Therefore, 
restrictive interventions that are a proportion of the ad libitum intake, but still more than 
weight maintenance requirements, also caused weight gain. Thus, most rodent studies 
investigate the effect of reduced weight gain, rather than weight loss with different 
schedules of restriction (270-272, 274, 275, 279, 280).  
In summary, rodent studies have described a positive effect of differing schedules of 
calorie restriction on glycaemia, weight loss and body composition. However, these 
findings should be interpreted with caution as there are significant limitations in the 
methodology, not least inadequate calorie matching in the continuously restricted control 
groups.  
 Human Studies of Scheduled Calorie Restriction 
Time Restricted Feeding 
Stote et al, 2007, and Carlson et al, 2007, compared the effect of time restricted feeding, 
consumption of total daily food between 17:00 and 21:00, to a calorie matched three-
meals-per-day diet on weight loss, body composition and glycaemia (116, 283)(Table 
1.2). They demonstrated weight loss and a reduction in FM with a single meal per day. 
There was also an elevation in fasting glucose and worsening of glucose tolerance on 
OGTT. Based on the OGTT there appeared to be a decreased first phase insulin response 
and a relative impairment in insulin sensitivity in the once a day meal group. A 
confounding aspect of this study was the substantial difference in meal size the evening 
prior to an OGTT or the fasting glucose sampling. The reduction in weight despite an 





based. This implies that adherence to an exceptionally large meal may have been 
overestimated. The authors comment that, given the choice, participants on the one-meal 
per day group would have chosen to eat less. There was no effect of meal schedule on 
fasted morning plasma insulin, HOMA-IR, glucagon, leptin or adiponectin.  
LeCheminant et al, 2013, found that if night-time feeding is eliminated between the hours 
of 19:00 and 06:00 total daily energy intake was reduced compared to controls (284), 
suggesting an impact of altered schedule on energy intake, though REE was not measured 
in this study. A recent short-term study of breakfast omission indicated that morning 
fasting compared with a standard breakfast was not associated with a compensatory 
increase in eating later in the morning and was associated with a lower total energy intake 
over the course of the whole day (285).  
In summary, time-restricted-feeding within a 24-hour period, lowers total daily energy 
intake compared with isocaloric controls. Time restricted feeding compared to 
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Table 1.2. RCT’s of intermittent versus continuous energy restriction in humans.  
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AL: Ad libitum; DXA: Dual energy x-ray absorptiometry; HbA1C: Glycated haemoglobin; TG: Triglycerides; HDL: High density lipoprotein; LDL: Low 
density lipoprotein; IGF-1: Insulin-like growth factor 1; IL-6: Interleukin-6; TNF-α: Tumour necrosis factor-α; TChol: Total Cholesterol. EI: Energy 
Intake. IF: Intermittent Fasting. CDR: Continuous Daily Restriction; HOMA-IR: Homeostatic model assessment of insulin resistance; BIA: 
Bioimpedence analysis;N/A: Not assessed 
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Intermittent fasting versus Continuous Daily Restriction 
Intermittent fasting, including ADF, compared to continuous daily restriction (CDR) has 
been studied in 12 randomised controlled trials in humans (Table 1.2). The heterogeneity 
of these studies is both a strength and a weakness, offering an insight into the 
permutations of intermittent fasting that may be most effective, but with results that have 
not always been reproduced. These studies vary with respect to; study duration, 
population studied, diet prescription, type of control, estimation of calorie requirements, 
weight lost, energy expenditure assessment, body composition assessment outcomes, and 
metabolic assessment.  Of these study characteristics, inadequate calorie matching 
between diet prescriptions in the control and intervention groups is perhaps the greatest 
limitation of the existing intermittent energy restriction literature so far. This is in keeping 
with the intermittent fasting literature in animals, and the bariatric literature concerned 
with diabetes remission.  
Study Duration 
Trials of IF versus CDR varied from nine weeks to one year(293),(286, 294). Three 
studies contained an initial weight stabilisation period varying from one to three weeks 
(287, 290, 295). The duration of active weight loss was most commonly 12 weeks in 
duration, but between nine weeks and six months(243, 287, 288, 290, 292), (293),(286, 
289). In studies that contained a weight maintenance period following weight loss, weight 
regain was invariably seen.  
Study Population 
The studied populations varied chiefly with respect to gender, baseline weight and the 
presence of diabetes. As with many dietary intervention studies, there was a 
preponderance of women-only studies which limits the validity of these findings to REE 
and body composition results in men. Change in REE during the menstrual cycle, with 
menopause or with the oral contraceptive pill, reduces the validity and precision of 
assessments of energy expenditure by indirect calorimetry or doubly labelled water 
(296),(297),(298). None of the women-only RCT’s that assessed energy expenditure 
attempted to time measurements of energy expenditure with the menstrual cycle (286, 
292-294).  
Six studies examined obese participants, four studied overweight or obese participants, 
and two studied normal or overweight participants. The physiology of the established 
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obese, compared with overweight or normal weight participants is different. In particular, 
weight loss attempts in the normal weight individuals can result in preferential fat mass 
regain not seen in the obese, this may affect observed changes in body composition 
during weight loss followed by weight maintenance (110). Only two RCT’s studied 
individuals with T2DM. The sample size per treatment group ranged from five to 54 
participants(293), (290, 291) ,(289).  
Diet Prescription: Intermittent Fasting Group 
The calorie prescription for IF involves the duration of fasting, the calorie prescription, 
and the non-fasting calorie prescription.  
The duration of the fasting component of each cycle of an intermittent fast ranged from 
24-hours to two weeks (299),(295). The proportion of time spent fasting during the 
intervention period varied from 14% to 50% (295),(291). It is not yet clear whether time 
spent in negative calorie balance, independent of degree of negative energy balance, is 
an important feature of intermittent energy restriction.  
With regard to the fasting day prescription, one study combined a complete fast with ad 
libitum intake on alternate days (244). Six of the twelve studies used a fasting day 
prescription of 25-30% of requirements, while one used a fasting day prescription of 50% 
requirements(243, 286-289, 295). Three of the studies prescribed calorie intakes as fixed 
calorie counts for all participants(290-292). One study did not prescribe a fixed calorie 
intake but adjusted calorie intake on an individual basis to ensure 1% weight loss per 
week (294). Clearly these are very different diets that will produce very different degrees 
of weight loss. The prescription of a hypocaloric diet as a proportion of estimated daily 
energy requirements, rather than the use of fixed calorie prescription is preferred. It 
avoids variation in the degree of negative calorie balance that inevitably occurs in 
populations of varying size and thus total energy expenditure.  
The calorie prescription for the non-fasting components of the intermittent fasting group 
all have in common a calorie intake that is designed to be greater than or equal to the 
maintenance requirements of the individual. Seven studies controlled for the non-fasting 
day calorie intake, and five used ad libitum intake on non-fasting days(286, 287, 291-
295),(243, 244, 288-290).  Of those studies that prescribed energy intake, one study 
prescribed 125% daily energy requirements, three prescribed 100% daily energy 
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requirements, and the remaining three prescribed fixed calorie intakes that could not be 
related to participants energy requirements(286) ,(287, 293, 295) ,(290-292).  
The combination of overfeeding or ad libitum intake with underfeeding in an intermittent 
fasting diet, makes interpretation of metabolic outcomes and any weight change 
outcomes difficult. Depending on the hypothesis, ad libitum intake may be more 
appropriate, but it does not allow for comparison with a calorie matched CDR control, 
being unpredictable. 
Diet Prescriptions: Control Group 
The diet prescription for the CDR control group resembled that of the IF group in terms 
of how it was prescribed, i.e. fixed calorie count or proportion of estimated daily energy 
intake, and what the estimates were based on. All but one of the studies had a CDR 
control, Varady et al, 2013, used an ad libitum control (243). Calorie matching between 
the control group and the intermittent energy restriction group was present in only four 
studies, when ad libitum prescriptions in either the IF or CDR group were excluded (286, 
287, 295), (292). Assuming ad libitum intake represents 100% requirements an additional 
two studies could be considered calorie matched (288, 289).  
Estimation of Energy Requirements 
The method of determining an individual’s total daily calorie requirements is important 
as it is the foundation of the hypocaloric intervention (section 2.3.3). Measurement of 
total daily energy expenditure by doubly labelled water or REE by indirect calorimetry, 
combined with estimates of physical activity measures are more accurate and valid than 
predictive equation of energy expenditure (chapter six). Of the nine studies that tailored 
energy prescriptions to individuals; one study used doubly-labelled water, two studies 
used indirect calorimetry combined with a physical activity measure, five studies used 
predictive equations, one study constantly varied the diet prescriptions based on the 
weight loss achieved (286), (293, 295), (243, 244, 287-289), (294). This last approach 
quite obviously introduces a major bias in the objective assessment of differential weight 
loss achieved. However, the hypothesis being tested in this study was that IF would 
produce different changes in body composition with comparable degrees of weight loss 
using either IF or CDR, and so was more appropriate to addressing this question.  
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Study Outcomes: Weight Loss 
Eight out of twelve studies identified no difference in weight loss between the IF and 
CDR groups (244, 286, 288-292, 294). Only one of these matched calorie intakes 
between groups (286). Of the four that did find a difference, two did not match calorie 
intake and weight loss was commensurate with the prescribed calories(243, 293). Harvie 
et al, 2013 found that a higher proportion of participants in the IF group achieved the 
pre-specified target of 5% weight loss from baseline over 12 weeks (287). In one of the 
IF groups, IF-Carb (Table 1.2), participants ate 68%, rather than 100% of predicted 
requirements on their non-fasting days and lost most weight, while the IF-PF group ate 
77% rather than 100% of requirements and lost more weight that the CDR group who 
consumed the highest proportion of calories overall. Byrne et al, 2018, found a difference 
of 5.9 kg weight loss in the IF group compared to the CDR group over 16 weeks. 
Remarkably, despite all participants completing daily food diaries for 16 weeks, the 
energy intake data was not analysed, and mere diary completion was taken as a measure 
of dietary adherence. This recent study was published five years after that of Harvie et 
al, 2011. Thus, the presence of a known confounder for these studies of IF vs CDR was 
unaccounted for. This is the only human RCT with a calorie matched control to suggest 
that IF confers greater weight loss than CDR (295).  
Study Outcomes: Body Composition Assessments 
Whether or not IF offers advantages in terms of preferential FM, rather than lean mass, 
lost has been examined in all but two studies (244, 288). Underwater weighing, air 
displacement plethysmography, dual x-ray absorptiometry (DXA) and bio-impedance 
analysis were the methods used to assess body composition change. These techniques are 
discussed in detail in section 2.3.1. Two studies did not assess body composition, six 
studies found no difference in body composition (244, 286, 289, 290, 292, 293).  
The studies that found no difference in body composition with IF compared to CDR, had 
some confounding factors. One study running for 72 weeks had a 40% drop out in the 
ADF group; another had only five participants per intervention group, and four studies 
did not match calorie intake in the IF and CDR groups (286), (293), (289), (290),(244), 
(292). 
Four studies did find a difference in body composition change with IF (243, 287, 294, 
Byrne, 2018 #451), (295). Arguin found greater FFM loss with IF, as assessed by DXA 
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(294). Though it is unclear if calorie intake was matched in both groups in this study, the 
weight loss was comparable. The absolute difference between treatment groups over the 
intervention period was 0.6 kg. This reduction in lean mass is of questionable clinical 
significance and close to the lower limit of detection for modern DXA scanners (300). 
Byrne et al, 2018, used air displacement plethysmography and found greater FM loss 
with intermittent fasting (295). Harvie et al, 2013, found greater reduction in FM using 
bio-impedance analysis (BIA) with the IF and carbohydrate restriction group, compared 
to CDR. However, this was not found with the IF and ad libitum protein and fat group, 
compared to CDR (Table 1.2) (287). This is likely due to differences in calorie intake 
between the two different IF groups. Varady et al, 2013, found greater FM loss of 3.6 kg 
with IF, assessed by DXA. However, in this study, the control group did not lose any 
weight (243).  
In summary, most studies demonstrated no change in body composition with IF. One 
study that achieved comparable weight loss between groups demonstrated only a minor 
change in lean mass with IF. Studies that have demonstrated a preferential reduction in 
FM with IF, are mainly limited by unmatched, or unknown calorie intake between 
groups.  
Study Outcomes: Metabolic Assessment.  
Seven studies assessed at least one marker of glycaemia. These included fasting insulin, 
fasting glucose, an intravenous glucose tolerance test or HbA1C. Three studies identified 
improvements in glycaemia with intermittent fasting (244, 287, 289). Catenacci et al, 
2016, found an improvement in fasting glucose, but no difference in fasting insulin or 
the glycaemic response to an intravenous glucose tolerance test. Harvie et al found 
reductions in serum insulin and HOMA-IR in two studies (287, 289). One of these studies 
assessed fasting insulin, HOMA-IR and triglycerides on the morning after a two-day fast, 
and within two days of resuming a normal diet, in a subgroup of participants. This 
demonstrated a reduction in insulin, HOMA-IR and triglycerides after fasting of 23%, 
29% and 18% respectively in fifteen IF participants, with no significant changes in the 
nine CDR participants. Though only a small subgroup analysis it provides important 
preliminary information in support of a possible benefit of intermittent fasting.  No other 
studies timed their assessments of glucose homeostasis in this way.  
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In addition to glycaemia, seven studies assessed lipid profiles (243, 244, 287, 288, 291, 
292, 294). Varady et al, 2011 demonstrated a reduction in triglycerides only with IF in 
one study where participants had comparable weight loss (288). In a second study, the 
only study with a metabolic outcome as a primary end-point, IF was associated with a 
reduction in LDL cholesterol, triglycerides and an increase in LDL particle size (243). 
However, the control group did not lose any weight. Though the LDL particle size did 
increase significantly over 12 weeks in the IF group but not in the CDR group, the 
difference between groups for this change was not statistically significant. Hill et al, 
1989, demonstrated a reduction in total cholesterol in the IF group, the only lipid 
assessed, (292), again with comparable weight loss between groups.  
Leptin, adiponectin or ghrelin have been assessed in three studies. Compared to an ad 
libitum control without weight loss, IF reduced leptin and increased adiponectin (243). 
When compared to a CDR with a lower calorie intake than the IF group, there was no 
difference in either adiponectin or leptin (289). Catenacci et al, 2016, found no difference 
in ghrelin or leptin between treatments (244). 
Study Outcome: Energy Expenditure 
Differences in energy expenditure between CDR and IF have been examined in five 
RCTs (244, 292-295). Four used indirect calorimetry to assess REE. One used chamber 
calorimetry to assesses energy expenditure during sleep, cycling and sedentary activity 
(293). Catenacci et al, 2016, measured REE using a canopy hood indirect calorimeter 
before and after eight weeks of intervention. Results were adjusted using regression for 
FM and FFM. There was a trend toward a lower REE in the CDR group that did not 
achieve statistical significance. This may have been due to the relative smaller calorie 
deficit in the CDR group (244).  
De Groot et al, 1989, studied 27 women in three studies. The design was complex (Table 
1.2). Room calorimetry was conducted at baseline, week one and week four. The 
reduction in sleeping energy expenditure only was lower in the CDR group (10%) 
compared with the ADF group (3.7%) after 20 days of dieting. Due to differences in body 
composition, scaling by dividing sleeping energy expenditure by FFM was performed. 
Though this produce significant differences between groups, this method of allometric 
scaling is considered flawed (section 2.3.2) (293).   
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Arguin et al, 2012, examined REE in twenty five post-menopausal women randomised 
to IF consisting of five weeks of low-calorie diet sufficient to induce 1% weight loss per 
week, alternating with five weeks of weight maintenance until 15 weeks low-calorie diet 
was achieved. The CDR group performed 15 weeks of the low-calorie diet continuously. 
REE was performed after the first five weeks of low-calorie diet in both groups, and 
again at 15 weeks. There was no baseline measurement. Total REE for 24 hours, without 
adjustment for body composition, were presented. Failure to scale the energy expenditure 
measurements and choosing to perform the first calorimetry after five weeks of the 
intervention may have obscured important differences between groups (294).  Hill et 
al,1989, measured energy expenditure before and after the 12-week weight loss 
intervention, and adjusted REE using FFM. They found no difference in body 
composition between groups (292).  
Within the last 12 months, Byrne et al, 2018, conducted a study that was powered to 
detect differences in REE between IF and CDR groups (295). They were the only group 
to study the impact of IF vs CDR on adaptive thermogenesis explicitly. This study has 
several strengths, the use of REE measurements to prescribe energy intake and DXA to 
assess body composition, repeated calorimetry assessments to adjust energy intake 
during the study, adequate power to detect changes in REE, calorie matched energy 
prescriptions, the use of a male only population to reduce variance in REE.  The authors 
found greater reduction in energy expenditure for predicted weight in the CDR group 
compared to the IF group, this appears to support the concept that an interrupted fasting 
regimen attenuates adaptive thermogenesis occurring in the context of calorie restriction.  
However, there are some substantial limitations with the calculation of adaptive 
thermogenesis and the dietary intake assessment methods in this study. As outlined in 
section 1.6.3.4.7.3, no assessment of dietary energy intake was made during the study.  
Adaptive thermogenesis was calculated using two different equations. The first method, 
used regression equation at baseline to develop an equation of predicted REE based on 
FFM and FM results. Though both groups appeared well matched, the authors found 
group allocation at baseline was a significant predictor of energy expenditure, indicating 
bias in group allocation at the start. Therefore, separate regression equations were 
developed for each treatment group prior to the start of the intervention. This clearly 
introduces bias, as there is no logical reason why allocation to a treatment group should 
alter REE prior to starting the treatment. The second method involved the application of 
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a single, previously published regression equation to both groups, this was developed 
from a different population. As outlined in chapter five, predictions of REE have been 
shown to have variable validity in different populations. Predicting energy expenditure 
from baseline measurements for use in a repeated measures design in the same 
individuals reduces variance and improves validity of prediction equations. The 
discordant results between these methods for assessing adaptive thermogenesis raise 
questions as to the validity of both. A more valid approach would have been the use of a 
single regression equation developed from all participants irrespective of randomisation 
status. 
In summary, the few RCT’s of IF and CDR in humans demonstrate considerably 
heterogeneity in method. Potential advantages of intermittent fasting include, 
improvements in lipids, glycaemia, a reduction in adaptive thermogenesis with weight 
loss and preferential FM reduction. The studies to date have yielded inconsistent results 
with significant limitations including; use of a control group that is not calorie matched, 
the use of calorie prescriptions that are not individually tailored and the absence of energy 
expenditure assessments. Where energy expenditure measurements have been included, 
inappropriate allometric scaling has been a potential confounder in some studies.  
1.7 Summary 
The rise in diabetes in the past 50 years has paralleled the rise in obesity.  Treatment of 
obesity with bariatric surgery has demonstrated the possibility of diabetes remission.  
More recently this has been shown with very low-calorie diet intervention. The discovery 
of leptin, pioneered a greater understanding of the hormonal contribution to human 
energy homeostasis. Translating all this knowledge into effective and implementable 
dietary interventions for the treatment of both diabetes and obesity requires carefully 
conducted diet intervention studies. Furthermore, the response to energy restriction and 
the effect of adaptive thermogenesis in modifying the expected laws of energy balance 
require greater understanding. Adaptive thermogenesis is triggered by a sustained 
reduction in energy intake, through unclear mechanisms. If the sustained reduction in 
energy intake were interrupted using a different schedule of energy restriction, such as 
intermittent fasting, would this overcome the maladaptive effects of adaptive 
thermogenesis on weight loss, body composition and metabolic homeostasis? This 
hypothesis is the fundamental question of this thesis.  
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1.8 Thesis Outline 
Chapter two of this thesis is a methodological overview incorporating the common 
methods used in the studies performed during this PhD. Chapter three is an account of in 
silico validation and precision testing of indirect calorimetry. Chapter four outlines two 
studies of test-retest reliability using indirect calorimetry. Chapter five is a cross sectional 
study assessing the relationship between body composition and REE in New Zealand 
ethnicities, the Predictions of Resting Energy Expenditure in Māori and Pacific 
populations (PREEMPt) study. Chapter six is a randomised control study of the risk of 
hypoglycaemia during IF in participants with diabetes, the IF-Hypo study.  Chapter seven 
is the culmination of the preceding work and is a randomised controlled trial of the effect 
of continuous versus intermittent fasting on adaptive thermogenesis, the Changes in 
Resting Energy Expenditure with Different Schedules of Calorie Restriction (CREEDS) 





In the previous chapter, the restriction of dietary energy intake as a treatment for diabetes 
and obesity was discussed, the role of adaptive thermogenesis in compromising weight-
loss attempts was highlighted, and the potential benefit of altering the schedule of dietary 
intake to reduce adaptive thermogenesis during weight loss was proposed.  
The first part of this chapter discusses the principles of measuring of REE by indirect 
calorimetry, as this method is central to four of the studies described in this thesis. This 
is followed by a discussion of the methodological considerations when measuring 
adaptive thermogenesis during weight loss. Finally, a description of the methods used in 
the thesis is presented.   
The validation studies and test-retest reliability studies that form chapters three and four, 
respectively, were methodological studies that resulted in many changes to our testing 
protocols for indirect calorimetry. It is the revised indirect calorimetry protocols that are 
discussed in this chapter. The original testing protocols and the details of their refinement 
are presented in chapter four. The protocol for validation testing, which differs from that 
used for human measurements, is presented in chapter three. 
2.2 Studying Energy Balance in Humans 
Calorimetry means the measurement of heat energy. In the late eighteenth-century 
Antoine Lavoisier and Pierre Laplace measured the heat produced by a hamster in their 
custom-made calorimeter. By surrounding a ventilated chamber with ice and collecting 
meltwater produced as the animal radiated heat, heat production was measured. Lavoisier 
identified that heat production and oxygen consumption were linked and so proceeded to 
investigate oxygen consumption in man, documenting the quantity of oxygen produced 
at rest and observing that it increased after a meal and with exercise (301). Thus, practical 
calorimetry was born. The theory of how energy balance estimates are arrived at in 
clinical studies of obesity is described here. The practical measurement, materials and 
performance characteristics of the instruments used are described in section 2.4 below.  
69 
 
2.2.1 Physiology of Aerobic Metabolism and Breathing 
The energy required for REE is produced by metabolism of macronutrients such as fat, 
carbohydrate and protein. The metabolism of these macronutrients proceeds through 
several well-described intermediate steps and culminates in a final common pathway, the 
respiratory chain (302). Several important advances in physics preceded the science of 
indirect calorimetry.  
Boyle’s Law, Charles' Law and Dalton’s Law enable descriptions of the quantity of gas 
standardised for temperature and pressure. The volume of a given quantity of gas will 
change with temperature and pressure, however when the temperature, pressure and the 
partial pressure of a gas are measured, volumes can be expressed in a comparable 
standardised way (303, 304). Thus, all gas volumes in indirect calorimetry are expressed 
at a standard temperature and pressure (STP), 273 K (0 C) and 101.3 kilopascals (kPA).  
Avogadro’s law allows the relationship between the volume of gas at a standard 
temperature and pressure to be related to the molar mass of the gas (305). It is far easier 
to deal in STP volumes than interconverting to molar or mass quantities in indirect 
calorimetry. This is because the parameter of interest, energy expenditure in kilocalories 
per minute is calculating using STP gas volumes per min rather than consumption of 
molar or mass equivalents of oxygen, for example.   
Dalton’s Law, fundamental to the respirometry equations used in indirect calorimetry, 
states that in a mixture of gases the pressure exerted by the mixture is equal to the sum 
of the partial pressures of the individual components of the mixture (306). These laws 
have been embodied in the Ideal Gas Law (307). This law states that the volume occupied 
by one mole of any gas at standard temperature and pressure is 22.4l.    
Hess’ Law, based on the second law of thermodynamics, states that the net energy 
produced or consumed in a reaction is equal to the sum of the energy produced/consumed 
in its intermediate steps (308). Hess’ Law allows estimation of the net energy production 
of complete macronutrient metabolism without needing to measure or estimate all the 
intermediate steps involved in the process.  Carbon dioxide (CO2), water vapour (WVP) 
and energy in the form of adenosine triphosphate are produced in this process, and 
oxygen (O2) is consumed. Depending on the substrate being metabolised, a different 
amount of energy, CO2 and O2 will be produced by complete metabolism (309).  The 
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measurement of CO2, O2 and energy production by complete oxidation of macronutrients 
has been studied now for over a century. The stoichiometric relationship between energy 
production, CO2, O2 and WVP enables extrapolation of energy expenditure based on 
measurement of the gases (310). 
2.2.2 Types of Calorimeter 
The early calorimeter developed by Lavoisier and Laplace allowed measurement of heat 
production from aerobic respiration based on the weight of melting ice. Knowing the 
latent heat of melting ice, the rate of energy produced could then be calculated. This was 
the first direct calorimeter. Lavoisier’s later use of oxygen volumes to measure energy 
production was an example of an indirect calorimeter (311).  
Direct calorimeters measure heat production from an organism and are extremely costly, 
complex and require substantial technical expertise. This limits their widespread use. 
Most calorimetry studies in humans involve either indirect calorimetry or non-
calorimetric methods. 
Non-calorimetric methods are distinguished from direct and indirect calorimeters in that 
they do not measure the immediate products of respiration - heat, CO2, O2 or WVP.  
Indirect calorimeters do not directly measure heat but measure other products of 
respiration that are then used to calculate energy produced by respiration. Indirect 
calorimeters are now widely used in clinical and physiology research. They come in a 
variety of configurations and are relatively inexpensive. Indirect calorimeters may be 
further divided based on the volume in which the subjects’ breath is sampled and where 
the flow rate is generated relative to the subject. Indirect calorimetry can be conducted 
using any contained volume with a controlled inflow and measured outflow of air. Most 
commonly a canopy, a room, or a mask are used to gather samples.  
In a canopy hood configuration, a ventilated transparent hood is placed over the head and 
neck of the participant, and resting energy expenditure may be assessed. In a mask 
configuration, a tight-fitting mask is worn over the face, this is more suitable for 
measuring energy expenditure during physical activity as the seal on the calorimeter is 
not disrupted by movement as it would be with a canopy hood. In a whole-room indirect 
calorimeter, the participant resides in a large room, often for several days, while air is 
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sampled from an outlet. The whole-room calorimeter can be used to measure total energy 
expenditure and its components.  
2.2.3 Conventions and Terminology used in Indirect Calorimetry 
Several conventions are used in the literature on indirect calorimetry which are observed 
throughout this thesis. The concentration of a single gas in a mixture of gases is expressed 
as a fractional concentration. For example, the fractional concentration of O2 in inspired 
air is 20.94%, however fractional concentrations are more commonly expressed as a 
proportion relative to a maximum value of one, 0.2094.  Gas volumes are expressed in 
STP volumes, the volume that would be occupied at standard temperature and pressure.  
Barometric pressure is expressed in kilopascals (kPA) and energy expenditure is 
expressed in kilojoules (kJ). Resting energy expenditure is calculated from the rate of 
change of O2 and CO2 per unit time. These quantities are designated VO2 and VCO2 
respectively. Though depleted during respiration, VO2 is always represented as a positive 
value.  
The flow of air into the hood is known as incurrent air and is drawn into the hood via a 
hole in the top surface. The air flow that flows out of the hood is altered by the depletion 
of O2 and enrichment with CO2 and water vapour (WVP) during respiration. The flow of 
air out of the hood is known as the excurrent air. The fractional concentration of incurrent 
O2 is denoted FiO2, while the fractional concentration of incurrent CO2 is denoted FiCO2. 
The fractional concentrations of these gases in excurrent air are denoted FeO2 and FeCO2, 
respectively (Fig 2.1). The flow rate is designated FR.  
In a canopy hood pull through configuration (Fig 2.1) ambient air is “pulled” through a 
hood, FeO2, FeCO2, the flow rate of the excurrent air (FR), FiCO2, WVP and barometric 
pressure (BP) and temperature are also measured. Incurrent oxygen (FiO2) can be 
measured and, once corrected for barometric pressure and water vapour pressure, it 
should equal 0.2094.   
 Pull or push configuration refers to the location of the generated flow through the volume 
relative to the subject. If the flow rate generator is upstream of the subject it is a push 
configuration. In a pull configuration, the flow rate is generated downstream of the 
participant. All calorimetry in this thesis is pull configuration. Thus, the controlled and 
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measured flow rate in a pull configuration is the excurrent flow rate. The equations 
required to calculate REE are dependent on a knowledge of the configuration. 
 
 
2.2.4 Measurement of REE by Indirect Calorimetry 
The O2 concentrations, CO2 concentrations, water vapour pressure, barometric pressure, 
and excurrent flow rate can be used to calculate the VCO2, VO2 and thus REE from the 
calorimeter subject. These calculations and their derivation are well described by 
Lighton, 2008, and are based on a few simple principles (312). First, the summed 
fractional concentrations of nitrogen, oxygen and carbon dioxide in incurrent air (FiN2, 
FiO2, FiCO2, respectively) must equal the summed fractional concentration of the 
nitrogen, oxygen and carbon dioxide in excurrent air (FeN2, FeO2, FeCO2 respectively). 
This is because none of the other constituents of air are altered by respiration and so 
remain unchanged. Secondly, oxygen depletion concentrates CO2 in expired air and this 
effect must be accounted for in estimating VCO2 and vice-versa.  
VCO2 is calculated as:  
Equation 2.1   VCO2 =
FR∗((FeCO2−FiCO2)+ FiCO2∗(FiO2−FeO2))
(1+FiCO2)
   
This equation reflects the difference in incurrent and excurrent CO2 concentrations 
multiplied by flow rate over time. It also incorporates a correction factor. This is to 
account for the concentration of CO2 by O2 depletion. The term “FiCO2* (FiO2 - FeO2)” 
results in a negative value when O2 depletion occurs. This is calculated and added to the 
Figure 2.1 Incurrent and Excurrent Air Flow During Canopy Hood Calorimetry 
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difference in FiCO2 and FeCO2. A similar calculation is used to estimate VO2, however 
as VO2 is represented as a positive value FiO2 is subtracted from FeO2, not vice versa, 
and the correction factor is subtracted not added to the main term. Finally, FiO2 can be 
assumed to be a constant 0.2094:  




The respiratory quotient is defined as the ratio of VCO2:VO2 and is calculated as:  
Equation 2.3:   𝑅𝑄 = 𝑉𝐶𝑂2/𝑉𝑂2  
Finally, REE can be calculated as described by Weir, (310): 
Equation 2.4: 𝐸𝑛𝑒𝑟𝑔𝑦 𝐸𝑥𝑝𝑒𝑛𝑑𝑖𝑡𝑢𝑟𝑒 =  3.941 ∗ 𝑉𝑂2  +  1.106 ∗ 𝑉𝐶𝑂2 
Thus, the measurement of REE can be achieved using equations specific to a pull- 
configuration indirect calorimeter. Two additional considerations in the estimation of 
REE using indirect calorimetry are the washout effect and the time constant of a given 
calorimetry configuration.  
 Washout Effect and the Z transformation 
To calculate VO2 and VCO2 accurately using indirect calorimetry, the VO2 and VCO2 of 
the participant needs to be determined from air flow out of the fixed volume chamber. 
Time-lag correction, the shifting forward of samples in time, will address time delay in 
making this assessment, but it does not affect the dilution of expired gas concentrations 
in a fixed volume of air that is constantly being depleted and replaced by fresh air. This 
concept is best illustrated graphically (Fig 2.2).   
A hood or room calorimeter may be considered a closed container filled with gas. The 
excurrent flow rate from these containers is controlled and known and determines the 
inflow rate. Extrapolating the change of gas occurring relies upon an understanding of 
the factors affecting gas concentration within the room. The production of CO2 or 
depletion of O2 per unit time from a participant within the container, are the measures of 
interest. As they are measured, CO2 and O2 are diluted by the air already in the container, 
in a manner proportional to the volume of the container. In addition, they are also diluted 
by the replacement of air in the container with atmospheric air in proportion to the flow 
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rate through the system. Over time these diluting effects slow the attainment of the final 




Figure 2.2. The ‘Washout Effect’ 
Ink of an unknown intensity is dropped into a bath with an inflow and an outflow. The intensity of the ink is the parameter of interest.  
Initially there is a delay as the ink diffuses through the container and the outflow water remains clear (A). As it begins to mix with the 
water in the bath, the intensity of the ink is diluted and is apparently less intense as it is monitored at the outflow (B). Over time, with 
continued addition of ink at the same rate to the water a state of equilibrium is reached where further addition of ink produces no 
significant further colour change in the outflowing water (C). By this time the intensity of the ink in the outflowing water is 
representative of what is in the bottle.   
76 
 
The difficulty with the washout effect is estimating what the true VO2 and VCO2 are 
prior to the achievement of non-steady concentration based on the recorded 
measurements. In whole-room calorimetry there is a large washout effect due to the large 
volume of the room.   
To estimate the steady-state concentrations a mathematical transformation known as the 
instantaneous transformation or z-transformation is applied (313).  It is closely related 
conceptually and mathematically to the time constant. They are two different applications 
of the same property: the relationship of the excurrent gas concentration to time in a flow 
through calorimetry system. The z-transformation enables estimation of the 
concentration at steady-state, while the time constant is a calculation of the time required 
to get to steady-state.  
The z transformation is given by:  




It is a function of the effective volume of the chamber (EV), the flow rate through the 
chamber (FR) the time change between consecutive samples (dT) and the base of the 
natural log (e). The term EV, reflects the canopy or chamber setup and is a theoretical 
term that reflects not just the physical volume of the canopy, but other factors such as 
scrubbing column volumes, dead space, and sensor sensitivity to changing values.  
 The Time Constant and Choice of Flow Rate 
The time taken for excurrent air flow to change with VO2 production, for example, can 
be calculated by dividing the volume (V) of the calorimetry system by the flow rate (FR) 
through the system. This gives the time constant (T).   
Equation 2.6:  𝑇 =  𝑉/𝐹𝑅 
T can also be used to calculate the proportion of the final value (F) of VO2 that will be 
achieved in an indirect calorimeter over a given period, T, after a step change in metabolic 
rate has occurred. This is possible by 
Equation 2.7:  𝑇 = − (
𝑉
𝐹𝑅






V is the chamber volume in millilitres, T is the time in minutes required to reach F, the 
specified proportion of the final value in percent, FR is the flow rate in mls/min, ln is the 
natural logarithm (314).  
A responsive system has a low time constant and can be achieved by using a low volume 
container, as with a canopy hood, or with a high flow rate. The downside of a high flow 
rate is that the washout effect is more pronounced and the change in measured 
concentration of gases becomes smaller for a given true change, and thus potentially 
harder to detect. At a minimum, the change in measured concentration of gas needs to be 
greater than the accuracy of the sensors, (see Table 2.2), to be detected.  
Canopy hood calorimetry recordings are typically less than an hour in duration and so 
24-hour REE is calculated from this shorter sample. The extrapolation to a 24-hour 
estimate involves certain assumptions, for example that no substance that may alter REE 
during the day is consumed, e.g. smoking, caffeine or medications such as 
methylphenidate or theophylline (315-317). Furthermore, sleeping metabolic rate is 
assumed to be equivalent to REE, when in fact it is approximately 5% lower (318).  The 
practicalities of obtaining accurate measures for the components in these equations; 
FiCO2, FiO2, FeCO2 and FR are described in section 2.4.4.  
2.3 Requirements for the Study of Adaptive Thermogenesis  
Adaptive thermogenesis was defined in chapter one as the reduction in REE, beyond that 
which is expected for the change in body composition, occurring during a period of 
dietary energy restriction. This definition has implications for the accurate assessment of 
adaptive thermogenesis.  
Resting energy expenditure varies with body weight, FM and FFM. Two individuals of 
the same weight, one with a high proportion of muscle mass and the other with a high 
proportion of FM will each have a different REE due to differences in the metabolic 
activity of FM and FFM.  During weight loss, both FM and FFM may change by different 
amounts. To determine adaptive thermogenesis accurately, the expected change in REE 
for the change in body composition must be calculated and compared to the measured 
change in REE. In addition, REE must be ‘scaled’ or expressed in a way that allows 
meaningful comparison between individuals of different sizes and body compositions.  
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A further requirement in the study of adaptive thermogenesis is the prescription of a 
standardised hypocaloric diet. There are many factors that determine daily energy 
expenditure (Fig 1.1), these vary between individuals. Thus, a fixed calorie intake will 
provide a different proportion of the total daily energy requirements for different 
individuals. To standardise a hypocaloric diet, individual daily energy requirements must 
be calculated and the diet prescription based on these. Adherence to this diet prescription 
must also be assessed.  
In summary, to study adaptive thermogenesis during a hypocaloric diet intervention; 
REE and body composition need to be measured with precision and accuracy, REE needs 
to be normalised for inter-individual comparison, energy requirements must be estimated 
and adherence to the dietary prescription needs to be assessed. The principles for 
measurement of REE have already been discussed in section 2.2.4.  
2.3.1 Body Composition Assessment  
Resting energy expenditure is determined primarily by body composition, and FFM. 
There are several methods used for the assessment of body composition of which bio-
impedance analysis, dual energy x-ray absorptiometry (DXA), densitometry and MRI are 
some of the most common. Balance methods (section 2.3.1.1.6) are discussed briefly as 
they are used in multi-compartment models and are relevant to the assessment of body 
composition with weight loss.  
 Body Composition Assessment Methods 
Levels and Compartmental Models of Body Composition Analysis 
One of the starting questions of body composition analysis, is at what level the 
composition of the body will be assessed. Wang et al, 1992, proposed that body 
composition could be considered at five levels of increasing complexity; atomic, 
molecular, cellular, tissue-system and whole body (319). Many of the body composition 
assessment methods discussed below operate at the tissue-system level. While whole 
body MRI can be used to assess all tissues in the body, other methods assess the 
composition of the body by categorising them into tissue compartments of similar density 
(320). This requires certain assumptions to be made regarding the stability of the water 
content, and thus density within each compartment. DXA, for example is a two-
compartmental model dividing the body into FM and FFM. Body composition can be 
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assessed using more complex compartmental models by combining two or more of body 
composition assessment methods. Examples include, a three-compartment model 
comprising fat, water and fat free dry mass, or a four-compartmental model comprising 
fat, water, mineral and protein. In these examples, whole body water can be assessed 
using labelled water, FM using densitometry and mineral content using whole body 
potassium and bone mineral content using densitometry (321). The additional cost and 
inconvenience of multi-compartmental methods is a disadvantage and must be weighed 
against the relative gain in accuracy that it provides.  
Bioelectrical Impedance Analysis  
Bioelectrical impedance analysis (BIA) involves the measurements of body composition 
based on resistance, more accurately called impedance, to the flow of an electrical current 
through tissues (322). Bioelectrical impedance analysers consist of surface electrodes 
that deliver a fixed current through to the body via a point of contact such as the hands, 
ankles or feet. They combine a weighing scale function in addition to body composition 
measurements. Under Ohm’s law the measured voltage across the electrodes following 
application of the current is inversely proportional to the impedance, which in turn is 
related to the tissue volume or mass. Using this principle, a quantitative measure of the 
size of different body compartments can be obtained (323). Multifrequency BIA involves 
currents of varying frequency that produce estimates of intracellular fluid, extracellular 
fluid, FFM, FM and total body water. In contrast to other methods such as DXA (section 
2.3.1.1.3) and deuterium dilution (section 2.3.3.1), BIA is inexpensive, precise, 
acceptable to participants and does not require substantial technical expertise.  
However, BIA relies upon several assumptions that can reduce the accuracy of the 
technique if they are not met. First, Ohm’s law is applicable to cylindrical conducting 
materials; thus, a mathematical adjustment is made to account for the non-cylindrical 
shape and the theoretical length of the cylinder. These adjustments may have variable 
accuracy depending on the shape of the individual being measured (324). Secondly, 
electrical conductance through human tissue, relies upon fluid volumes and electrolytes, 
thus hydration and a normal electrolyte balance is assumed. Fluid and electrolyte shifts 
may occur during weight change and violate these assumptions (325). Thirdly, as there 
is no theoretical basis for a relationship between FM and impedance, it is determined 
experimentally in sample populations of individuals. Regression equations have been 
80 
 
developed that plot the relationship between the electrical parameters and body fat 
determined by alternate methods (326). The validity of this relationship relies upon the 
reference method itself being accurate, and the sample population resembling the 
population in which the technique will be used with respect to age, gender, health status 
and ethnicity (323). Rush et al, 2006, evaluated BIA equations in New Zealand Asian 
and Fijian Indian Adults, and Māori and Pacific children and found reduced validity of 
equations in these ethnicities as the equations were developed in predominantly white 
populations (327, 328).  
DXA 
DXA measures body composition by passing x-rays of two different energy levels 
through the body. The energy of these rays is reduced in proportion to the depth and 
density of the tissue prior to hitting a detector (329). DXA is used to identify tissues of 
different density such as FM, Bone and FFM. DXA is quick and convenient to perform, 
and involves only a small dose of radiation. The coefficient of variation with DXA’s is 
as low as 1% for FM and FFM (300). Most commercial DXA scanners are not suitable 
for very obese patients due to the weight limit, the width of the scanning table or the 
height of the scanning arm.  
Densitometry 
Densitometry refers to body compositions assessment methods that rely on measuring 
body composition by assessing body weight and body volume, and thus density. These 
methods are distinct from DXA which relies on a different principle, x-ray attenuation, 
to assess body composition. Underwater weighing, or hydro-densitometry was the 
original method used to do this. Participants need to be submerged, often several times, 
to obtain an average weight and density. Residual lung volumes also need to be measured. 
Apart from the specialised equipment required to measure underwater weight and 
residual lung volume, patient burden is a significant disadvantage of this approach.  
Air displacement plethysmography, another densitometry method, does not require 
immersion in water and performs well compared to hydro-densitometry. Participants are 
placed in an enclosed chamber and air displacement used to estimated body volume. A 
potential limitation with both densitometry methods is that the body density needs to be 
converted to an estimate of body composition. As with predictive equations of REE, the 
validity of these equations may be affected by factors such as age, body habitus or 
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ethnicity (330, 331). However, it is a valuable technique that can be combined with other 
body composition methods to develop multicompartment models (332).  
Magnetic Resonance Imaging 
Magnetic resonance imaging involves application of a strong magnetic field to the body, 
which excites hydrogen atoms in body tissues. These atoms gradually return to their pre-
excitation state at different rates in different tissues, releasing radio-wave signals as they 
do so. The radio-wave signals are used to generate images that discriminate between 
different parts of the body. MRI can be used for whole body composition and has a high 
precision  (332).  The chief disadvantages of MRI scanners are their size and cost, being 
available in only a few research centres. As the scanners are narrow they may not be 
acceptable to participants with claustrophobia or permit measurement of vey obese 
participants (333). Quantitative MR is an application of the MRI technique that results in 
a quantitative estimate of tissue, such as fat. It has been used to detect very small changes 
in fat deposition in specific tissues such as the liver and pancreas (167).  
Balance Methods 
Balance methods involve estimating the rate of change of FM by measuring net energy, 
electrolyte and/or nitrogen balance in dietary intake and excreta (334). While the 
composition of weight lost can be measured, the absolute body composition prior to, or 
following weight loss must be assessed by a different method. Balance methods are 
costly, labour intensive, require considerable expertise and must be performed in an 
inpatient setting. They involve an error of approximately 5% in the estimation of FM due 
to assumptions required by the method (335).While balance methods are not feasible in 
larger trials due to the cost and analytic work involved, they can be used for detailed 
metabolic studies in small cohorts and may be of use in the assessment of body 
composition during weight loss.  
 Body Composition Assessment During Weight Loss 
Fat free mass is a convenient body composition term but is biologically heterogenous, 
consisting of metabolically active components, such as mitochondria rich muscle fibres, 
and inactive components such as water, glycogen and electrolytes. Changes in the 
glycogen content of muscle within the first few days of weight loss can result in 
secondary water loss. Electrolytes, minerals, proteins and intracellular lipid content are 
82 
 
also altered during weight loss (336). These changes violate the assumptions of 
electrolyte and fluid balance upon which many body composition analysis techniques 
depend.  As simpler body composition methods use two compartment models, they are 
potentially prone to reduced accuracy during weight loss. To assess this error, they have 
been compared to four-compartmental models or MR. 
Muller et al, 2012, evaluated the superiority of a combination of energy balance, nitrogen 
and fluid balance methods versus; air displacement plethysmography, quantitative MR 
and BIA (337). Ten participants, who lost 3.6 kg over one week were assessed for change 
in FM. Air displacement plethysmography significantly overestimated FM though not 
fat-free mass during weight loss, and the authors recommended against its use in the 
assessment of short term changes in FM. BIA demonstrated little systematic error but a 
very large interindividual variation in weight lost. DXA was not assessed in this study. 
Jebb et al, 1993, found little difference in mean FM loss assessed by balance methods 
compared with BIA during under and over feeding in three individuals (334).   
Pourhassan et al, 2013, compared doubly labelled water, air-displacement 
plethysmography and deuterium dilution to a four-compartment model, in the assessment 
of body composition during weight loss (338). Overweight and obese men and women 
lost an average 11.2 kg over approximately two years.  There were no statistically 
significant differences between the four-compartment model and DXA, air displacement 
plethysmography or deuterium during weight loss, however the mean bias for DXA was 
greater than the other two methods. Limitations of the study were the heterogeneity in 
the rate of weight lost, and non-standardized time points for body composition 
assessment.   
The performance of DXA in this study raises an important point about using the four-
compartmental model as a reference method for FM and FFM estimation. In both the 
Pourhassan study and in the original description by Fuller of the four-compartmental 
model, DXA is used to provide bone mineral density estimates not estimates of FM or 
FFM. Deuterium dilution and densitometry contribute to the estimates of these latter. 
Fuller et al, 1992, highlight this in their original paper and cite it as the reason why DXA 
estimates are more likely to differ from air displacement plethysmography or deuterium 
dilution methods (321). The four-compartmental model, thus improves overall precision, 
compared with DXA alone, but does not necessarily improve on criterion validity as 
83 
 
compared with a true independent reference method.  The absence of such a method 
remains a major limitation in the assessment of methods of body composition analysis.  
Mahon et al, 2007, also studied deuterium, air-displacement plethysmography and DXA 
compared to a four-compartment model during weight loss. Twenty-seven obese 
postmenopausal women lost a mean 9% of body weight over nine weeks. No significant 
differences in the assessment of FM, FFM or body fat percentage were found between 
groups (339).  
In summary, a range of body composition assessment techniques are available, each with 
their own relative merits. A four-compartment method is considered optimal to mitigate 
potential errors with body composition assessment during weight loss. Studies comparing 
two compartment methods with a four-compartment reference method have not 
highlighted a single superior method for body composition analysis during weight loss.  
2.3.2 Allometric Scaling of Resting Energy Expenditure 
Allometry is the study of the relationship between size and other physiologic measures, 
such as head size or organ mass or energy expenditure. The term was originally coined 
by Teissier and Huxley in reference to the field of relative growth of limbs to body mass 
(340). In the study of energy expenditure, allometry is relevant to assessing how REE 
may vary with measures of size. As outlined in section 2.3, this is important as inter-
individual changes in size may account for changes in absolute REE and confuse the 
detection of changes in REE that may be due to an intervention, such as an energy 
restricted diet. Thus, normalising REE based some measure of size is recommended in 
studies of REE (341).   
In the past, body surface area, calculated by incorporating height and weight, were used 
for normalizing REE (342). However, these methods did not fully account for variations 
in inter-individual REE. It was later recognised that allometric scaling using body 
composition, rather than total mass, could be used to explain some of this inter-individual 
variation (343). Thereafter body composition assessment methods have been a 
cornerstone of REE assessment, allowing allometric scaling. Body composition 
parameters such as FM and FFM, are now used to scale REE, but what is the best way to 
do this?  
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The simplest approach is to divide the REE by the body composition measure. This 
approach has been shown by Poehlman et al,1995, to produced biased estimates of REE 
(344). Instead, using uni- or multivariate regression of REE, incorporating FFM, with 
other covariates such as FM, age or gender produces measures of REE that more 
accurately represent interindividual variations in REE. This has also been confirmed in 
growing children and adolescents, a group with a greater rate of growth than adults, by 
Zakeri et al, 2006 (345).  Such regression equations used for allometric scaling are like 
the prediction equations described in section 2.3.3.2. The application of these equations; 
the comparison of REE in the context of a trial rather than the calculation of resting 
energy expenditure to estimate dietary energy requirements, is the chief difference.  
While the use of regression equations with FM or FFM is arguably one of the most 
common methods for allometric scaling of REE, it is not a perfect solution, limited as it 
is by challenges of body composition assessment (section 2.3.1). The FM and FFM 
“compartments” are heterogenous and composed of small tissue compartments of 
varying metabolic activity. Moreover, regression equations developed in this way have a 
non-zero intercept. Thus, in theoretical models that represent whole body composition in 
terms of FM or FFM only, at zero FM and zero FFM, some energy expenditure is still 
expected. This is a biologically implausible scenario. With the advent of MRI for detailed 
body composition phenotyping, allometric scaling has been extended to include organ 
size. Bosy-Westphal et al, 2009, have shown that the non-zero intercept can be accounted 
for by differences in organ mass between individuals, assessed by MRI (346). The 
incorporation of organ mass, improves the explanation of variance in REE by 10%, 
compared to scaling with just FM and fat free-mass. The liver contributes most to REE 
followed by the brain, kidney and heart, in keeping with the relative size of these organs.  
Currently, allometric scaling using organ mass, FM and FFM is the ideal approach to 
allometric scaling, however this method is beyond the reach of most research centres 
because of the cost of the technology. 
In summary, multivariate regression of REE using body composition measures is a useful 
method to normalise REE between individuals of different sizes and body compositions.  
2.3.3 Estimating Energy Requirements 
Total energy expenditure can be measured in free living individuals using the doubly 
labelled water method (section 2.3.1.1) or by studying participants housed in a whole-
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room indirect calorimeter (section 2.2.2). If these methods are not available, total energy 
expenditure may be calculated from estimates of physical activity related energy 
expenditure and diet-induced thermogenesis combined with REE measured by indirect 
calorimetry.  Finally, if no measurements of energy expenditure are possible, REE can 
be estimated using predictive energy equations. These in turn may be combined with an 
estimate of physical activity to obtain an approximation of total daily energy 
requirements.  
 Doubly labelled water 
Doubly-labelled water (DLW) involves the administration of water containing stable 
hydrogen (deuterium) and oxygen isotopes. As oxygen in water is in equilibrium with 
the oxygen in expired carbon dioxide it can be used to trace cellular respiration and thus 
energy expenditure. The elimination of water through perspiration, breathing and 
urination confounds this assessment. The addition of the hydrogen isotope allows the 
elimination of oxygen due to cellular respiration to be distinguished from elimination in 
fluid (347). The DLW technique is an excellent method for the study of total energy 
expenditure in free living individuals, it may be combined with REE and measurements 
of diet induced thermogenesis to estimate physical activity related energy expenditure. 
The chief drawbacks of the method are the cost of isotope, the expertise necessary to 
perform the calculations required and having access to a laboratory with the equipment 
and expertise for the method. Deuterium dilution is a related application, that assesses 
the dilution of the stable isotope, deuterium, in body compartments. It is used in the 
assessment of body composition, rather than energy expenditure.   
 Predictive Energy Equations 
Equations to predict energy expenditure have been developed using multivariate step-
wise regression based on large datasets from different populations (348-352).  By 
incorporating covariates relevant to REE determination in the equation, significant 
predictor variables are retained and coefficients determined which are incorporated in an 
algorithm.  Depending on how they will be employed, equations may use simple 
anthropometric measures, such as weight and height, or body composition measures such 
as FM and FFM.  The strongest predictor of REE is FFM, followed by FM, accounting 
for approximately 60-70% and 30% of the variance respectively, observed in REE in 
large populations. In one of the largest cohort analyses, Lazzer et al, 2007, developed 
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regression equations based on indirect calorimetry measurements and bio-impedance 
analysis of 8,780 Caucasians (350). However, the validity of a predictive equation 
developed in one ethnicity can be problematic when applied to other ethnicities, 
particularly where inter-ethnic differences in the relationship between body composition 
and surrogate markers of body composition, such as BMI exist. This is particularly 
relevant in the New Zealand population and is discussed in chapter five.  
 Diet Induced Thermogenesis 
Diet induced thermogenesis, like REE can be measured by indirect calorimetry using a 
canopy hood configuration or a whole room calorimeter. Participants have fasting 
measurements of REE taken, with repeat energy expenditure measurements, following a 
meal. Diet induced thermogenesis is calculated as the difference between fasting REE 
and REE following a meal. It may take between four and eight hours for REE to return 
to its fasting level following a meal. This makes accurate assessment of REE with 
canopy-hood calorimetry challenging, as participants must remain stationary and awake 
throughout.   
In the absence of measurements, diet induced thermogenesis may be estimated. Diet 
induced thermogenesis accounts for a small proportion of total energy expenditure, 
approximately 5-10% and exhibits a high intra-individual variation of up to 50% (18). 
Diet induced thermogenesis is proportional to total dietary energy intake and can be 
approximately estimated as a fixed proportion of total prescribed energy intake.  
 Physical Activity Assessment  
The accurate assessment of physical activity in free living individuals is a challenging 
task. The most accurate measurements of physical activity are conducted in a chamber 
calorimeter or during direct observation in an inpatient metabolic ward where the 
intensity and duration of all activities are recorded. The disadvantage of this approach is 
the cost, participant burden, and the reduced validity of the assessments when applied to 
free-living individuals. In studies of free-living individuals, doubly labelled water 
(section 2.3.3.1), accelerometry and physical activity logs are amongst the most common 




Accelerometry involves equipping participants with accelerometers that register 
movements in space using sensors. Sensors are typically attached to the trunk or limbs in 
a specific configuration to register certain types of movement. This provides a surrogate 
marker of physical activity. These movements can be converted to energy expenditure 
values, using predictive equations. There are several challenges with the use of these 
devices for assessment of physical activity however. First, their accuracy may be reduced 
by interindividual variation in movement, for example different gaits with walking. 
Secondly, not all physical activities are measured with the same fidelity, and most 
accelerometers are designed to assess specific activities, such as walking, without 
capturing the full range of physical activities that may occur in a day (353). Thirdly, 
predictive equations developed in lean healthy participants may have reduced validity in 
the obese or in participants of a different gender (354). Plasqui et al, 2013, performed a 
systematic review of validation studies of accelerometry in free living individuals 
compared to doubly labelled water. Correlation between methods varied between 0.18 
and 0.88 across a range of accelerometer types and populations. The difference between 
doubly labelled water and accelerometer varied from a mean underestimate of 1430 
kJ/day using accelerometry, to a mean overestimate of 1674 kJ/day, with wide limits of 
agreement (355).   
Physical activity records 
As total daily energy requirement is a more useful measure than resting energy 
expenditure, when prescribing daily food intake, the REE can be combined with a record 
of physical activity to approximate total daily energy requirements. Physical activity 
records may be prospectively completed or filled-in based on recall and may capture the 
type and duration of physical activity over hours, days or weeks.  
The energy cost of physical activities can be expressed as a ratio of the energy consumed 
performing that activity to resting energy expenditure - this is known as the metabolic 
equivalent value of the activity (MET). The MET value of a wide range of physical 
activities have been estimated or experimentally determined and are published in the 
Compendium of Physical Activities (356). The value of the MET is that it can allow 
estimation of physical activity energy expenditure when combined with the individuals 
weight and a record of the type and duration of the activity. Clearly aggregating all the 
88 
 
separate activities that make up an individual’s daily movements can be unwieldy. For 
simplicity the energetic cost of physical activities may be grouped into light, moderate 
and vigorous physical activity categories, each allocated its own MET. These estimated 
METs can be combined with physical activity recall methods to estimate physical activity 
related energy expenditure. The advantages of using physical activity records are their 
convenience and low cost. The chief drawbacks are recall bias and potentially low 
accuracy (357, 358).   
In this thesis, physical activity is measured using the international physical activity 
questionnaire (IPAQ), one of the better studied physical activity records (359).  The 
IPAQ assesses physical activity by asking participants to recall the duration of time spent 
doing activities in four different domains at three levels of intensity. Physical activities 
are divided into work-related, transportation-related, domestic and leisure time physical 
activity. In the IPAQ, physical activity intensity is assessed as walking, moderate or 
vigorous. Moderate physical activity is defined as activity sufficient to increase the rate 
of breathing but during which it is still possible to hold a conversation. Vigorous physical 
activity is defined as activity sufficient to increase the rate of breathing such that it is not 
possible to converse. The IPAQ scoring protocol multiplies the MET value of walking, 
moderate and vigorous physical activity by the individual’s body weight and time spent 
doing the activity to produce an estimate of calories spent over the previous week. The 
IPAQ has been showed to have good reproducibility and has been validated against 
doubly labelled water in a New Zealand population by Maddison et al, 2007 (360). They 
demonstrated good agreement between doubly labelled water and the IPAQ estimates at 
low levels of physical activity, ~ 1000 – 2000 kJ/day. The consistency of the IPAQ makes 
it a useful tool in repeated measures assessments. 
2.3.4 Assessment of Dietary Intake  
In an outpatient setting, dietary intake assessment mainly relies on subjective methods 
including food-records, food frequency questionnaires, 24-hour recall or focused 
macronutrient questionnaires (361, 362). Subjective methods such as these have several 
limitations, not least under-reporting of energy intake (363). Objective measures include; 
measuring ingested food of known composition during an inpatient stay in a metabolic 
research centre and digital photography/videography, which has been integrated into 
mobile phone based calorie counting, or food recording apps (108). These are not without 
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their challenges such as cost, user acceptability, participant adherence to image capture, 
interpretation of poor quality images and scaling of images (364, 365). A growing area 
of research is the use of biomarkers, such as 24-hour urinary fructose or sucrose, to adjust 
or calibrate reported dietary intake. While several biomarkers have been identified and 
validated, their reproducibility and sensitivity to change over time remains largely 
unknown and they are not error-free (366). In addition, the calibration process assumes 
that the reference method’s error is independent of the subjective intake measurement 
error, which is not always the case (367).  
Prospectively completed food records are one of the most commonly used methods of 
dietary intake assessment. They are more accurate with respect to energy intake and less 
prone to bias, than food frequency questionnaires or methods based on recall (368-370).  
However, they have some well-established limitations such as; the change in eating 
behaviours during a period of recording, also known as ‘reactivity’; under-reporting of 
energy, sodium and protein intake and increasing participant burden (363, 371-374).  
The reporting bias inherent may vary depending on the populations studied. In 
prospectively completed food records of three to four days has been assessed by 
comparing recorded energy intake with measurements of total energy expenditure during 
weight stability. In these studies, energy intake was under reported by 12% in men 
compared with women and was more likely to occur in the obese (375, 376). Using 
prospectively filled seven day food records, dietary fat was underreported in obese men 
during weight stability (377). 
Despite these limitations, prospectively filled food-records are less burdensome and more 
accurate than records of longer duration (378). They are also sufficiently long to ensure 
a representative sample of daily energy intake, which may vary considerable from day to 
day. Four-day food records were used in this thesis and are described in section 2.4.3.  
2.4 Description of Methods 
Having described the general principles of indirect calorimetry and outlined the 
methodological requirements for a study of adaptive thermogenesis during a low-calorie 
diet intervention, what follows is a description of the protocols used to obtain various 
measurements obtained during the studies described in this thesis.  
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2.4.1 Anthropometric Measurements:  
Unless otherwise indicated, all anthropometric measurements were made in the morning 
between 0730 – 1030 with participants having fasted since 2200 the night before.   
 Height and Weight 
Height was measured using a stadiometer (Leicester Height Measure, Invicta Plastics, 
UK). Participants were measured with their heels in contact with the backplate, weight 
evenly distributed, standing erect with a neutral head position. Duplicate recordings were 
obtained and repeated until there was concordance to within one centimetre.  Weight was 
measured in kilograms to the nearest 0.1 kg using a digital weight scales (TBF-300, 
Tanita, USA) with participants dressed in a single layer of light clothing. Weight was 
adjusted for the weight of light clothing assuming a standard 0.2 kg for all participants.  
 Waist circumference and Hip circumference  
Waist and hip circumference were measured in centimetres to the nearest 0.1 centimetre 
in accordance with the World Health Organisation recommendations (379). Waist 
circumference was measured at the midpoint between the lowest palpable rib and the 
iliac crest. Hip circumference was measured around the widest point of the buttocks. All 
measurements were made with the tape measure parallel to the ground, with the 
participant in a relaxed upright posture. Duplicate measurements were taken and if there 
was a difference of more than one centimetre between them they were repeated until 
concordant.  
2.4.2 Body Composition Assessment 
Body Composition was assessed using BIA and DXA (section 2.3.1).  
 Bioelectrical Impedance 
A multifrequency tetrapolar bioimpedence analyser (TBF-300, Tanita, USA) was used 
to measure body composition in the intermittent fasting study and for weight in all 
studies. The TBF-300 has been validated against DXA and deuterium dilution (section 
2.3.1) as a measure of body composition. It compares favourably with deuterium with 
differences in measurement of FM between BIA and deuterium ranging from -2.1% to 
+1.4%, depending on gender and ethnicity, in an obese adolescent population (380). 
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Compared to DXA for estimates of body fat percentage BIA using the TBF-300 had a 
correlation coefficient of 0.58 (p<0.001) (381).  
 DXA 
DXA Equipment and Quality Control Procedures 
A Hologic Horizon A (Hologic, USA) was used for all DXA scans. The Horizon A 
consists of a 196cm x 66cm bed with a weight limit of 220 kg and an arm carrying an x-
ray emitter and receiver on a mechanised track. It captures body composition data in three 
longitudinal passes. Between each pass the x-ray beam and patient are repositioned so 
that the three passes form a fan beam, this virtual fan beam provides rapid data acquisition 
over approximately three minutes for each scan, reducing the amount of time the 
participants need to remain still. The Horizon comes with custom software for control of 
image acquisition, scan analysis and report generation. The “whole body composition” 
automated scanning protocol was selected for all studies.  
Dual energy x-ray absorptiometry scans for the PREEMPt study (chapter five), were 
performed at a commercial centre, Pacific Radiology, by an accredited radiographer with 
experience in body composition scanning and reported by a radiologist with over 10 
years’ experience in clinical densitometry. For the CREEDS study, (chapter seven) all 
DXA scans were conducted by me at the Centre for Translational Physiology, University 
of Otago, Wellington following acquisition of a new DXA scanner. I received training 
and certification from the Australian and New Zealand Bone and Mineral Society in the 
operation of a DXA scanner. Both sites were accredited to perform densitometry.  
At both sites the scanner was calibrated before every recording and otherwise at least two 
times per week as per Australian and New Zealand Bone and Mineral Society 
recommendations (382). Intermittent radiographic uniformity testing, a test of the 
integrity of the imaging components and related signal processing, was performed 
approximately once weekly. Both procedures were mandatory and participant 
measurements could only be performed once they had been completed and passed 
predefined quality control standards, otherwise the system remained locked.  
Phantom precision and accuracy  
As part of the calibration process, the accuracy of the DXA machine was checked using 
a ‘phantom’ provided by the manufacturer. The phantom is a synthetic block for which 
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the weight, area and density are known. After calibration measured density, area and 
weight were plotted against the reference values. During the CREEDS study, compared 
to the reference value of 0.927g/cm2, the mean density was 0.927g/cm2 with a standard 
deviation (SD) of 0.002 g/cm2.  
Operator Specific In-vivo Precision  
Operator inexperience is a recognised source of error when performing DXA (383). At 
Pacific Radiology, the radiographer and radiologist that performed the scans had recently 
published their rates of precision for body composition scanning using the same 
instrument, personnel and site as the PREEMPt study (300). These results are presented 
in Table 2.1.  
As the DXA machine at the Centre for Translational Physiology was new, the operator-
dependent precision was unknown. Therefore, while the CREEDS study was running, 
we conducted a DXA precision study. The lead investigator of that study was Terry O’ 
Donnell and the co-ordinating investigator was Juliet Bergin. I performed duplicate scans 
in 29 lean and obese participants, the least significant change (LSC) based on these 29 
scans are presented in Table 2.1, with permission, as an indicator of the operator-specific 
precision of DXA scanning during the CREEDS study.   
The least significant change (LSC) is a marker of precision and indicates the minimum 
change necessary between two repeated measurements to be 95% certain that any change 
truly happened (384). The LSC is presented as the percentage coefficient of variation. 
The International Society for Clinical Densitometry (ISCD) recommends an acceptable 
LSC of 3%, 2% and 2% for total FM, total lean mass, and percent FM respectively these 
values are included for comparison. An LSC of 3% means that a change of 3% of the 
mean or more needs to be measured to be certain that a change truly occurred (383). 
Thus, for a mean FM percentage of 50%, a LSC of 2% would be a change of 1% FM 
percentage. Similarly, for a mean FM of 40 kg, a LSC of 3% would be a change of 1.2kg. 
Therefore, our data which is presented in Table 2.1 demonstrates an LSC for FFM, FM 
and % FM of 1.27%, 2.19% and 2.35%. These are within the acceptable range set by the 
ISCD, with the exception of percentage FM, which was not used for allometric scaling 













Fat Free Mass 1.27% 1.45% 2.00% 
Fat Mass 2.19% 2.15% 3.00% 
% Fat Mass 2.35% 2.09% 2.00% 
 
Participant testing Procedure 
All scans were done in the morning with the participants fasted and hydrated. Participants 
wore standard hospital clothing for every scan. Their height and weight were measured 
prior to being scanned and entered into each recording. In the PREEMPt study, which 
involved blood sample collection prior to scanning, a pregnancy test was performed 
within 24 hours of the scan for female participants and the results reviewed prior to 
proceeding with the scan. A form was provided to participants before every scan which 
contained questions relating to fracture risk, previous fractures, recent contrast 
containing scans, details of any prosthetics material and the date of any recent x-rays. 
Patients were not scanned if they had had a contrast scan within the previous two weeks. 
This did not affect any participants in the PREEMPt or CREEDS studies. The whole-
body bone mineral density data was checked to ensure participants were not outside the 
normal range for their gender and age. After discussing the body composition results with 
a member of the research team, all participants were provided with a hard copy and pdf 
version of their scans.  
Jewellery including piercings and glasses were removed prior to scanning and all pockets 
emptied. Participant were positioned according to the National Health and Nutrition 
Examination Survey (NHANES) method:  on the scanning table lying supine, palms 
down and separated from the body, arms slightly angled together, and the face up with 
neutral chin. For comfort, ankles were not strapped but separated and inverted with the 
big toes slightly touching. The Hologic Horizon scanning table contains a line border 
Table 2.1 Least Significant Change in DXA Measurements  
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within which all participants were centred vertically and horizontally. Participants were 
instructed to lie still for the duration of the three-minute scan. Baseline scans were 
referred to when positioning participants for subsequent scans. 
Where an individual was too wide to fit completely on the scanning bed a mirror image 
scan was performed according to the NHANES protocol (385). Briefly, the participant 
was positioned to the right of midline with the left arm moved out of the scanning field. 
All the body including except the left arm and forearm was imaged. During analysis, the 
Horizon’s mirror image protocol was used to transpose data from the right to the left arm. 





2.4.3 Dietary Intake Assessment 
Four day prospectively-filled food records were used to assess differences in adherence 
between treatment arms to a daily energy intake prescription in the CREEDS study 
(chapter seven) and the IF-Hypo study(chapter six). Though many factors influence self-
reported dietary intake such as BMI, prior obesity and gender, there is currently no 
evidence that the schedule of dieting as conducted in these studies causes systematic 
variation in reporting (369). In addition, following a prescribed calorie intake, a 
prospective food record serves to demonstrate competent calorie counting and an 
awareness of prescribed targets to the research team who can provide additional 
education if needed. It also encourages reflection on daily energy intake, which may have 
a positive effect on adherence compared with not keeping a record (371, 377).  
Prospectively filled four-day food records were used in both the IF-Hypo study and 
CREEDS studies, a copy of the four-day food record used in the CREEDS study is 
included in appendix B.  Participants were instructed in their use and completion prior to 
issuing. Every food record had a sample entry. Emphasis was placed on specifying the 
quantity of food consumed, listing all the ingredients and including brand names. Each 
food record was reviewed by the research team after completion for error or lack of detail 
and this was discussed with the participant.  
Food records, were entered by a trained member of the research team into FoodWorks™ 
(Xyris Software, Australia) a nutritional research database. FoodWorks™ utilises the 
New Zealand FOODFiles database and the Australian AusFoods and AusBrands 
databases. The FOODFiles database was developed by the New Zealand Ministry for 
Health and the New Zealand Institute for Food and Plant research and is the most 
comprehensive food nutrient database in New Zealand. The AusFoods and AusBrands 
databases are based on the AusNUT 2011-2013 database developed by the Food 
Standards Authority Australia New Zealand.  
2.4.4 Indirect Calorimetry  
Indirect Calorimetry was used in all but the IF-Hypo study. As I was the first person in 
our institution to use the indirect calorimeter, there was no technical expertise on site, or 
measurement protocol. I needed a detailed knowledge of all aspects of the indirect 
calorimetry machine components, configuration and signal processing to; develop the 
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measurement and calibration protocols, train and test new operators, adapt the automated 
analyses to our own requirements, and perform validation and precision testing of the 
Promethion (chapters three and four), and most importantly to critically analyse the 
measured data. 
 The Promethion Metabolic Monitor:  
The Promethion (Sable Systems, USA), is an indirect calorimetry system that comprises 
a gas analyser, an air flow generator, an atmospheric or “baseline” sampling unit, an 
interface module to communicate with the lab computer, a CO2 and WVP scrubbing 
column to remove CO2 and WVP from the air during calibration, a rotameter to control 
the flow of calibration gases, Bev-a-line™ tubing to connect the components, an air filter 
and a canopy hood (Fig 2.3) It may be used for both canopy hood and room calorimetry 










A schematic of the Promethion’s configuration for canopy hood studies is presented in 
figure 2.3.  Excurrent air, after passing from the subject, through a custom air mixer and 
filter is subsampled by the flow rate generator, and the residual air expelled. The 
subsample is passed through a physical low pass filter to reduce noise or spikes caused 
by the sampling process. The air sample is then split in two channels as it passes into the 
gas analyser. The gas analyser outputs to an interface module which is connected to a 
desktop computer, containing Caloscreen software (Sable Systems, USA).  The air mixer 
is not part of the standard setup and was added to the excurrent air flow prior to the main 
air filter, to reduce variation in the gas signals from respiration. The mixer consisted of a 
repurposed acrylic cylinder containing 2 offset disks with large perforation to enforce air 
mixing.  
The Promethion performs several functions of a standard calorimeter – flow rate 
generation, gas measurement, data acquisition and analysis. It has a novel “dual-channel” 
configuration that allows it to offset sensor drift. Sensor drift occurs when gas sensors, 
exposed to a constant gas concentration starts to “drift” off the true value with prolonged 
exposure. In calorimetry this issue is circumvented by “baselining” – switching from the 
excurrent air flow measurement to an incurrent air flow measurement. While this 
prevents sensor drift, it comes with a loss of data while the excurrent air flow is left 
unmonitored. The Promethion gas analyser (GA-3m2, Sable Systems) contains two rows 
of sensors, called ‘channel one’ and ‘channel two’ each of which houses a WVP thin-
film capacitative analyser, an infra-red CO2 sensor, a fuel cell O2 sensor, a barometric 
pressure sensor, a temperature sensor and a differential pressure flow rate sensor. The 
channels are embedded on a temperature-controlled plate that is set to 37C, warms the 
excurrent air samples, and is continuously monitored during recordings. Baselining can 
be customised via Caloscreen so that channel one is monitoring excurrent air while 
channel two baselines and vice versa. Each channel constantly alternates between 
measuring excurrent air and atmospheric air during a recording. At the end of the 
recording all excurrent measurements and atmospheric recordings in both channels are 
merged (Fig 2.4). The merging process is described in more detail in appendix C. The 
duration of baselining and the frequency of baselining are programmable and, after 
experimentation during nitrogen flow studies, (chapter three) were set to a frequency of 
every 10 minutes for three minutes with an offset of five minutes between channel one 
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and channel two. This protocol allows for relatively short duration calorimetry recordings 
of 35 minutes in duration with an even number of baselining sequences between channels 




Performance characteristics of the Promethion components have been obtained from the 
manufacturer’s website(386), and are presented in Table 2.2.  
‘Scrubbing’ of CO2 and WVP refers to the removal of carbon dioxide and water vapour 
pressure from sampled air. In the Promethion system this is necessary for calibration. 
Ascarite and drierite were used as CO2 and WVP scrubbing chemicals, as 
recommended by the manufacturers. 




Sensor Type Range Accuracy Resolution Drift with constant temp 
and N2 Flow at 50 
ml/min 
CO2 Infrared 0-5% 1% of reading 0.0001% <0.002%/hr 
O2 Fuel-Cell 0-100% 0.1% of reading 0.0001% <0.01%/hr 
WVP Thin-Film Capacitative 0-6 kPA 1% of reading 0.0001 kPA <0.01 kPa/hr 
Barometric 
Pressure 
NA NA 0.1% of reading 0.0001 kPA NA 
Main Flow Rate Differential Pressure 50-250 
LPM 
2% of reading .01 LPM NA 
Baselining Flow 
Rate 
Differential Pressure 0-2000 
ml/min 
2% of reading 0.001 ml/min NA 
Subsampling Flow 
Rate 
Differential Pressure 0-2000 
ml/min 
2% of reading 0.001 ml/min NA 




Calibration of O2, CO2 and WVP analysers. 
The Promethion metabolic screening system requires intermittent calibration of its 
analysers. This calibration involves exposing the sensors to minimum and maximum 
values of their respective gases and adjusting the readings if they are not aligned with the 
minimum and maximum values. Calibration of the WVP, CO2 and O2 sensors were 
performed as per the manufacturer’s instructions. 
Data Acquisition and Signal Processing  
The analysis of the electronic data signals produced by indirect calorimeters necessarily 
requires the use of signal processing methods. Signal processing involves the analysis, 
creation, and modification of signals (387) created, in this case, by changing gas 
concentrations produced by aerobic respiration at rest. When this work is performed by 
a computer it is known as digital signal processing (DSP). While several DSP techniques 
are applied to readings from different types of calorimeter, such as the z-transformation, 
the actual values used to implement these techniques should be determined or at least 
checked experimentally for any new calorimeter setup to ensure the technique performs 
as expected. A detailed treatment of signal processing is beyond the scope of this thesis, 
but the signal processing methods that are used in the analysis of our calorimetry 
recordings are described in appendix C.  
Sampling frequency and data selection 
Calorimetry data for analysis were taken from 900 seconds into the recording until 1800 
seconds into the recording, this was to allow the patient to achieve a resting state. A 
typical recording lasted between 2010-2030 seconds, this last four minutes enabled 
smoother running of the automated data processing.  
Samples were collected every second for the entire recording period. Provided the 
protocol described in section 2.4.4.2 was adhered to and no significant movements were 
made during the recording, all data from 900-1800 seconds were included in the analysis.  
Small movements such as moving fingers or toes are common in indirect calorimetry, 
such movements lasting less than three seconds were ignored. If larger movements were 
made or there was any doubt about the impact of certain movements, the time stamped 
data plus the time lag from onset to offset of physical movements were excluded from 
calculation of the mean VO2 and VCO2 and compared to the analysis involving all data 
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points to assess the impact on the recordings. If any alterations to the standard analysis 
were made, these were recorded with the raw data for later reference.  
Application of the z-transformation & Flow Rate Selection 
The time to achievement of steady-state in our canopy hood configuration is in the order 
of minutes, and participants are allowed to rest for the first 15 minutes of a recording 
there is no need for the z-transformation to compensate for washout effect with the 
canopy hood setup. However, it is used to compensate for sensor delay when a sensor 
switches from monitoring excurrent air flows to atmospheric air flows in the Promethion 
configuration. The z-transformation is applied to every sample recorded before any 
further data analysis. 
In our system the canopy volume is 18.4 litres. Thus, based on equation 2.7, to reach 
99.9% of the final value the response time would be: 
𝑇 = − (
18400
1000000




I.e. a response time of 1.04 minutes to reach 99.9% of final value, close to steady-state. 
The true value, empirically determined by nitrogen dilution (chapter four), is slightly 
longer than this, underscoring the difference between effective volume and physical 
volume described above. During nitrogen dilution we found that a flow rate of 80 SLPM 
provided the ability to detect relevant changes in energy expenditure with an acceptable 
response time. This was used for all our studies. 
 Testing Procedure for Participants  
Resting energy expenditure is susceptible to influence from physical activity, recent food 
intake, stimulants such as caffeine, nicotine, physical ailments, ambient temperature, 
menstrual cycle, rest time prior to starting the recording, body composition 
(388),(18),(389),(390) , (391, 392),(393), (298), (394), (395).  
To minimise variation in resting energy expenditure measurements due to these factors 
the following protocol was implemented; participants were asked to arrive at the testing 
centre by car and to avoid vigorous physical activity for 24 hours prior to the visit. 
Parking was available less than 200m from the testing area. No caffeine or alcohol were 
allowed for 24 hours prior to the visit. All visits were conducted between 0730 – 1100 in 
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the morning. Participants were advised to notify us prior to the visit if they were unwell 
or had a fever. A complete medications and medical history was taken from all 
participants prior to enrolment in studies using indirect calorimetry. Patients with active 
medical conditions or taking medications that interfered with basal metabolic rate were 
excluded from the studies.  Current smokers were excluded from the studies as were past 
smokers with a history of any chronic lung disease. Indirect calorimetry recording 
occurred a minimum of 25 minutes after the participants arrived. Prior to the calorimetry, 
body composition scanning while recumbent, anthropometric measures while standing 
and/or questionnaire responses while sitting were obtained.  Ten minutes minimum were 
necessary once the patient was recumbent to place the canopy hood and seal the 
impermeable skirting around the participant with adhesive tape to avoid air leaks.  
All indirect calorimetry studies were performed with participants wearing standard 
hospital clothing, at temperature of 23.0 – 23.5C with controlled relative humidity of 
40% and atmospherically isolated from the operator. Participants were positioned 
reclining at 30-45 degrees in a reclining chair with their legs elevated for comfort. 
Previous research has shown that a reclining, rather than completely supine position 
makes little difference to the assessment of REE (396). Moreover, it is more comfortable 
for obese participants than lying flat. A selection of movies was offered to the participants 
to watch during the recording. All participants were asked to remain still and awake for 
the duration of the recording. Participants were constantly monitored visually through a 
window, if they appeared to be falling asleep the light intensity in the room was 
temporarily adjusted. The calorimetry room was entered via an antechamber with two 
sealed doors, so that if an operator needed to enter the room, contamination of the 
atmospheric air in the room by that outside was minimised. On the rare occasion an 
operator needed to enter the room, it was with breath held, for less than 30 seconds and 
only if necessary. All operators demonstrated competence to perform calorimetry using 
nitrogen dilution before being allowed to measure human participants. Participant 
movements, variation in environmental condition, and any other events of note during 
the measurement were recorded with the calorimetry recording.  
Body composition assessment occurred on the same day for all studies in the CREEDS 
to allow appropriate allometric scaling of resting energy expenditure. For the PREEMPt 




To minimise inter-operator variability, I was present for all but two of the 149 human 
calorimetry recordings carried out during the PhD. I conducted all daily -calibrations and 
checked weekly and monthly calibrations were up-to-date prior to every recording. I 
visually inspected all data channels prior to running the automated analysis to identify 
any errors evident in the raw data. 
2.4.5 Biochemical Tests  
All blood samples for biochemical tests were taken fasted between the hours of 0800 – 
12:00, after calorimetry. Venous blood samples were centrifuged at 3,000 rpm for 10 
minutes. The supernatant was aliquoted into cryotubes and stored at -80C until analysed.  
All tests, excluding point-of-care glycated haemoglobin (HbA1C) and lipid profiles in 
the CREEDS, were performed by accredited commercial laboratories. Point-of-care 
testing (Cobas b101, Roche, Switzerland) was used for the CREEDS study. This method 
had correlation coefficients of greater than 0.99 compared with the equivalent 
measurement techniques used in the other studies (397). 
Measured thyroid function tests included free thyroxine (FT4), free tri-iodothyronine 
(FT3) and thyroid stimulating hormone (TSH). All samples were collected in serum 
separator tubes. FT4 and FT3 were analysed by competitive electro-chemiluminescence 
immunoassay, and TSH by sandwich electro-chemiluminescence immunoassay (Cobas 
602, Roche, Switzerland). Glucose was collected in fluoride-oxalate tubes, and analysed 
by hexokinase method (Cobas c501, Roche, Switzerland). Commercially tested lipids 
were collected in serum separator tubes and were analysed using enzymatic colorimetric 
assay for high density lipoprotein (HDL), triglycerides and total cholesterol (Cobas c501, 
Roche, Switzerland). Low density lipoprotein (LDL) was calculated from these values 
using the Friedewald formula (398):  
𝐿𝐷𝐿 =  𝑇𝑜𝑡𝑎𝑙 𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 – (𝐻𝐷𝐿 + 𝑇𝑟𝑖𝑔𝑙𝑦𝑐𝑒𝑟𝑖𝑑𝑒𝑠/2.2) 
Blood for lipid measurement using the point-of-care device was collected in EDTA tubes, 
and analysed using an enzymatic colorimetric assay (Cobas b101, Roche, Switzerland) 
for determination of total cholesterol, HDL and triglycerides. LDL was also calculated 
using the Friedewald equation. All samples for HbA1C analysis were collected in EDTA 
tubes. Commercially tested HbA1C was analysed using ion exchange high performance 
liquid chromatography (Vatiant Turbo, Bio-rad Labs, USA). Point-of-care HbA1c was 
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analysed using photometric transmission measurement (Cobas b101, Roche, 
Switzerland).  
Liver function tests included; aspartate transaminase (AST), alanine transaminase (ALT), 
gamma glutamyl transferase (GGT), bilirubin and alkaline phosphatase (ALP). Blood 
was collected in serum separator tubes for liver function test measurement and analysis 
performed using spectrophotometric assays (Cobas, Roche, Switzerland).  
2.4.6 Statistics and Data Analysis 
All statistical analysis was conducted in R, a statistical computing program, except for 
the IF-Hypo study analysis which was carried out in SAS (SAS Institute, USA) (399).  
2.5 Summary 
The measurements outlined in this chapter are central to the studies described in later 
chapters. Of these measurements, the DXA and indirect calorimetry methods required 
critical assessment of performance, first as the devices were new to the research centre, 
and secondly because they are fundamental in the study of adaptive thermogenesis.  
While the theory, calculations and practical measurements of REE by indirect 
calorimetry are complex, it was only through an understanding of these, that the 
performance of the indirect calorimeter could be critically assessed and refined. This 
process of methodological refinement and performance assessment are described in 
chapters three and four.  
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  Validation and Precision Testing of a Canopy Hood 
Indirect Calorimeter 
3.1 Introduction 
A major inflection-point during the work presented in this thesis was the measurement 
of REE in the first participant of the PREEMPt study, presented in chapter five. As the 
first user of a new indirect calorimeter there was no way of knowing what the quality of 
the recording was or what raw calorimetry data ought to look like. Consequently, the 
PREEMPt study was suspended until I reassured myself of the quality of the Promethion 
and my measurements. The first test-retest reliability study (chapter four), and the 
validation and precision studies presented below were essential steps in building operator 
experience and developing our current indirect calorimetry protocols.  
3.2 Validity and Precision  
Validity is defined as the degree to which a test measures the quantity it is supposed to. 
It is also known as accuracy or external consistency. It reflects the systematic error or 
bias due to the error inherent in a measurement method. Precision is the consistency of a 
test with repeated trials. This is also known as the reliability or internal consistency of a 
test. It reflects the random variability that occurs as a result of random errors associated 
with the measurement method rather than a change in the quantity being studied (400). 
Both validity and precision are important. Precision without validity results in consistent 
reproducible measurements of the wrong quantity. Conversely it is not possible to have 
validity without precision.  
As outlined in section 2.2.4, the objective of using indirect calorimetry via a ventilated 
hood is to estimate resting energy expenditure. The process is complex. It involves 
different components that need to work quickly, accurately and synchronously. 
Measurement error can occur at any stage of data collection, calibration, equipment 
maintenance or data analysis.  The method requires accurate measurement of VO2 and 
VCO2, and by implication any intermediate steps required to determine these values. As 
this is a dynamic situation, validation of the method then must involve changing these 
gas concentrations. Moreover, it must be known a priori what the expected change in gas 
concentrations will be. Apart from using a validation method that reflects the physical 
principles of indirect calorimetry, it is also important to validate within a range of 
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physiologic values that are expected in the individuals that will be measured. Techniques 
that simulate VO2 depletion, VCO2 production or both are used based on either one of 
two principles; nitrogen dilution or alcohol combustion.  
3.3 Validation and Precision by Nitrogen Dilution 
3.3.1 The Principle of the Nitrogen Dilution Method 
The nitrogen dilution technique for open circuit, indirect calorimetry was described by 
Fedak et al, 1981 (401). Nitrogen is inert, so does not react with other gases and thus 
does not alter in volume in an environment where other gases are changing. The nitrogen 
dilution technique involves adding a known flow rate of nitrogen to a continuously 
monitored flow of mixed gas, to produce a relative depletion of the other gases. Of these, 
O2, rather than CO2 is the gas of interest, as O2 depletion but not CO2 production, can be 
simulated by the nitrogen dilution method.   
3.3.2 Respirometry Calculations for Nitrogen Dilution 
What flow rate of nitrogen (FRn) will produce a pre-specified VO2? This relationship 
depends on how VO2 is usually calculated which in turn depends on the indirect 
calorimetry configuration. The appropriate choice of equation, as with calculation of VO2 
and VCO2, is critical for developing a valid validation test. Fortunately, the relationship 
between VO2 and the flow rate of nitrogen (FRn) can be mathematically derived. Pure 
nitrogen is used for validation and the flow rate is the primary determinant of VO2 as 
alluded to above. While the mathematical derivation for the nitrogen dilution formula 
may appear complicated, it is a relatively straightforward set of algebraic manipulations 
and substitutions. 
The principles of this derivation are based on those outlined by Bakken et al, 1991,(402) 
and Fedak et al, 1981,(401). The equations outlined in these papers cannot be directly 
applied to our measuring system as Bakken’s equations rely on scrubbing CO2 from the 
incurrent air flow, while Fedak proposes equations for dealing with incurrent air that has 
not been scrubbed of water vapour. The Promethion system does not scrub incurrent air 
flows of CO2 and mathematically adjusts for water vapour so that incurrent air can be 
considered scrubbed of water vapour. Though the derivation of equations for the 
Promethion system were published in 2017 (403), these were not available to me when I 
was preparing for the validation in 2016. Moreover, this publication outlines a set of 
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equations appropriate to validation with a CO2 and N2 mixture not N2 alone. A precision 
gas mixer is required for dual gas validation, this equipment is not currently available at 
our centre. I derived equations specific for our own nitrogen-only validation as Fedak’s 
equations could not be readily applied to our own system. In doing so I was kindly 
assisted by Dr Thomas Foerster (Sable Systems, USA), who generously shared his 
derivations for dual gas validation.  
 Generating the FRi term 
Under normal circumstances nitrogen flows in and out of an indirect calorimeter room 
or canopy hood setup without ever being altered. This can be represented algebraically. 
The flow rate of nitrogen into a canopy hood in this case is given as the incurrent flow 
rate, FRi, multiplied by the incurrent nitrogen concentration expressed as a fractional 
concentration FiN2. Put another way, the total incurrent volume moving per unit time 
multiplied by the proportion of that total volume that is taken up by nitrogen:  
Eq.3.1:   𝐹𝑅𝑁2 =  𝐹𝑅𝑖 ∗ 𝐹𝑖𝑁2 
The same is true for the excurrent flow rate of nitrogen:  
Eq.3.2  𝐹𝑅𝑁2 =  𝐹𝑅𝑒 ∗ 𝐹𝑒𝑁2 
Thus, the unchanged nitrogen content passing through the system can be represented as: 
Eq.3.3   𝐹𝑅𝑖 ∗ 𝐹𝑖𝑁2 =  𝐹𝑅𝑒 ∗ 𝐹𝑒𝑁2 
The addition of supplemental nitrogen to the flow through system to mimic VO2 is:  
Eq.3.4  𝐹𝑅𝑒 ∗ 𝐹𝑒𝑁2 =   𝐹𝑅𝑖 ∗ 𝐹𝑖𝑁2 +  𝐹𝑅𝑘 ∗ 𝐹𝑘𝑁2  
where k indicates the nitrogen validation gas flow. In an indirect calorimetry pull system, 
the FRi term is problematic as only FRe is monitored. Rearranging equation 3.4, it can 
be shown that:  







 Generating the Fractional Nitrogen terms:  
Neither FiN2 nor FeN2
 are directly measured as there are no “nitrogen sensors” in the 
Promethion. However, based on Dalton’s law of partial pressures, when gases are 
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expressed as fractional concentrations the sum of these gases must add to one. Given that 
CO2, H2O and O2 and N2 occupy >99% of air and the other components are inert the 
following holds:  
Eq.3.6   1 =  𝐹𝑖𝑁2  + 𝐹𝑖𝑂2  +  𝐹𝑖𝐶𝑂2  +  𝐹𝑖𝐻2𝑂 
Thus, the normal of atmospheric nitrogen into the hood can be expressed as: 
Eq.3.7  1 − 𝐹𝑖𝑂2 − 𝐹𝑖𝐶𝑂2 − 𝐹𝑖𝐻2𝑂   =  𝐹𝑖𝑁2. 
The flow of nitrogen out of the hood can be expressed as:  
Eq.3.8   1 − 𝐹𝑒𝑂2 − 𝐹𝑒𝐶𝑂2 − 𝐹𝑒𝐻2𝑂 = 𝐹𝑒𝑁2 
Finally, the flow rate of supplemental nitrogen (FkN2) as part of the nitrogen validation 
procedure can be expressed as:  
Eq.3.9  1 − 𝐹𝑘𝑂2 – 𝐹𝑘𝐶𝑂2 – 𝐹𝑘𝐻20 =  𝐹𝑘𝑁2 
Note as we used pure nitrogen rather than a combined H2O, CO2 and N2 mixture equation 
3.9 more correctly reads:  
Eq.3.9  1 =  𝐹𝑘𝑁2 
For combined CO2, and N2 dilution an alternative equation 3.9 could be used:  
Eq.3.9 (alt)  𝐹𝑘𝑁2 = 1 − 𝐹𝑘𝐶𝑂2 
Substituting the FiN2, FeN2 and FkN2 values in equation 3.5, using equations 3.7, 3.8 and 
3.9, respectively:  







As the gases are ‘mathematically’ dried as described appendix C, the H2O terms can be 
removed:  






    
 Generating the VO2 term  
VO2 is the difference between the incurrent and excurrent O2 volumes per unit time:  
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Eq. 3.11  𝑉𝑂2 = 𝐹𝑅𝑖 ∗ 𝐹𝑖𝑂2 − 𝐹𝑅𝑒 ∗ 𝐹𝑒𝑂2 
Substituting for FRi using equation 3.10 gives:  






] ∗ 𝐹𝑖𝑂2 −
𝐹𝑅𝑒 ∗ 𝐹𝑒𝑂2 
This can be simplified using the FRe term:  








The left-hand side of equation 3.13 corresponds to the calculations used by the 
Promethion to determine the measured VO2. Applying this equation to a human 
calorimetry recording, the measured VO2 is the true VO2 (tVO2) and FRk = 0, as no 
nitrogen is being added to the system. This can be represented as follows:  
𝐹𝑅𝑒 ∗ [
𝐹𝑖𝑂2(1 − 𝐹𝑒𝑂2 − 𝐹𝑒𝐶𝑂2) − 𝐹𝑒𝑂2(1 − 𝐹𝑖𝑂2 − 𝐹𝑖𝐶𝑂2)
1 − 𝐹𝑖𝑂2 − 𝐹𝑖𝐶𝑂2
] = 𝑡𝑉𝑂2 =  mVO2  
During nitrogen validation however, this does not happen. The measured VO2 produced 
by the machine is not the tVO2, which is zero, as the nitrogen gas does not alter oxygen 
volume, being oxygen free. Equation 3.13 thus becomes:  
0 = 𝐹𝑅𝑒 ∗ [
𝐹𝑖𝑂2(1 − 𝐹𝑒𝑂2 − 𝐹𝑒𝐶𝑂2) − 𝐹𝑒𝑂2(1 − 𝐹𝑖𝑂2 − 𝐹𝑖𝐶𝑂2)
1 − 𝐹𝑖𝑂2 − 𝐹𝑖𝐶𝑂2
]
−                                   𝐹𝑅𝑘 ∗ [
𝐹𝑖𝑂2 ∗ (1)
1 − 𝐹𝑖𝑂2 − 𝐹𝑖𝐶𝑂2
] 
Rearranging this equation:  
Eq.3.14:   𝐹𝑅𝑒 ∗ [
𝐹𝑖𝑂2(1−𝐹𝑒𝑂2−𝐹𝑒𝐶𝑂2)−𝐹𝑒𝑂2(1−𝐹𝑖𝑂2−𝐹𝑖𝐶𝑂2)
1−𝐹𝑖𝑂2−𝐹𝑖𝐶𝑂2




The right-hand side of this equation is the apparent VO2 and corresponds to a theoretical 
prediction of the VO2 value the Promethion system should give for any given flow rate 
of nitrogen, the predicted VO2 (pVO2):  






 By comparing the mVO2 to the pVO2 a measure of the accuracy of the system termed 
“oxygen recovery” can be obtained: 






  .  
The FRk required for a given pVO2 is:  
Eq.3.17:   𝐹𝑅𝑘 =  𝑝𝑉02 ∗ [
1−𝐹𝑖𝑂2−𝐹𝑖𝐶𝑂2
𝐹𝑖𝑂2




This last equation provides the means to develop a predicted flow rate required to produce 
the desired VO2.  
As it requires knowledge of the FiCO2, which can only be determined after the recording, 
the ability to precisely set the predicted VO2 in advance is prone to a small error.  
However, CO2 values have a very small effect on the outcome particularly as the CO2 
sensors are sensitive and reliable and atmospheric CO2 concentrations are far lower than 
FiO2(404). Notwithstanding these considerations, once FiCO2 is considered the 
generated pVO2 can be calculated accurately and then compared with the measure VO2 
to produce the oxygen recovery.  
3.3.3 The Experimental Setup for Nitrogen dilution 
Performing the Nitrogen validation studies required some modification to the calorimetry 
setup used in human studies. The chief differences are the use of a mass flow controller 
for nitrogen flow control, the use of an additional computer program for nitrogen flow 
data capture and remote control of the mass flow meter, and the channelling of nitrogen 
from the gas cylinder into the canopy hood via a sealed tubing system.  
 Mass Flow Controllers  
Mass flow controllers are electronic devices used to deliver a constant mass flow of a 
gas. As previously noted, gas volumes change with varying temperature and pressure. 
Mass flow controllers vary the volumetric flow rate based on concurrently recorded 
temperature and pressure to ensure a constant mass flow rate. This is analogous to 
delivery of a constant volume of gas at a fixed temperature and pressure, the theoretical 
“environment” assumed by the derivations. The mass flow controllers are programmed 
by inputting the desired STP volumetric flow rate. They are also used in the Promethion 
system to generate the main flow rate and subsampling flow rates.  
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An Alicat mass flow controller (MC-5SLPM-D, Alicat Scientific, USA) calibrated by 
the manufacturer for planned nitrogen flows between 0 – 3 SLPM, was used. The 
accuracy of this mass flow controller was 0.8% of the reading and 0.2% of the maximum 
flow rate of 3SLPM. Thus, for a programmed flow rate of e.g. 800 mls/min the error 
would be 3000x2x10-3 + 800x8x10-3), 12.4 mls/min or 1.6%. Similarly, the precision is 
0.2% full scale, 6mls/min or 0.75% for a flow rate of 800mls/min (405).  
A gas leak is a major potential source of error. Two Clippard push-on male connectors 
¼” OD to 1/8” NPT (Clippard Instrument Laboratory, USA) were used to connect the 
Bev-A-Line tubing to the mass flow controllers. Their threads were first wrapped in 
Teflon tape and the seal checked with a small amount of soapy water rubbed around the 
connection as per the manufacturer’s instructions. The absence of bubbles during a 
nitrogen flow confirmed a good seal.   
 Data Acquisition and Analysis 
Data acquisition and data logging were performed using the stand-alone interface for 
Alicat Instruments. This is a virtual interface that allows control of all setting on the mass 
flow controller from a computer (406), available from: 
https://www.alicat.com/support/software-drivers/labview-virtual-instrument-drivers/.  It 
also graphs in real time; the mass flow rate, volumetric flow rate, set-point flow rate and 
temperature. These data can be logged and the logging frequency can be customized so 
that information is captured every millisecond, second, minute, etc. This software has 
several advantages to a manual approach. First, the nitrogen input with time can be 
accurately recorded. Secondly, any problems with the nitrogen flow can be quickly 
identified visually during the recording, rather than waiting for data analysis after the 
study has been completed. Thirdly, changing flow rates is a matter of typing in a new 
volume and the change occurs within milliseconds, while manual entry requires “dialling 
up” to a new flow rate, which is difficult to do according to a time-specific protocol.  
 Configuration of the Equipment 
To run the nitrogen dilution studies, the canopy hood was placed on pillow within the 
atmospherically isolated chamber. Pure nitrogen was run from a pressurised nitrogen 
tank via Bev-A-Line tubing into the mass flow controller gas inlet. A second tube ran 
from the mass flow controller gas outlet through a custom port that had been bored into 
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the wall of the atmospherically isolated chamber. To avoid air-leaking, a custom rubber 
seal was created that was fastened around the port and perforated to admit the tubing 
only. Once in the chamber the tubing was run into the canopy hood between the base and 
the pillow, the canopy skirting was wrapped around this entry point and under the pillow 
to prevent air leak.  
The most important part of this setup was the use of a custom “diffuser”, a closed-end 
perforated plastic cup, sitting over the tip of the tubing sitting in the canopy hood (Fig 
3.1). The addition of the diffuser, produced a dramatic improvement in validity in the 
order of approximately 20-30%. It works by preventing the nitrogen gas escaping via the 
hood air inlet after it leaves the tubing. The nitrogen enters the closed cup and exits via 
many tiny perforations in the sides. A schematic of the nitrogen validation setup is 
presented in Fig 3.1.  
  




3.3.4 Nitrogen Dilution Test Protocol  
 Step 1: Initialising the mass flow control software.  
Once the equipment was setup as described above, the stand-alone interface for Alicat 
Instruments was started on the laboratory computer. The nitrogen tank was pressurised 
to ensure flow through the tubing. Using manual control of the mass flow controller the 
baud rate was set to 9600 bits on the mass flow controller, the flow rate was set to a 
negligible 0.003 SLPM and the control was set to RS-232 to enable remote access. The 
baud rate is a measure of the speed of communication between the mass flow controller 
and the data logging software. Both must be matched for communication to occur.  
 Step 2: Setting up the calorimetry recording.  
Caloscreen was opened and the flow rate set to 80 SLPM with a baselining frequency of 
10 minutes and a baselining duration of three minutes. Once the recording started, the 
sample number counter was used as a timestamp for all subsequent events. The start of 
the recording was considered timepoint zero.  
 Step 3: Data logging the mass flow controller output.  
Using the stand-alone interface, a connection with the mass flow controller was 
established on the lab computer by specifying a baud rate of 9600 bits and the correct 
communications port (COM port) on the lab computer. Once this was done, the setting 
and real-time readings began to graph within the interface program at a rate of one sample 
per millisecond. The sampling frequency for the mass flow controller was reduced to one 
sample per second and data logging was started. The sample time at which the data-
logging started was recorded.  
 Step 4: Altering the nitrogen flow.  
After at least 90 seconds from the start of the recording, the nitrogen flow was 
instantaneously increased to a flow rate of 0.757 SLPM. Assuming an FiO2 of 20.95 %, 
this would produce a predicted VO2 of 0.2011 STP L/min. The flow was monitored 
graphically and reduced to 0.003 SLPM at least 400 seconds after the increase in 
nitrogen. This was to allow sufficient time to reach steady-state and to enable smooth 
running of the macro. Data logging was stopped at 900 seconds and the calorimetry 
recording was stopped after 1450 samples.  
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 Step 5: Data selection and Analysis:  
All data analysis was performed in R (399). After running the automated macro as 
described in appendix C, markers were placed on the calorimetry recording to indicate 
the onset and offset of the nitrogen flow. VO2, time, nitrogen onset and offset were 
exported and combined with the data log produced by the Alicat standalone interface. 
The data log was matched to the calorimetry data by aligning the nitrogen onset marker 
from the calorimetry data with the change in nitrogen flow rate from 0.003 to 0.757 in 
the Alicat data log. For the remainder of the data analysis, the time of nitrogen onset was 
designated timepoint zero, all time intervals are presented in seconds.  
To determine the achievement of steady-state, the first order differential of the VO2 
reading with respect to time was derived, dVO2/dT. This plots a graph of the rate of 
change of VO2 over time (Fig 3.2). Using this graph, steady-state can be objectively 
defined as dVO2/dT = 0. This can be visually identified by graphing the data. A rolling 
mean technique was used to reduce noise so the time point at which the slope became 
zero was easier to identify. A rolling mean is a technique used in signal processing by 
which a prespecified “window” consisting of n samples centred on an x value, are used 
to calculate the mean value of f(x), for each timepoint x1, x2, x3…xn etc. A window of 10 
samples was used to smooth the signal.  Visual examination of these data after smoothing, 
identified that steady-state was achieved by 300s at a conservative estimate. Thus, the 
mean VO2 at steady-state was calculated for all samples between 300 seconds and the 
time of nitrogen offset. Validity was measured using percentage oxygen recovery, which 





The mean, standard error, sample number and 95% upper and lower confidence intervals 
were calculated for VO2 and % oxygen recovery for each trial (Table 3.1). The early pilot 
tests, mainly numbers 1-8, contained several errors primarily due to incorrect setup which 
resulted in incomplete data collection. Where such an error was identified, the trial data 
was not analysed. Thus 12 of the 21 nitrogen dilution studies are presented here. Precision 
was assessed using the standard deviation of the mean VO2 across all 12 trials using 





3.3.5 Nitrogen Dilution Trial Results 
Twelve trials were conducted according to the protocol. Early trials were discounted due 
to; incorrect baselining specification during calorimetry setup, incomplete data logging, 
premature software termination for the mass flow controller data log or presumed 
nitrogen leak from the hood prior to using a sealed cup at the nitrogen gas outlet. As a 
result, the trials are numbered discontinuously 9-21. 
The percentage O2 recovery across all trials was (M: 101%, SD: 0.5%). The fraction of 
inspired CO2, required for calculating the predicted VO2 was 0.0005% in all studies. The 
VO2 remained consistent at steady-state as indicated by a low SD for each trial (Table 
3.1). The results of the nitrogen dilution trials are presented in Table 3.1 and Fig. 3.3. 
  




















9 0.205 0.002 102 0.008 102.2 - 102.2- 
10 0.204 0.002 102 0.008 101.8 – 101.8 
12 0.204 0.002 102 0.012 101.6 – 101.6 
13 0.204 0.002 101 0.009 101.5 – 101.5 
14 0.203 0.001 101 0.005 101.4 – 101.4 
15 0.204 0.002 101 0.009 101.4 - 101.4 
16 0.202 0.001 101 0.006 100.5 - 100.5 
17 0.201 0.001 100 0.006 100.1 - 100.1 
18 0.202 0.002 101 0.008 100.8 - 100.8 
19 0.204 0.001 101 0.005 101.5 - 101.5 
20 0.204 0.001 101 0.006 101.5 - 101.5 
21 0.203 0.001 101 0.003 101.1 - 101.1 
Mean 0.203 0.001 101 0.007 101.3 – 101.3 
 





Figure 3.3:  
Oxygen 





3.4 Validation and Precision by Alcohol Combustion 
3.4.1 The Principle of Alcohol Combustion.  
A more traditional and oft - used method for validation of indirect calorimetry is the 
alcohol combustion method (407). The complete combustion of a known quantity of 
ethanol produces a known quantity of carbon dioxide and consumes a known quantity of 
oxygen according to the following stoichiometric relationship:  
1 𝑚𝑜𝑙 𝐶2𝐻5𝑂𝐻 + 3 𝑚𝑜𝑙 𝑂2 → 2 𝑚𝑜𝑙 𝐶𝑂2 + 3 𝑚𝑜𝑙 𝐻2𝑂  
Ethanol can be converted to mass in grams based on its molar mass and as the volume of 
1 mol of any gas at STP is 22.4 litres:  
 46𝑔 𝐶2𝐻5𝑂𝐻 + 67.2 𝐿 𝑂2 → 44.8 𝐿 𝐶𝑂2 +  67.2 𝐿 𝐻2𝑂  
Per gram of ethanol burned, the expected O2 consumption and WVP production is 1.46 
l. The expected CO2 production is 0.973l CO2. Similarly, the rate of alcohol burned can 
be used to calculate a predicted VO2 and VCO2. The RQ for ethanol is 0.6667, and the 
heat of combustion is 1367 kJ.  
As a volatile chemical, ethanol and other alcohols tend to evaporate. This is one of the 
chief challenges in performing an ethanol combustion (408). A tight-fitting container cap 
for the ethanol, and minimising the wick surface area exposed to the air can help to reduce 
this, but it can be challenging to eliminate evaporation entirely.  
3.4.2 Data Acquisition  
As with nitrogen validation, continuous monitoring of the system input, in this case 
ethanol combustion, was necessary to ensure a consistent and known burn rate. PuTTY 
software (409), available from www.putty.org, was used to register and log continuous 
weight readouts from a digital weighing scale (Highland™ HCB1002, Adam Equipment, 
Australia) at 0.5 second intervals. This was done using PuTTy’s serial terminal interface 
by enabling the data logging function.  The laboratory computer was connected to the 
digital scales via an extended RS-232 to USB connection.   
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3.4.3 Configuration of the Equipment 
The experimental setup used in the ethanol burns is pictured in Fig 3.4. A jeweller’s 
alcohol lamp, consisting of a glass bottle with a brass cap was partly filled with 99.9% 
ethanol. A clean, trimmed 5mm diameter cotton wick was drawn out of the aperture at 
the top so it was protruding 1-2 cm above the surface of the brass cap. This lamp was 
placed on the scales which sat on a fireproof blanket within the canopy hood. To avoid 
the hot gas escaping out the inlet located in the top of the hood, the outlet tubing and inlet 
port attachments were switched, so air was drawn in the side of the canopy hood and out 
the top of the hood. To avoid heat damage to the acrylic canopy hood it was propped up 
on blocks 30 cm high placed behind and at the sides of the scales. As the canopy skirting 
was not large enough to cover this arrangement, a new larger skirting was created by 
cutting a central hole in a large vinyl sheet. This was clamped to the circumference of the 
table to ensure there no air leak. The larger skirting decreased the response time of the 
canopy hood configuration compared with the nitrogen validation approach or human 
calorimetry recordings. However, the steady state value achieved, and thus the estimate 
of validity, will not have been affected by the change in volume.   
 
Figure 3.4: Calorimeter configuration for ethanol burn trials.  
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3.4.4 Ethanol Combustion Test Protocol 
 Step 1: Setting up the Burn Equipment  
The Promethion calibrations were checked to ensure they were up to date. With the 
apparatus setup as in Fig 3.4, the digital scales were switched on and tared to zero and 
the vinyl skirting left open.  
 Step 2: Data Logging and Starting the Recording  
The PuTTy software on the laboratory computer was started and set to logging the scale 
output data timestamped with the computer date and time. A calorimetry recording was 
initiated in Caloscreen with a flow rate of 80 SLPM and a baselining interval every 10 
minutes for three minutes. The start of this recording was designated timepoint zero and 
all subsequent events timed in relation to this. 
 Step 3: Starting the Ethanol Burn  
The operator entered the environmentally isolated room that housed the burn equipment, 
to light the ethanol lamp. At this point a stopwatch was started. The vinyl skirting was 
closed over and clamped to the table before leaving.  
 Step 4: Completing the Burn  
The ethanol burn initially burns yellow, with a sooty flame due to incomplete 
combustion. With our apparatus, a clean consistent blue flame was achieved after three 
minutes. For this reason, data logging was started 200 seconds and calorimetry 300 
seconds after lighting the flame. The flame was extinguished by the operator, with breath 
held, after 15 minutes of calorimetry exactly.  
 Step 5. Completing Data Logging  
Calorimetry was stopped after a further 550 seconds. The PuTTy data logging was 
stopped simultaneously. Timestamps for the start of data logging, start of calorimetry and 
extinguishing of the flame and the end of calorimetry were used to collate the ethanol 
weight data and the calorimetry data.  
3.4.5 Data Analysis  
Expedata’s automated data analysis (appendix C), was performed on the raw calorimetry 
data. The VO2, VCO2, REE and sample number data were exported along with the PuTTy 
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data log to a comma separated value file. Both the calorimetry and weight log data were 
time matched, all Putty samples that preceded the start of the calorimetry recording were 
discarded and analysis was performed on the remaining samples. The mean VO2, VCO2 
and RQ values were taken between 600 -900 seconds into each recording, as steady-state 
had been achieved by this point.  
The burn data were analysed using R(399). The burn rate was calculated using linear 
regression of the ethanol weight readout against time. The slope of the regression line 
was taken as the burn rate and used to calculate the predicted VO2 and VCO2 based on 
the calculations above. Predicted RQ was 0.667. Validity was expressed as the ratio of 
the measured value to the predicted value for each of VO2, VCO2, WVP and RQ, 
known as the “percentage recovery” of these measures. As the ethanol burn rate is not 
constant between burn readings, the percentage recovery was used to assess precision 
by correlating readings from all burn trials, descriptive statistics for the burn rate are 
presented.  
3.4.6 Ethanol Combustion Test Results 
Ethanol combustion was extremely linear in most studies (Fig 3.5). Two outliers, trial 
number 14 and 15, burned slowest, produced the least linear burn and the poorest O2 and 
CO2 recovery. Linear regression produced an excellent fit, with an adjusted R
2 for the 
linear model >0.999 in all but trial number 14 and 15. The range of simulated VO2 varied 
substantially from 0.150 - 0.412 SLPM, while VCO2 varied from 0.100-0.275 SLPM. 
The validity as indicated by the % recovery of all burns conducted per protocol was 
(M:109%, SD: 15%) for VO2 and (M:112%, SD: 15%) for VCO2. Excluding trials 14 
and 15 this improved to an accuracy for VO2 of (M:103%, SD: 5.1%) and for VCO2 
(M:102%, SD:5.2%). It is worthwhile noting that RQ varied very little, even when there 
was major variation in VCO2 and VO2. The results of the ethanol burn trials are presented 



















10 0.201 1.0000 106.1 105.9 0.666 
11 0.171 0.9990 107.6 107.4 0.666 
12 0.188 0.9997 103.1 102.2 0.661 
13 0.154 0.9994 114.3 113.4 0.662 
14 0.127 0.9967 127.2 127.1 0.667 
15 0.103 0.9982 152.3 150.7 0.660 
16 0.278 1.0000 97.3 97.8 0.671 
17 0.283 1.0000 97.4 96.2 0.660 
18 0.243 0.9999 98.2 97.9 0.666 
19 0.210 0.9997 101.3 100.1 0.659 
20 0.249 1.0000 99.1 95.8 0.646 
21 0.213 0.9990 100.8 100.2 0.663 
22 0.199 0.9997 106.4 106.0 0.664 
Mean 0.201 0.999 109 112 0.662 
 
3.5 Characterization of the VO2 Response to Nitrogen Dilution  
3.5.1 The Z-Transformation Does Not Reflect the VO2 Response Seen During 
Nitrogen Dilution 
While performing the nitrogen dilution studies, it became apparent that change in VO2 in 
response to a nitrogen infusion was non-linear. Moreover, the VO2 response was not the 
bounded exponential curve that the z-transformation assumes. Due to the washout effect 
(section 2.2.4.1), a change in resting energy expenditure that is sustained for a shorter 
duration than it takes to achieve an approximation of steady-state, approximately 300 
seconds, will never produce a resting energy expenditure measurement that reflects the 
true resting energy expenditure. Thus, the need to perform the z-transformation (313). If 
the transformation does not accurately reflect the change in VO2 over time in an indirect 
calorimeter system, the predicted steady-state values are called into question. The aim of 
characterising the VO2 response to nitrogen dilution was to determine if the VO2 response 
could be modelled better with a different curve. This would allow more accurate 
transformation of measured VO2 to steady-state values.   




3.5.2 Curve-Fitting the VO2 response:  
 Non-linear Regression 
I characterised the time response relationship of VO2 during nitrogen dilution by 
describing the response curve using a non-linear regression approach. Non-linear 
regression, as with linear regression, fits a line to a series of points and produces estimates 
of the parameters that describe the curve. Several parameters can be incorporated in a 
function described this way. Curve fitting enables objective and reproducible estimation 
of the parameters that define the curve, that is not based on graphical inspection alone. 
For example, rather than finding the midpoint of a curve visually, it is determined by 
analysing a range of possible values for the specified curve type and selecting the one 
that provides that best fit. The type of curve produced illustrates the physical properties 
of the nitrogen dilution technique and can potentially be used to predict the Promethion 
input based solely on the VO2 output values.  
This last point underscores a key limitation of indirect calorimetry; that the measured 
energy expenditure assumes the participant exists in a steady-state, or that otherwise this 
steady-state can be accurately predicted. Human energy expenditure does vary in time, 
and this variation may be of interest, as much as the averaged values that we currently 
use are. Just as the periodicity of the electrocardiogram or electroencephalogram can be 
related to pathological states or used in diagnosis, the variation in energy expenditure 
over time may vary with different diseases or under different environmental conditions. 
This is biologically interesting. However, recording this variation accurately is 
challenging.   
 Selecting the VO2 Response Curve 
An iterative process was used whereby the properties of the VO2 curve were described 
and matched to a known non-linear curve, that may better represent the VO2 response 
than the bounded exponential curve. These properties were, a gradual increase in VO2 
over time until a maximum value, the steady-state value, was achieved. A rate of change 
that initially increased exponentially until 50% of the maximum value was achieved and 
then decreased in an exponential fashion (Fig 3.2). These properties most closely 
resembled a logistic curve, frequently used to describe population growth(410). The 
logistic curve is given by: f(x)  =  
1
1+𝑒−2∗(x−3)
 .  
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The logistic function describes a sigmoid curve that reaches a maximum value, 1, 
initially exponentially until it reaches 50% of the maximum value 3, thereafter it 
increases in a bounded exponential fashion. The second coefficient, 2, modifies the 
steepness of the slope.  For nitrogen dilution, 1 corresponds to the steady-state VO2 
value, 3, corresponds to the point at which 50% of the maximum value is achieved.  2 
is a function of the volume in which the nitrogen dilution is occurring: the larger the 
space the slower the rate of change of VO2. It is also a function of the flow rate, FR, 
which increases the rate of change of VO2, and a constant k.  
 Fitting the Logistic Curve 
To test the fit of this curve to the data non-linear least squares regression (nls package, 
R), was used (411). This method iteratively attempts to fit the measured data from each 
of the trials to the logistic curve model in a stepwise fashion until a maximum fit is 
achieved. Unlike linear regression, starting estimates for each parameter must be 
provided. These are refined by the non-linear regression procedure to produce the best 
fit. For 1, the predicted VO2 was used. For 3, the time point at which 50% of the max 
VO2 was achieved was used. For 2, a model was constructed with 1 and 3 specified, 
and 2 set to one. As 1 and 3 were constrained using the estimates, the starting estimate 









SE p-value  2 
k 
SE p-value 3 
Time to Midpoint 
(s) 
SE p-value Model Correlation 
9 0.2071 0.0003 <2e-16  0.045 0.0004 <2e-16 59 0.22 <2e-16 0.999 
10 0.1985 0.0004 <2e-16  0.047 0.0003 <2e-16 70 0.32 <2e-16 0.996 
12 0.1990 0.0004 <2e-16  0.063 0.0012 <2e-16 52 0.35 <2e-16 0.986 
13 0.2018 0.0004 <2e-16  0.050 0.0008 <2e-16 50 0.35 <2e-16 0.988 
14 0.1991 0.0004 <2e-16  0.051 0.0007 <2e-16 57 0.30 <2e-16 0.997 
15 0.1978 0.0004 <2e-16  0.052 0.0007 <2e-16 65 0.32 <2e-16 0.999 
16 0.2014 0.0002 <2e-16  0.074 0.0007 <2e-16 43 0.15 <2e-16 0.963 
17 0.1995 0.0004 <2e-16  0.052 0.0007 <2e-16 53 0.30 <2e-16 0.994 
18 0.203 0.0003 <2e-16  0.047 0.0004 <2e-16 62 0.25 <2e-16 0.998 
19 0.2019 0.0004 <2e-16  0.054 0.0007 <2e-16 55 0.28 <2e-16 0.995 
20 0.2016 0.0003 <2e-16  0.049 0.0005 <2e-16 58 0.23 <2e-16 0.998 
21 0.2001 0.0005 <2e-16  0.040 0.0006 <2e-16 77 0.39 <2e-16 0.986 
Mean 0.2009 0.0003 <2e-16  0.052 0.0003 <2e-16 59 0.29 <2e-16 0.991 
 
 
Table 3.3: Model estimates and correlation with measured data for the logistic curve 
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 Fitting the Bounded Exponential Curve  
For comparison, the bounded exponential curve described by the z-transformation was 
also fitted to the measured data using non-linear regression. As outlined in chapter two, 
the z transformation is given by,  
𝑍 = 1 − 𝑒(−𝐹𝑅(𝑑𝑇/𝐸𝑉))  
where EV, is a theoretical quantity comprised of the actual physical volume contained 
by the canopy hood and tubing as well as theoretical dead space. The flow rate was 80 
litres/min, or 1.333 l/sec, dT was the time elapsed since the start of the validation. As 
both time and flow rate are accurately measured and identical for all studies, they were 
incorporated as constants in the model. The remaining parameter, EV, is more difficult 
to estimate being comprised in part of difficult-to-measure dead space. Thus, the starting 
parameter used was based on the physical volume of the canopy hood calorimeter and 
tubing. The volume of the canopy hood is 18.4l, and the volume of the cylindrical air 
mixer, tubing and air filter was estimated by measuring the dimensions of each 
component. In total the estimated volume was 37.4 l.  
For each nitrogen validation recording, the VO2 predicted by the bounded exponential 
model output, its correlation with the measured result, and correlation with the VO2 
predicted by the logistic model are presented in Table 3.4. The predicted VO2 for the 
logistic model and bounded exponential model, and measured VO2 are pictured in Fig 
3.6.  
As an additional step, the EV estimate was iteratively changed from the starting estimate 
of 37.4 l to see if the prediction of VO2 could be improved beyond that provided by the 

















9 272 5 <2x10 -16 0.78 75 0.984 
10 304 6 <2x10 -16 0.81 90 0.987 
12 205 4 <2x10 -16 0.84 63 0.989 
13 205 4 <2x10 -16 0.83 64 0.993 
14 225 6 <2x10 -16 0.87 75 0.990 
15 226 6 <2x10 -16 0.89 83 0.986 
16 245 8 <2x10 -16 0.80 55 0.983 
17 207 5 <2x10 -16 0.86 69 0.988 
18 214 5 <2x10 -16 0.88 79 0.983 
19 210 6 <2x10 -16 0.86 70 0.987 
20 214 6 <2x10 -16 0.88 74 0.988 
21 216 5 <2x10 -16 0.91 97 0.987 
Mean 229 6 <2x10 -16 0.85 75 0.987 





Figure 3.6: Change in Predicted VO2 with Time for Logistic and Bounded Exponential Models and Experimentally Measured VO2  
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 Comparing Logistic and Bounded Exponential Models 
The logistic models correlated well with the measured data, with a mean correlation of 
0.99 between the observed data and that predicted by each model. The model parameters 
across all tests (Table 3.2) were; 1 (M:0.2009, SLPM, SD:0.0023 SLPM); 2 (M:0.05, 
SD:0.01); 3 (M:59 sec, SD:8 sec).  
By contrast the estimates produced by the non-linear regression procedure for the 
bounded exponential model correlated poorly with the measured VO2 (r: 0.85). Using the 
manually calculated value for EV in the bounded exponential model, the correlation 
improved to r: 0.987. 
3.6 Discussion 
Validation and precision testing using two methods, nitrogen dilution and ethanol burn, 
were conducted to assess the in-silico validity and precision of the Promethion indirect 
calorimeter. Finally, the nitrogen validation data were used to investigate whether 
modelled VO2 using a logistic curve, rather than a bounded exponential curve produced 
by the z-transformation, would be more accurate.  
3.6.1 Comparison of Nitrogen Dilution and Ethanol Combustion Methods 
 Nitrogen Dilution Precision and Accuracy 
The nitrogen dilution studies demonstrated a mean O2 recovery of 101% (95%CI: 99.6 
to 102.4%) indicating a high in-silico precision and a high degree of accuracy. Both VO2 
and VCO2 are involved in the nitrogen dilution calculations. However, VCO2 is not 
robustly assessed using nitrogen dilution only, as the very low concentrations observed 
during the nitrogen dilution studies are not in the physiological range of expired air. 
Nonetheless, accurate barometric pressure, flow rate, temperature and water vapour 
detection were necessary to contribute to the validation and precision results seen with 
the nitrogen dilution technique.  
A mixed N2 and CO2 gas dilution such as that conducted by Rising et al, 2017(403), is a 
better assessment of REE, as it involves a more accurate simulation of VCO2. A precision 
gas mixer is required for this technique which could otherwise be easily conducted using; 
the equations outlined by Rising et al, a second mass flow controller, calibrated for 
physiologic human ranges, and Alicat Software modified to monitor two mass flow 
132 
 
controllers simultaneously. With this setup, it would be possible to use the combined gas 
flow to mimic REE variation, such as that seen with human REE measurements. This 
would enhance validity of the method, as it would bear more resemblance to in-vivo 
indirect calorimetry measurements  
 Ethanol Burn Precision and Accuracy 
The results of the ethanol burn validation differed from those suggested by the nitrogen 
dilution method. Both the O2 recovery and VCO2 recovery were greater than expected at 
103% (95%CI: 93 to 113%) and 102% (SD:92 to 112%) respectively, while the RQ was 
0.662, close to the expected 0.667 expected value. Compared to the nitrogen dilution 
study the accuracy was reduced and the measured precision was poorer as indicated by 
the wide 95% confidence intervals.  
There are several potential reasons for these results. Firstly, the ethanol burn method 
assumes complete combustion of ethanol. While the hood is well supplied with oxygen, 
there is the possibility that intermediary products form and are combusted on the cotton 
wick during the 30-minute burn.  During studies 14 and 15, the ethanol reservoir was 
lower than for the other studies, with the jeweller’s lamp approximately half filled. It was 
replenished after study 15. Evaporation from the wick within the enclosed lamp may have 
led to erratic ethanol capillary flow from the reservoir to the flame accounting for the 
non-linear burn rate during these studies, a violation of the assumptions of the method. 
While the burn rate appeared stable for the other studies, the substantial errors produced 
by tests 14 and 15 were reflected in ostensibly minor reductions in the squared residuals 
and minor fluctuations in the measured burn rate during the test (Fig 3.5). It is possible 
that lesser degrees of erratic combustion in the other tests may have contributed to the 
reduced validity and precision compared with the nitrogen validation. 
Secondly, evaporation from the wick outside the lamp may also have reduced accuracy 
but one would expect that the VO2 consumption would be less than predicted were this 
the case as O2 is not altered with evaporation.  
 VO2 and VCO2 values estimated by Nitrogen and Validation Methods 
While VO2 for the nitrogen dilution studies was calculated to be a physiological 0.201 
SLPM, the simulated VO2 for the ethanol burn studies ranged from 0.154 – 0.413 SLPM, 
VCO2 value ranged from 0.100 to 0.275 SLPM in the ethanol burn study, these are 
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relatively physiologic, values. The VCO2 value for the nitrogen dilution study were a 
fixed 0.0005% which is below a physiologic range, unsurprising given the method is 
designed to test VO2 consumption only.  
 Should RQ alone be used for Validation of Indirect Calorimetry? 
RQ alone does not detect errors that affect both VCO2 and VO2 equally. Assuming the 
gases are well mixed the potential errors that fall into this category are many: air leaks, 
inaccurate barometric pressure/temperature/water vapour sensors, unstable flow rate 
generation or inaccurate flow rate detection. The advantage of using the RQ is that it does 
not rely on weighing the ethanol to estimate burn rate, however this seems a small 
inconvenience relative to the enhanced detection of error using O2 and CO2 recovery.  
In summary, the assessment of the validity and precision with nitrogen dilution was 
considered more reliable than that produced by ethanol combustion. This was chiefly due 
to the violation of the assumption of a constant burn rate, and the error introduced by a 
high rate of water vapour production using the ethanol combustion method.  
3.6.2 Models of the VO2 response to Nitrogen Dilution 
 The Logistic Model predicts VO2 better than the Bounded Exponential Model 
The observation during the nitrogen dilution trial that the measured VO2 curves did not 
resemble the bounded exponential curve that the z-transformation is based on was 
supported by two pieces of evidence. First, the first order differential of the nitrogen 
dilution data (Fig 3.2) is not an exponential curve. One of the mathematical properties of 
an exponential curve is that its derivative is also an exponential. Fig 3.2 illustrates that 
the first order differential consists of a rate of change that increase to a point, then 
decreases. Integrating a graph of this type produces an exponentially increasing graph, to 
a point, followed by an exponentially decreasing graph. I.e. a sigmoid curve, rather than 
an exponential.  
Secondly, the specification of a logistic curve in the non-linear regression produced a 
curve that correlated more closely with the measured data than either the non-linear 
regression bounded exponential curve, or the manually calculated bounded exponential 
curve.   
134 
 
Why did the non-linear bounded exponential curve perform correlate so poorly? The non-
linear regression method is not without error. Potential sources of error may be in the 
selection of data – though this does not appear to have been a problem in this case, as the 
same starting value was used for both the manually calculated and the non-linear 
regression method. A more plausible explanation is that there were insufficient data at 
the start and the end of the change in VO2. These are the regions that differentiate the 
models most, and as they are of relatively short duration there may not have been 
sufficient samples to inform an adequate model fit.  
The slope of the resulting non-linear regression curves appeared inappropriately shallow 
(Fig 3.6), and this informed the decision to proceed with manually altering the EV 
parameter iteratively until a maximum fit was achieved for each curve. This greatly 
improved the correlation with measured data but was still less than that seen with the 
logistic curve.  
 Why is VO2/VCO2 Production Not Predicted by the Bounded Exponential 
Model 
Christensen et al, 1946, first describe the response to chemical production of CO2 vapour 
in a closed calorimetry system as an exponential function of time involving the volume 
of the measurement chamber, the flow rate from the chamber as well as the amount of 
CO2 produced(413). The equation that relates these factors is a bounded exponential one. 
In this experiment, VCO2 was simulated by dropping sulphuric acid at a fixed rate onto 
sodium bicarbonate.  
This simulation method does differ from the nitrogen validation method described here 
in two ways. Firstly, the production of a simulated VCO2 using sodium bicarbonate 
cannot be instantaneously induced as with a mass flow controller. Also, the rate of 
production of VCO2 from a constant addition of sulphuric acid to bicarbonate is not 
linear, but as with any chemical reaction is itself an exponential function of time. This 
does not serve well as a step function for evaluating response times. The z-transformation 
operates on the basis that changes in energy expenditure occur instantaneously. 
Naturally, Christensen’s paper and Bartholomew’s later paper predated modern mass 
flow controllers but it does beg the question whether the transformation derived from 
these older methods requires re-evaluation.  
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 Current and Possible Uses of the Z-Transformation 
The z-transformation is currently used in the Promethion to reduce the time lag when gas 
analyser channels are switched. The sensor lag associated with switching expired air for 
atmospheric air can be reduced this way, with a small z-transformation.  
A second application of the z-transformation is in room calorimetry. The relationship 
between a gas entering the hood calorimeter and being detected is complex. For one, the 
detection of the true value is delayed until it reaches “steady-state” after about three 
minutes. Once a participant has started the recording, variations from the mean VO2, 
VCO2 or REE that are not sustained longer than three minutes will never have their true 
value registered on the indirect calorimeter.  This problem is much greater in indirect 
room calorimetry for two reasons. First, changes in energy expenditure, not merely 
averaged values, are often under investigation in a larger room calorimeter as participants 
are free to move. Second, the room volume is so much larger than a hood calorimeter 
that it may take several hours to come to steady-state. The z-transformation applied to 
room calorimetry helps calculate steady-state values before they have been achieved.  
The z-transformation has relatively minor role in indirect hood calorimetry. With both 
the logistic models and the bounded exponential models, steady-state is achieved after 
six minutes. For all the indirect calorimetry recordings data is taken from 900 samples 
onward, thus the z-transformation does not need to be used.  
The purpose of examining the bounded exponential model more closely relates to 
potential future applications to hood calorimetry. If changes in VO2, VCO2 and REE are 
accurately modelled, as with the logistic curve, then the true values can be extrapolated 
from the measured values, second by second. Human resting energy expenditure 
measurement during hood calorimetry may thus be extended from the simple mean, 
currently in use, to a measure of true physiologic variation in energy expenditure.  
Though outside the scope of this thesis, a complementary approach would be to describe, 
mathematically, the relationship between the input to the system (‘true VO2’) and the 
synchronous output of the system (‘measured VO2’), this is known as the impulse 
response. Once obtained, the impulse response can be used to calculate an output from 
any possible input and vice versa. This is possible using a branch of signal processing 
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known as systems identification to determine the calorimetry’s impulse response. This 
work has already been completed as an extension of the work in this thesis.  
3.7 Conclusion 
In summary, validation and precision assessments of the Promethion indirect calorimeter 
canopy hood configuration were conducted using nitrogen dilution and ethanol 
combustion. A high level of accuracy and precision, M: 101% (SD: 0.5%), were 
demonstrated using nitrogen dilution. The ethanol combustion method demonstrated 
lower accuracy and precision, M:103% (SD: 5.1%), even after exclusion of two studies 
with obviously inconsistent burn rates. The development of models to predict measured 
VO2 and VCO2 in the presence of a varying input, such as a nitrogen gas flow, may be of 




 Calorimeter Performance in Human Subjects 
4.1 Introduction 
This chapter contains results of the first and second test-retest reliability studies. The in-
silico studies presented in the preceding chapters were performed between the first and 
second test-retest reliability studies following several protocol revisions discussed in this 
chapter. The follow-up test-retest reliability study was performed on duplicate measure 
data that were being collected for another study. These data were kindly provided by 
Terry O Donnell using the protocol I developed (section 2.4.4). I was not involved in the 
calorimetry data collection but completed the data analysis for this second study.  
Test-retest reliability is a measure of precision. In the case of indirect calorimetry this 
measure indicates how well the calorimeter can detect changes in energy expenditure 
over time. A high precision means small changes can be detected with confidence. In 
preparation for a repeated measures study of adaptive thermogenesis, CREEDS study 
(chapter six), it was important to establish that the calorimeter was reliable had high 
precision during repeated measure human studies. I also wanted to quantify this 
reliability in terms of absolute energy expenditure change to help with planning for the 
CREEDS study and any other future studies of energy expenditure. Both aims were 
achieved with the second test retest reliability study, having incorporated lessons learned 
from the first study.  
4.1.1 How is test-retest reliability quantified?   
Test retest reliability is a function of variance. In any series of measurements there will 
be the mean and the variance from the mean. Every measurement can be expressed in 
terms of its deviation from the mean. Squaring the deviation eliminates directionality. 
The mean of the sum of the squares gives the variance of the data, the average dispersion 
of points from the mean.   
The nitrogen dilution and ethanol burn procedures assessed error due to measurement by 
the calorimeter in quantities that had very little variance, as the burn rates and nitrogen 
inputs were reasonably consistent across studies. Isolating measurement error in this way 
is useful as it allows problems with the equipment and process to be identified more 
easily than if other sources of variation, such as biological variation, were present.  
However, this reliability assessment cannot be used to determine how well the 
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calorimeter would perform with repeated measurements in human participants with 
natural biological variation. To do this, a more complete analysis of precision is required.  
Despite being a fundamental aspect of any instrument, there is no uniformly observed 
method for measurements of test-retest reliability. A recent meta-analysis found the most 
common tests for reliability analysis were t-tests, the correlation coefficient, Bland-
Altman plots and the intra-class correlation coefficient (414). T-tests evaluate group 
average changes over two time-points, but do not incorporate variation at the individual 
level. Pearson’s correlation coefficient evaluates the strength of an association between 
a first and second reading but does not incorporate systematic error. Neither Bland 
Altman limits of agreement, t-tests or Pearson’s correlation coefficient allow for more 
than two measurements per subject in an assessment of reliability. By contrast, the intra-
class correlation coefficient (ICC) does account for individual variation, systematic and 
random error, and can be used to assess many repeated measurements. The use of the 
ICC to assess reliability is supported by several authors (384, 414-417).  
4.1.2 The Intra-class Correlation Coefficient (ICC) 
The intra-class correlation coefficient (ICC) can be generally expressed as the ratio of 
the between subject variation in a measurement to the between subject variation plus the 
error (equation 4.1) (415).  




Thus, if the error in the measurement is large the ICC will be low, and vice-versa.  
This ICC definition has multiple permutations as outlined by Shrout and Fleiss and 
McGraw and Wong (417, 418). Different calculations for the ICC are used depending on 
the design of the reliability analysis. In selecting the appropriate calculation for the ICC 
the following factors were taken into consideration (416). First, the test-retest reliability 
study was a fully crossed design – all subjects were measured at all time-points and the 
testing time points were considered fixed effects, being representative of any repeated 
testing that may occur in future studies, thus a two-way ICC model was chosen. 
Secondly, an average measure ICC was used. This is appropriate when the outcome of 
interest is the within subject variation across all time-points, rather than the variation of 
measures at a single timepoint. Thirdly, as the outcome variables, VO2, VCO2 and REE 
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are continuous variables, the ICC was chosen to reflect the absolute agreement between 
repeated tests rather than the consistency, which is more appropriate for ranked variables.  
The between subject variance, between test variance, and residual variance can be 
calculated using a repeated measure analysis of variance (ANOVA). If a significant effect 
of repeated tests is present when the measurement of interest should not be changing, this 
indicates systematic error. In this way the subject variance, systematic error (test 
variance), and random error (residual variance) can be partitioned. 
Eq. 4.2   𝐼𝐶𝐶(2,1) =
 
Mean Square Subject − Mean Square Error
 Mean Square Subject +(k−1)Mean Square Error + 




where, k is the number of trials for each subject and n is the number of subjects (417).  
4.1.3 Standard Error of the Mean and Least Significant Change 
The ICC is a relative measure of precision. If the variance in energy expenditure within 
a group of individuals is high and the total error associated with that measurement is also 
high this will produce the same ICC as a group with proportionately low variance in 
energy expenditure and low total error variance of the measurement. Clearly this latter 
scenario is desirable as a small systematic change, for example due to a drug treatment, 
will be easier to detect. This simply reflects the distinction between ICC, a property of 
an instrument, and sensitivity to change which is a property of both the instrument but 
also the population being tested.  Absolute measures of precision are more useful for 
determining a minimum detectable effect size between measurements. The standard error 
of the mean (SEM) can be calculated from the ICC and the standard deviation of all 
measurements to provide an absolute measure of precision (384):  
Equation 4.3:  𝑆𝐸𝑀 = 𝑆𝐷√1 − 𝐼𝐶𝐶 
 The SEM can be used to calculate the least significant change (LSC). The LSC is the 
minimum change in a measurement that has a less than five percent probability of being 
due to chance alone (equation 4.4).  
Eq. 4.4:  𝐿𝑆𝐶 = 𝑆𝐸𝑀 ∗ √2 ∗ 1.96  
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4.2  The First Test Re-Test Reliability Study 
4.2.1 Objectives  
To assess the test-retest reliability of VO2, VCO2 and REE in lean healthy individuals 
using the Promethion indirect calorimeter when tested on three separate days in the same 
week.  
4.2.2 Study Population 
Participants were recruited by advertising within the university and local hospital staff 
mailing lists. Inclusion criteria were age 18-65yrs, and the absence of any active current 
medical conditions. Exclusion criteria were: a diagnosis of obstructive sleep apnoea, or 
an Epworth sleepiness score greater than nine; current smoking; weight change greater 
than five kg in the preceding three months; pregnant or breastfeeding; and the use of oral 
steroid medications. Each participant provided written informed consent.  
Under the terms of the New Zealand Health and Disability Ethics Committee’s guidance, 
a formal application to the committee was not required for this study as it was regarded 
as a minimal risk observational study (419).  
4.2.3 Methods 
 Anthropometry 
Weight and height were measured for all participants. FM and FFM were measured by 
bio-impedance analysis. Anthropometry was conducted as outlined in section 2.4.1 
 Indirect Calorimetry 
All visits were conducted at the Centre for Translational Physiology, University of Otago 
Wellington. Indirect calorimetry was performed as described in section 2.4.4 with some 
exceptions. First, there was no low pass filter for the atmospheric sampling inlet or 
between the hood and air filter, as this was a modification added after the first test re-test 
reliability study. Secondly, calorimetry was conducted in a clinic room approximately 20 
metres square in size. Thirdly, two operators and computers were co-located with the 
participant in the room throughout the recording. Fourthly, the recording duration was 
46 minutes with a baselining interval of 60 seconds and a baselining frequency of once 
every six and a half minutes. Calorimetry data were taken from 15 until 40 minutes into 
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the recording. Finally, as the testing room did not contain a temperature or humidity 
control, temperature was recorded using a room thermometer/hygrometer at the start and 
end of the calorimetry recording.  
 Statistical Analysis 
The mean VO2, VCO2 and REE between 15 and 40 minutes were taken for each 
recording. This was used to calculate the ICC, SEM and LSC as described in section 4.1. 
Two-way ANCOVA specifying the participants as a random effect and the testing 
occasion as a fixed effect was used to generate the variances. Pairwise t-tests were used 
for change in environmental conditions during the recordings and change in weight and 
body composition from visit one to visit three.  
Two measures of intra-recording variability were used. The mean standard deviation for 
VO2 was calculated by obtaining the standard deviation for VO2 within each recording. 
These values were then averaged across all participants. For example, if the standard 
deviations of VO2 within each recording for three participants were 0.001, 0.007 and 
0.010, the mean standard deviation for VO2 would be 0.006. Similarly, the percentage 
mean standard deviation of VO2 was calculated by expressing the standard deviation of 
VO2 within each recording as a percentage of the mean VO2 of each recording. These 
were then averaged across all recordings. The mean standard deviation and percentage 
mean standard deviation were calculated in the same way for VCO2 and REE. 
4.2.4 Results 
Three female and seven male participants aged 18-32 years were recruited. Nine 
participants were New Zealand European and one was Indian. Participants completed all 
three visits between three and nine days after the first visit. The average interval between 
the first and last visit was six days. Two participants took nine days to complete the study 
due to work commitments. 
There was a reduction in mean weight (M: -0.5kg; 95% CI: -0.14 to - 0.87 kg) and FFM 
(M:+1.38 kg; 95%CI: 0.1 – 2.6 kg) from visit one to visit three. By contrast, there no 
significant change in FM (M:+0.92kg; 95%CI: -0.4 to +2.3kg). The change in FFM was 
driven largely by a single outlier (fig 4.1). When this participant was excluded from the 
analysis the change in FFM (M: -1.0; 95%CI: -1.99 to + 0.01) and FM (M:+0.46kg; 
95%CI: -0.6 to + 1.5 kg) was non-significant. The weight change was unaffected (M:-
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0.57kg; 95%CI: -0.96 to -0.2kg). Two participants showed a large shift in fat mass, one 
of whom also had a shift in fat free mass, in the absence of significant weight change. 
This was probably to a measurement error, such as a change in hydration status between 
visits, or failure to remove jewellery during the visit on one occasion.  
 
The output from the analysis of variance, the reliability measures calculated from these 
data, and the measures of intra recording variability for VO2, VCO2 and REE are 
presented in table 4.1.  
The ANOVA output showed that the variance with repeated visits was small and similar 
to the residual error. For VO2, between-subject variation accounted for 93.7% (p < 
0.001), the study visit accounted for 3.4% (p = 0.27) and residual error accounted for 
2.6% of the variance. For VCO2, between-subject variation accounted for 94% (p 
<0.001), the study visit accounted for 1.7% (p = 0.68) and residual error accounted for 
4.4% of the variance. For REE, between subject variation account for 94.2% (p <0.001), 
the study visit accounted for 2.9% (p = 0.38), and residual error accounted for 2.9% of 
the variance.  
Fig 4.1: Change in weight, fat free mass and fat mass. 
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The least significant change, as a proportion of the mean VO2 VCO2 and REE 
respectively were 7.6%, 8.3% and 7.8%. The intra recording variation, calculated as the 
mean standard deviations, expressed as a percent of the mean value, for VO2, VCO2 and 








Mean 0.2240 0.1910 6590 
SD 0.0357 0.0329 1063 
Variance from ANOVA 
Subject 0.003879 0.003184 813361 
Visit 0.000151 0.000061 25329 
Residuals 0.000107 0.000151 24677 
Reliability Measures 
ICC 0.97 0.96 0.97  
SEM 0.0062 0.0057 188 
LSC 0.0172 0.0158 519 
Intra-recording Variability 
Mean SD 0.0454 0.0423 1318 
Mean %SD 20.3 22.2 20.1 
Thus, a relatively low variance seen with repeated testing, suggesting a high precision 
however the high intra-recording variation raised the suspicion of poor validity in the 
calorimetry recordings. This was confirmed during the early nitrogen validation studies 
and informed the development of the calorimetry protocol described in chapter two. 
Table 4.1: Dispersion, variances and reliability measures for VO2, VCO2 and 24 hr 




4.3 The Second Test-Retest Reliability Study 
The second test re-test reliability study was based on calorimetry recordings from 
participants who underwent two calorimetry visits within a week as part of an 
environmental exposure study. Though this study was designed to examine differences 
between cold and warm exposure in an environmental chamber, the first 30 minutes was 
at controlled thermoneutral conditions. The precision test was repeated in view of the 
change in the measurement protocol following the first test re-test reliability study.  
4.3.1 Objectives 
To re-assess the test-retest reliability of VO2, VCO2 and energy expenditure in non-obese 
healthy individuals in the recently validated Promethion indirect calorimeter when tested 
on two separate days in the same week, using the modified protocol developed from the 
results of the first test re-test reliability study.  
4.3.2 Study Population 
Participants were recruited by advertising within the university and local hospital staff 
mailing lists. Inclusion criteria were age 18-60yrs, with a BMI of 18-30 kg/m2. Exclusion 
criteria were; major cardiovascular disease; BMI>30; pregnancy; diabetes; any 
medications which may affect autonomic function. Each participant provided written 
informed consent. The overall trial was registered with the Australia New Zealand 
Clinical Trials Registry, trial number, ACTRN12616001459415. As the trial from which 
the second test retest reliability data were drawn also involved an intervention, ethics 
approval was obtained from the central region Health, Disability and Ethics Committee 
ref. 15/CEN/177. 
4.3.3 Methods: 
Weight, DXA scanning and indirect calorimetry were performed as outlined in chapter 
two. FM and FFM were assessed by DXA which was conducted only at baseline of the 
main study. Two days washout was allowed between visits to mitigate short term changes 
in REE due to the environmental intervention.  
All raw data channels were visually inspected for error prior to analysis. The mean VO2, 
VCO2, and REE were calculated between 15-30 minutes into the recording. Mean and 
standard deviations for all recordings are presented. Two-way ANOVA, using subjects 
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as random effects and visits as fixed effects were used to generate the variances.  ICC, 
SEM, LSC were calculated as outlined in section 4.1. The mean standard deviation and 
percentage mean standard deviation for VO2, VCO2 and REE were calculated as outlined 
in section 4.2.3.3.  
4.3.4 Results  
Thirty-two participants were recruited. Of these; four attended for one visit only; one 
calorimetry recording was unusable due to an incorrect baselining algorithm, and one 
participant attended their second visit 16 days after the first visit. The data for these six 
participants were therefore not used in the analysis. 
Of the remaining 26 participants, 13 were female and 13 were male. 18 participants 
identified as New Zealand European, four Asian and four Māori. Baseline age was (M:25 
yr; SD:7 yr). The mean interval between visit one and visit two was three days. Baseline 
weight was (M:72 kg; SD:13kg). One participant took 8 days to complete the second 
study visit, the others all completed both visits within a week.  
There was no difference in weight between visit one and visit two (M:0.22kg; 95%CI:-
0.07 to + 0.5kg), (fig 4.2) . The mean, variances, ICC, SEM and LSC are presented in 
table 4.2. For VO2, between-subject variation accounted for 95.9% (p <0.001), the study 
visit accounted for 0.2% and residual error accounted for 3.9% (p = 0.81) of the variance. 
For VCO2, between-subject variation accounted for 93.9% (p <0.001), the study visit 
accounted for 0.3% (p = 0.81) and residual error accounted for 5.8% of the variance. For 
REE, between subject variation account for 95.7% (p <0.001), the study visit accounted 
for 0.3% (p = 0.81), and residual error accounted for 4.0% of the variance. Thus, in the 
repeat, there was also not a significant impact of the repeated measurement, on the 
determination of either VO2, VCO2 or REE.  
 The least significant change, as a proportion of the mean VO2 VCO2 and REE 














Mean 0.2470 0.2120 7280 
SD 0.0172 0.0188 494 
Variance 
Subject 0.003973 0.003263 836813 
Visit 0.000009 0.000011 2326 
Residuals 0.000160 0.000202 35275 
Reliability Measures 
ICC 0.98 0.97 0.98 
SEM 0.0066 0.0076 201 
LSC 0.0184 0.0209 561 
Intra-recording Variability 
Mean SD 0.0172 0.0188 498 
Mean %SD 5.7 6.8 5.8 
 
4.4 Discussion 
Comparing the first and second reliability studies (table 4.3), the ICC, LSC and SEM 
values for VO2, VCO2 and REE are very similar. This was despite the identification of 
several sources of error that led to revision of the measurement protocol. 
 
Table 4.2: Dispersion, variances and reliability measures for VO2, VCO2 and 24 hr 









 TRT1 TRT2 TRT1 TRT2 TRT1 TRT2 
Mean 0.2240 0.2470 0.1910 0.2120 6590 7280 
SD 0.0357 0.0172 0.0329 0.0188 1063 494 
Variance 
Subject 0.003879 0.003973 0.003184 0.003263 813361 836813 
Visit 0.000151 0.000009 0.000061 0.000011 25329 2326 
Residuals 0.000107 0.000160 0.000151 0.000202 24677 35275 
Reliability Measures 
ICC 0.97 0.98 0.96 0.97 0.97 0.98 
SEM 0.0062 0.0066 0.0057 0.0076 188 201 
LSC 0.0172 0.0184 0.0158 0.0209 519 561 
Intra-recording Variability 
Mean SD 0.0454 0.0172 0.0423 0.0188 1318 498 
Mean %SD 20.3 5.7 22.2 6.8 20.1 5.8 
Table 4.3::Comparison of the dispersion, variance and reliability measures for both test-retest reliability studies.  
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4.4.1 Source of Error During the First Test Retest Reliability Study  
During the first test-retest reliability the calorimetry data contained large intra-recording 
variation for VCO2, VO2 and REE (fig.4.4). The main reason for this ‘noisy’ data was 
contamination of the atmospheric sampling inlet and the indirect calorimetry hood inlet 
by the operators. A key assumption of the calorimetry recordings is that the hood air inlet, 
which is not directly sampled, has the same gas concentration as the atmospheric sample 
inlet. Were CO2-enriched and O2-depleted air from an operator to enter the canopy hood 
inlet but not the atmospheric inlet, this assumption would be violated, and reduce the 
validity of the recording. This problem was easily solved by isolating participants and 
the atmospheric inlet for the second study. The atmospheric inlet was also placed close 
to the hood air inlet so samples passing into it would be representative of the incurrent 
air flow.  
A second source of error was inadequate air mixing. This is best understood by 
considering the air flows as inhomogeneous mixes of different gases. If such a mixture 
reaches the sensor chains directly there may be spikes in VO2 or VCO2 that do not 
accurately reflect the average values in the air volume at that time. This is reduced by 
mixing. A low pass filter is a digital signal filter that permits signals below a certain 
frequency to pass while blocking higher frequency ‘spikes’. It is used to improve noisy 
signals. The physical low pass filters that were added to the calorimeter were simply 
additional volume within which the travelling gas mixtures from the atmospheric sample 
or the canopy hood were mixed.  
The final major change to the experimental protocol between studies was a change in the 
baseline frequency and duration. During the first study, the atmospheric sampling 
duration and frequency was relatively short at one minute per channel on a six-and-a-
half-minute cycle. Using this baselining programme, the atmosphere was being 
monitored less than one third of the time. The baselining frequency was changed to three 
minutes per channel every ten minutes, sixty percent of the time. The first purpose of 
baselining, as outlined in chapter two, is to prevent sensor drift (section 2.4.4.1.1). Given 
the Promethion has a dual chain analyser setup this does not come at a cost of monitoring 
the excurrent air flows, as one sensor can do this while the other monitors the atmosphere. 
However, the baselining process is also crucial for monitoring incurrent gas flows. The 
shorter the baselining coverage the less likely the baselining values are to be 
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representative of what is entering the hood. Ideally, the sensors would alternate between 
incurrent and out-current flows so that both were constantly measured. However, there 
will always be a time-lag when switching between incurrent and excurrent air flow occurs 
as the sensor adjusts to the new readings. In addition, to copy from channel 1 to channel 
2 as outlined in appendix C, the baselining section for any one channel needs to be 
flanked by non-baselined segments (fig 4.3). By trial and error, it was determined that 
baselining for three minutes per channel on a ten-minute cycle is the closest to 
“continuous” baselining that can be achieved with the Promethion.    
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Oxygen tracings from channel 1 are pictured in red and tracing from channel 2 in blue. The interval between baselining 
sequences ( ) is required to allow copying across data channels.  





4.4.2 Measures of Quality during Human Indirect Calorimetry.  
The main differences between the first and second reliability studies is illustrated in fig. 
4.4. The final calorimetry recordings conducted for both studies are presented. A 
reduction in the variability in REE was seen following implementation of the newer 
calorimetry protocol. The reduction in ‘noise’ between the first and second test retest 
reliability studies was the clearest indicator of improvements in the quality of the 
measurement protocol. There was a small improvement in precision between studies as 
indicated by a rise in the ICC and a reduction in the variance due to the study visit in the 
second re-test reliability study (fig 4.3). However, these relatively small differences in 
precision suggest a consistent application of a protocol that chiefly compromised validity 








One of the challenges in assessing the quality of live subject indirect calorimetry 
recordings, is the inability to assess validity. As alluded to in chapter three, there is no 
way of knowing a priori what any one individual’s energy expenditure ought to be, and 
so no way to assess validity in a human subject. A potential solution to this issue is to 
cross validate REE measurements using alternate calorimetry methods such as direct 
calorimetry or doubly labelled water. However, doubly labelled water measures total 
energy expenditure and is prohibitively costly for large studies, and direct calorimetry is 
not widely available. Instead, the nitrogen gas and ethanol burn studies outlined in 
chapter three were carried out to determine the validity of measurements using the new 
protocol. This provides a measure of validity for the system and measuring protocol that 
is assumed to be maintained during human indirect calorimetry recordings.  
 Intra-Recording Variability as a Proxy of Validity 
A second challenge in assessing the quality of a human calorimetry recording is the 
elimination of variation during a recording that must occur when mean values of VO2, 
VCO2 and REE are used. These are the key parameters used in studies of REE and ought 
to be the focus of a calorimetry precision study. However, they do not reflect the 
recording quality. As validity is untestable during human recordings, the within-
recording variability can serve as a proxy for a valid recording. This is based on the 
understanding that REE should not vary by up to two or three-fold during a recording, as 
was observed during the first test-retest reliability study. This variability is best captured 
by a measure of within-recording variability such as the mean SD for all recordings.  
Within recording variability as a measure of validity has been used by Haugen et al, 
2003, during precision testing of an indirect calorimetry hood (420). Though this was not 
a primary outcome measure, a variation in VO2 of less than 15% over 15 minutes was 
used as a basis for selecting valid data for analysis. Such approaches are common and 
provide a reproducible measure of recording quality. One limitation of selecting ‘valid’ 
data in this way is the inherent assumption that all errors in measuring energy expenditure 
increase intra-recording variability rather than decrease it. Were human energy 
expenditure to vary at an average of 10% of the mean, a variability of less than 5% or 
greater than 15% would be equally invalid. Nonetheless, it remains one of the few 
available objective measure of recording quality. 
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The intra-recording variability for the ethanol and nitrogen validation studies, both test 
re-test reliability studies and the study by Haughen et al, 2003, are presented in table 4.4 
for comparison (420). 
 VO2 VCO2  REE  
TRT-1 20.3 22.2 20.1 
Nitrogen Dilution 0.8 2.2 0.6 
Ethanol Burn 0.8 2.2 0.6 
Haughen et al <15 NA NA 
TRT-2 5.7 6.8 5.8 
 
Both validation methods show minimal variation in the recording over time. This is 
unsurprising given they are both intended to produce constant values of VO2, VCO2 and 
REE over the measurement period that the mean SD was calculated. Thus, these values 
are an indicator of the within recording variation attributable to the measurement method.  
By comparison, the intra-recording variability during human studies for VO2, VCO2 and 
REE are several-fold higher. Using the <15% variability proposed used by Haughen, all 
recordings obtained during TRT2 study would have been considered eligible whereas 
only 43% of recordings in the first test-retest reliability study would have been eligible. 
Only one recording had an intra-recording variability greater than 10% during the second 
Test Retest Reliability study. An intra-recording variability of less than 10% may be used 
as a more stringent validity criterion during human studies.   
 Precision 
Both studies indicate that the precision was satisfactory with an LSC of 519 kJ/24 hours 
for the first test-retest reliability study and 560 kJ/24 hours for the second. The least 
significant change in the second study was higher due to the greater between participant 
variability, as a larger more heterogenous population was studied. Weight did not change 





significantly during either study, and what variation was detected in the first TRT1 study 
was likely due to error in the BIA measurement rather than true weight change. Though 
the variance in REE attributable to the visit was small, it is worth noting that it fell from 
3% of total variance during the first study, to 0.3% during the second study.  
This consistency in precision between studies appears to contradict the assertion that the 
measurement performance was better with the second test-retest study. However, the 
sources of error outlined in section 4.4.1 need not have affected precision provided they 
occurred at all visits. 
The consistent precision and lack of a significant effect of repeated visit, indicates no 
‘training effect’. A training effect occurs when a subject responds differently to repeated 
measurements. This may occur with indirect calorimetry if first-time participants are 
anxious lying in the enclosed hood but become used to it by the second or subsequent 
visits. The 15-minute acclimation period at the start of every calorimetry visit allows 
participants to become used to the hood prior to the first recording. This suggests that an 
initial training calorimetry test is not required with prospective studies of indirect 
calorimetry. 
4.5 Conclusion 
We conducted studies of test retest reliability of the Promethion indirect calorimeter 
before and after several modifications to the testing protocol. While these modifications 
did not have a significant improvement on the precision of the recordings, the validity of 
the recordings as reflected in the improved intra-recording variability was substantially 
better. An intra recording variability of <10% is suggested as a proxy of validity for 
human recordings.   
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 The PREEMPt Study 
5.1 Introduction 
The preceding two chapters outline the development of a valid and precise method of 
measuring human REE. The predictions of REE in Māori and Pacific populations 
(PREEMPt) pilot study, was designed to assess the variance in energy expenditure in 
overweight and obese Māori and Pacific populations. The rationale for the study was 
two-fold. First, the test-retest reliability studies in chapter four were conducted in 
predominantly New Zealand European lean individuals, most of whom were in their 
twenties. By contrast, my overall objective was to study adaptive thermogenesis in 
overweight and obese individuals undergoing weight loss. Based on New Zealand BMI 
prevalence data, these individuals were more likely to be in their 30’s, 40’s and 50’s. 
Thus, an overweight and obese local population would provide more accurate samples 
size estimates for the planned weight loss intervention study, the CREEDS study, 
described in chapter seven.  
Secondly, predictive equations can be used to prescribe energy intake in the absence of 
directly measured energy expenditure. However, the accuracy of these equations is 
unknown in New Zealand cohorts, and specifically in Māori and Pacific populations. 
Therefore, the PREEMPt study provides the data to estimate the sample size required to 
assess the validity of predictive energy equations in a New Zealand population.  
5.1.1 Predictive Energy Equations 
5.1.2 The Calculation & Applications of Predictive Energy Equations 
As outlined in chapter two (section 2.3.3.2) predictive energy equations allow calculation 
of REE and using physical and demographic information such as weight, height, age and 
gender. The Mifflin St Jeor Equations (equations 5.1 and 5.2) are examples of predictive 
energy equations:  
Eq.5.1: 
 𝑀𝑒𝑛:  𝑅𝐸𝐸 (𝑘𝑐𝑎𝑙)  = 10 𝑥 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑘𝑔)  +  6.25 𝑥 ℎ𝑒𝑖𝑔ℎ𝑡 (𝑐𝑚) –  5 𝑥 𝑎𝑔𝑒 (𝑦)  +  5 
Eq.5.2: 
 𝑊𝑜𝑚𝑒𝑛: 𝑅𝐸𝐸 (𝑘𝑐𝑎𝑙)  
=  10 𝑥 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑘𝑔) +  6.25 𝑥 ℎ𝑒𝑖𝑔ℎ𝑡 (𝑐𝑚)–  5 𝑥 𝑎𝑔𝑒 (𝑦𝑟)–  161 
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Predictive equations are used in national guidelines for daily recommended energy 
intake, food labelling guidelines, websites, smartphone apps, gym equipment and 
wearable technology. In effect, they are the only way an individual without access to 
measurements of energy expenditure can determine their daily energy intake. 
Increasingly, predictive energy equations are used as a personal indicator of healthy 
dietary calorie intake. As such, their accuracy deserves careful consideration when used 
in an obese New Zealand population.  
Predictive equations are developed using multiple regression which provides an estimate 
of the relationship between a predictor variable, such as weight, age or height, and resting 
energy expenditure. As with any statistical test, these estimates contain a component of 
error, represented numerically by the standard error of the estimate (SEE). The SEE is 
similar to the SEM, discussed in chapter four. Once a regression equation has been 
developed it is typically applied to a validation sample from which the SEE can be 
calculated as follows.  






Error is an intrinsic part of predictive equations. When used in the same populations in 
which they were derived error is minimised and validity increased, as the relationships 
between the predictor variables and energy expenditure are likely to be similar. For 
example, body weight and height are incorporated as proxy measures of combined FM 
and FFM in predictive equations. However, the contribution of FM and FFM to resting 
energy expenditure can vary by ethnicity (421).  
The validity of predictive equations in diverse populations is not a new concern. The joint 
FAO/WHO/UNU that provide guidance on the development of national 
recommendations for dietary energy intake, recommend that each country develop their 
own predictive equations for estimating REE (422). As a result, many predictive 
equations have been developed in the past 20 years. Below I briefly review four of the 




5.1.3 Commonly used Predictive Energy Equations 
 The Harris-Benedict Equations 
In 1918, Harris & Benedict developed some of the earliest predictive equations of human 
energy expenditure. The Harris-Benedict equations (equations 5.4 & 5.5) were derived 
by regression from measurements of 136 men, 103 women and 94 infants carried out at 
the Nutrition Laboratory, Carnegie Institute of Washington (348). Participants were aged 
21-70 years, weight 25-124.9kg and height of 151-200 centimetres.  
𝐸𝑞. 5.4: 𝑀𝑒𝑛: 𝑅𝐸𝐸 (𝑘𝑐𝑎𝑙𝑠)
= 66.5 + 5.0 ∗ (ℎ𝑒𝑖𝑔ℎ𝑡) + 13.8 ∗ (𝑤𝑒𝑖𝑔ℎ𝑡) − 6.8 ∗ (𝑎𝑔𝑒) 
𝐸𝑞. 5.5: 𝑊𝑜𝑚𝑒𝑛: 𝑅𝐸𝐸 (𝑘𝑐𝑎𝑙𝑠)
= 655.1 + 1.8 ∗ (ℎ𝑒𝑖𝑔ℎ𝑡) + 9.6 ∗ (𝑤𝑒𝑖𝑔ℎ𝑡) − 4.7 ∗ (𝑎𝑔𝑒) 
The equations were updated in 1984 (equations 5.6 and 5.7) by Roza and Shizgal, 1984, 
who incorporated 94 additional patients studied by Benedict after 1918 that represented 
a wider age range, (16 – 62 yr) than the original equation, (16 – 45 yr) (423). Though 
there is no mention of ethnicity in the original papers containing these equations, the 
census data for Washington state in 1910 indicate a prevalence of “whites” of 96.9%, 
with the remainder comprised of other ethnicities (424).  
𝐸𝑞. 5.6: 𝑀𝑒𝑛: 𝑅𝐸𝐸 (𝑘𝑐𝑎𝑙) = 88.4 + 4.8 ∗ (ℎ𝑒𝑖𝑔ℎ𝑡) + 13.4 ∗ (𝑤𝑒𝑖𝑔ℎ𝑡) − 5.7 ∗ (𝑎𝑔𝑒) 
𝐸𝑞. 5.7: 𝑊𝑜𝑚𝑒𝑛: 𝑅𝐸𝐸 (𝑘𝑐𝑎𝑙)
= 447.6 + 3.1 ∗ (ℎ𝑒𝑖𝑔ℎ𝑡) + 9.3 ∗ (𝑤𝑒𝑖𝑔ℎ𝑡) − 4.3 ∗ (𝑎𝑔𝑒) 
 The Schofield or WHO/FAO/UNU Equations 
In 1981, the World Health Organisation (WHO) and the Food and Agriculture 
Organisation (FAO), commissioned a review of human energy requirements with the 
intention of producing accurate predictive equations of REE. This was not the first such 
commission but developed previous estimates of human energy expenditure by 
addressing concerns regarding the quality and methodological rigor of earlier similar 
analyses. These concerns included the use of unreliable calorimetry devices, or 
measurement protocols and the inclusion of duplicate values (425).  
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The new analysis reported by Schofield was based on calorimetry recordings from 4937 
men and 2612 women taken during the 1930’s and 1940’s (352) and were cross-validated 
in an independent cohort of 3874 subjects. Subjects were almost exclusively from Italy 
or North America, except for 322 subjects from India. When the predictive equations 
were derived from the Indian subgroup only, they forecasted lower resting metabolic rate 
per unit mass. As a result, Schofield suggested that the validity of the equations may be 
comprised when used in populations that differ from the original North American and 
Italian cohorts. Subsequent analyses have demonstrated that the Schofield Equations 
consistently overestimate REE in ethnicities native to both tropical and temperate regions 
(426). 
The Schofield equations combine gender, age and weight to predict basal metabolic rate. 
They are still used to provide estimates of daily energy intake for the Australian and New 
Zealand nutritional guidelines (427, 428).  
 The Mifflin-St Jeor Equation 
Mifflin et al, 1990, developed a predictive regression equation based on a sample of 247 
women with a mean age of 45 years, and 251 men, with a mean age of 44 years, from 
Reno, Nevada (429). Once again, no ethnicity data was reported in this study. However, 
the ethnic distribution of Washoe County at the time of enrolment for the study was 88% 
White, 4% Asian and Pacific Island, 2% Black and 2% Native American (430). The 
rationale for this work was the change in body weight, body composition, physical 
activity and diet characteristics of the population that had occurred in the intervening 70 
years since the Harris-Benedict equations were developed. In the cohort of women and 
men respectively, the mean body weight was 70.2 kg and 87.5 kg, and the mean BMI 
was 26.2 kg/m2 and 27.5 kg/m2. Twenty-eight years later, the mean BMI in the New 
Zealand adult was similar was 28.0 kg/m2 and 28.1 kg/m2 respectively (4). This suggests 
that the Mifflin St. Jeor equation may be more valid for use in New Zealand populations 
than the Harris Benedict equation, which was developed in a cohort that was lighter and 
almost certainly had a different body composition to the average New Zealand adult.  
 The Oxford Equations 
In 2005 Henry published the Oxford equations alongside a critique of the Schofield 
equations (431). To address the limitations of the Schofield equations, he performed an 
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updated systematic review of 166 published studies of REE comprised of 10552 
individual measurements of REE. Recordings from 5794 men and 4702 women were 
included in this analysis. Notably, the Italian cohort that were included in the Schofield 
equations were excluded from the analysis on the basis that their REE was “unusually” 
high and raised concerns in relation to validity (425). The Oxford equations incorporated 
more studies based in tropical regions, accounting for 38% of the total cohort. An 
additional point of difference between the Schofield and Oxford equations was the 
exclusion of studies that reported only the lowest value of REE obtained during a 
recording from the Oxford analysis. This approach was considered biased compared with 
simply taking the mean REE (425).  
 Which equations to use?  
The Schofield and Oxford equations are a set of age, weight and gender specific 
equations. The performance of any one equation from within these sets is likely to vary 
as not all age and weight categories were equally represented in the data pool from which 
they were derived. This is reflected in the different standard errors for each equation. 
While the Schofield and Oxford equations are derived from a larger database of 
measurements than the other equations, these data are drawn from many studies that used 
diverse energy expenditure measurement techniques that will not have been cross 
calibrated. In addition, these databases incorporate studies that are now more than 100 
years old. The Mifflin St Jeor equations, by contrast, use contemporary measurement 
methods and all data were collected prospectively using the same measurement protocol.  
In one of the most recent and comprehensive reviews on this topic, Frankenfield et al, 
2005, examined the performance of the Mifflin-St Jeor, Schofield and Harris Benedict 
Equations. This work formed part of an evidence analysis report commissioned by the 
American Dietetic Association in 2005 (432). They reviewed the original studies from 
which each equation was derived and calculated the accuracy of each of the equations 
using individual-level data from each of these studies, rather than group means. The 
proportion of participants that had a predicted REE within 10% of the measured REE 
was used as a measure of accuracy. The Schofield equations only referenced group mean 
data and so could not be analysed using this metric. This work preceded the publication 




The findings of the working group found a paucity of data amongst all equations 
reviewed for US-residing ethnic minorities, particularly; Pacific Islander, Asian, African-
American, American Indian, Alaskan Native or Hispanic populations. Elderly 
individuals, particularly overweight or obese elderly were also under-represented. The 
Mifflin St Jeor equation performed best, with predictions of within 10% of measured 
values for 82% of non-obese and 70% of obese participants. The Harris Benedict was 
accurate in 45-80% of non-obese and 38-64% of obese individuals.  Two limitations of 
this analysis were the use of a definition of accuracy that excluded an equation developed 
from the largest pool of measurements, the Schofield equation, and the focus on 
predominantly US populations. Nevertheless, the American Dietetic Association has 
adopted the Mifflin St. Jeor equation as the most valid for a US population on the strength 
of the working group’s report.   
Ideally, a New Zealand specific predictive equation would be developed using a 
standardised, validated measurement protocol in the New Zealand populations for which 
it is being developed. In the absence of a New Zealand specific equation, validation of 
several existing equations against measurements of energy expenditure may identify an 
equation that is most accurate. This work is yet to be done, and the PREEMPt study was 
planned to lay the groundwork by providing data for sample size estimation.  
5.1.4 Sample Size Estimation for Measurement of Resting Energy Expenditure 
The aim of the PREEMPt study was to estimate the sample size requirements for a 
definitive study of the accuracy of predictive energy equations in Pacific and New 
Zealand Māori adults. A second application of the PREEMPt data was to provide sample 
size estimates for the CREEDS study (chapter seven). As the CREEDS study is designed 
to look at changes in resting energy expenditure beyond that expected for weight loss, it 
does not use total REE as an outcome variable. Rather, allometrically-scaled REE data 
using either FFM or a combination of FM and FFM (chapter two, section 2.3.2) were 
planned as the outcome variables.  
The accuracy and precision of either REE or allometrically-scaled REE measurement 
varies depending on the method of body composition assessment. DXA, though superior 
to BIA as an estimate of body composition is also considerably more expensive. Thus, 
sample size estimates using the data from both DXA and BIA were conducted.  
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5.2 The PREEMPt Study 
5.2.1 Outcomes 
1. The primary outcome was the difference between measured and predicted REE 
using the Schofield, Harris-Benedict, Mifflin-St. Jeor and Oxford equations.  
Secondary outcome variables included:  
2. The difference between body composition measured by DXA and BIA.  
3. Weight, waist circumference, height, BMI and body fat composition measured by 
BIA and DXA. 
4. HbA1c, fasting plasma glucose, high density lipoprotein (HDL), low density 
lipoprotein, triglycerides (TG), total cholesterol and cholesterol:hdl ratio.    
In addition to these outcomes, sample size requirements for a validation study of resting 
energy expenditure using either DXA or BIA, and sample size requirements for the 
CREEDS study using either DXA or BIA were performed.  
5.2.2 Study Population  
Participants were recruited from advertisements in general diabetes and endocrine 
clinics, local GP practices, the regional hospital and university staff mailing lists, 
advertisements disseminated via regional community noticeboards and local Pacific 
health networks.  
Inclusion criteria were; a BMI ≥25 kg/m2, self-identification as Māori or Pacific Island 
ethnicity and age 20-65yrs.  
Individuals were excluded if; they had a weight change of greater than five kg over the 
previous three months; were pregnant or breast-feeding; had a current medical illness or 
were taking medications that could influence resting metabolic rate; were a current 
smoker, or had a weight >220kg, the maximum weight limit on the DXA machine.  
Participants with prosthetic cardiac valves, cardiac pacemakers, joint-pins or metal plates 




 Ethics Approval, Māori Consultation and Funding 
Consultation with Māori was conducted during protocol development with Wellington 
Regional Hospital’s Research Advisory Group – Māori. Ethics approval was obtained 
from the Northern B, Health, Disability and Ethics Committee, ref. 15/NTB/175. 
Funding for the commercial DXA scans used in this study was provided by the 
Wellington Medical Research Foundation Ltd., registered charity no CC10659. 
 Study Procedures 
Eligible participants attended the Centre for Translational Physiology, University of 
Otago, Wellington for one visit. All participants provided written informed consent. 
Women of child bearing age had a pregnancy test performed with consent, prior to having 
the DXA. 
At the visit, questionnaires, anthropometry, phlebotomy and indirect calorimetry were 
completed.  Participants arrived by car having fasted from 2200h the night before and 
remained fasting until the DXA scan was completed.  
DXA, BIA, biochemical analysis of blood samples, and indirect calorimetry were 
performed as outlined in chapter two. The DXA scan was conducted on the same day as 
the indirect calorimetry. 
 Statistical Analysis 
The sample size for the study was 20 participants, 10 Māori & 10 Pacific. This number 
was chosen to provide an adequate sample of variation in resting energy expenditure. No 
subgroup analysis was performed.   
Mean, standard deviation and standard error of the mean were calculated for 
anthropometric, biochemical and calorimetric data. The difference between predicted and 
measured REE was performed using paired t-tests after log transformation to correct for 
skewed data.  
Bland Altman plots were used to present comparisons of predicted versus measured 
energy expenditure and BIA vs DXA for body composition analysis. BIA estimates of 
FM, FFM and body fat percent were calculated using the in-built regression equations on 
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the Tanita TBF-300 scales. Pearson’s correlation coefficient, r,  was used to quantify the 
relationship between measured and predicted energy expenditure.  
Allometric scaling of resting energy expenditure was conducted using linear regression, 
incorporating either FFM or both FFM and FM as predictors. Linear regression using 
body composition for BIA and DXA are presented separately.   
Power calculations were performed in G*Power 3 (433). For a definitive study of the 
accuracy of REE prediction, the mean, standard deviation and correlation of the measured 
and predicted REE were used. The planned analysis was a two-tailed, paired t-test. Power 
calculations for the CREEDS study were based on allometric scaling by linear regression 
of REE from the PREEMPt study. The root mean squared error (RMSE) of the regression 
model was used as the standard deviation of REE in both groups of the CREEDS study. 
For conservative and relaxed estimates, the upper and lower 95% confidence limits of 
the RMSE were also used to calculate sample size. The mean REE in the PREEMPt study 
was used as the anticipated mean REE in the control group of the CREEDS study. The 
mean intervention group REE was set at 95%, 90% and 85% of that of the control group. 
A one-way ANOVA with fixed effects was specified. Power was set at 0.80, alpha was 
set at 0.05 for all power calculations.  
5.2.4 Results 
 Demographic Characteristics 
Twenty participants, 10 New Zealand Māori & 10 Pacific Island were recruited. The 
Pacific participants consisted of seven Samoan, two Tokelauan, one Solomon Island and 
one Cook Island Māori. One participant identified as both Tokelauan and Samoan. Five 
Māori participants were male, the other five and all Pacific participants were female. The 
mean age was 44 years with a range of 24-60 yrs. Three participants had T2DM, 
controlled with tablets only. Hypoglycaemic medications were withheld on the morning 
of the visit until all assessments were completed, to avoid hypoglycaemia while fasted. 
Other medications, such as anti-hypertensives were continued. 
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 Body Composition 
Anthropometric measurements are presented in table 5.1. Bland-Altman plots of BIA 
versus DXA for assessment of lean mass, FFM and body fat percentage are presented in 
fig 5.1. There was a significant difference in FM predicted by Tanita’s inbuilt BIA 
equations compared with DXA, with BIA overestimating FM (M:1.76kg, 95%CI:0.03 to 
3.50; p:0.047). There was a trend toward overestimation of body fat percentage with BIA 
(M:2.13%, 95%CI: -0.3 to 4.5; p:0.07). There was no difference in lean mass estimation 
(M: -0.3, 95%CI: -6.3 to 5.7; p:0.91).  
  Mean  SD Range 
 
Weight (kg) 101.0 10.9 (83.1-123.6) 
Height (cm) 168 8 (156 – 189) 
BMI (kg/m2) 35.7 4.0 (30.3-44.3) 
DXA 
FFM (kg) 58.2 9.6 (46.0-83.8) 
FM (kg) 41.0 6.9 (29.7-55.2) 
% Fat 40.5 6.0 (28.0-47.7) 
BIA 
FFM (kg) 57.9 10.8 (46.3-87.1) 
FM (kg) 42.8 8.5 (33.8-63.5) 
% Fat 42.6 7.2 (29.5-55.2) 








 Measured Resting Energy Expenditure 
The mean resting energy expenditure for all participants was 7590 kJ/24 hrs (6188 – 
10108 kJ/24 hrs). The standard deviation was 1100 kJ/24 hours. Estimates of REE 
scaled for FFM and FM using DXA and BIA are presented in table 5.2. A comparison 
of fits for the regression models is presented in table 5.3. 
 Parameter  Estimate SEE 95% CI p-value 
DXA  
Model 1  FFM (kJ/kg) 100 11 (80 to 121) 4.94x10-8 
 Intercept (kJ) 1736 661 (-42 to 3514)  0.0175 
Model 2  FFM (kJ/kg) 100 12 (77 to 123) 1.76 x10-7 
 FM (kJ/kg) -5 16 (-16 to 5) 0.74 
 Intercept (kJ) 2013 1067 (-80 to 4104) 0.076 
BIA  
Model 3  FFM (kJ/kg) 32 22 (-10 to 75) 0.17 
 Intercept (kJ) 5740 1310 (3172 to 8309) 3.58 x 10-4 
Model 4  FFM (kJ/kg) 25 25 (-24 to 73) 0.33 
 FM (kJ/kg) -22.6 31 (-71 to 38)  0.47 
 Intercept (kJ) 7137 2322 (2586 to 11690) 7x10-3 
  
Table 5.2: Allometric scaling of REE by linear regression using FM & FFM from BIA 




 Method F-Statistic Adjusted R2 p-value 
Model 1 DXA 79.8 0.81 4.9x10-08 
Model 2 DXA 37.9 0.80 5.4x10-07 
Model 3 BIA 2.1 0.05 0.168 
Model 4 BIA 1.3 0.03 0.305 
 
 Predicted versus Measured Resting Energy Expenditure 
Predicted resting energy expenditure using the Schofield, Harris-Benedict, Mifflin St. 
Jeor and Oxford Equations are presented in table 5.4. Bland Altman plots of measured 
versus predicted resting energy expenditure are presented in Fig.5.2. As indicated by the 
mean difference between measured and predicted REE, all four equations underestimated 
REE, though the greatest bias was seen with the Mifflin St. Jeor equation. The limits of 
agreement were narrowest for the Schofield, followed by the Oxford, Harris- Benedict 
and Mifflin-St. Jeor equations.  
  










7590  1100 NA NA NA 
Schofield 7477  950 1.01 (0.97 to 1.06) 0.62 0.54 
Harris-
Benedict 
7434  736 1.02 (0.97 to 1.07) 0.65 0.52 
Mifflin-St. 
Jeor 
7197  686 1.05 (0.99 to 1.11) 1.82 0.08 
Oxford 7427  883 1.02 (0.97 to 1.07) 0.86 0.40 
Table 5.4: Difference between measured and predicted REE (kJ/24hrs)  
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Fig 5.2: Bland-Altman plots of measured versus resting energy expenditure (kJ/24 hours). 
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 HbA1c, Glucose, Lipids 
All female participants had a negative pregnancy test. HbA1c, glucose and lipids are 
presented in table 5.5. 
 Mean  SD Range 
HbA1C (mmol/mol) 38 13 28 to 70 
HbA1C (%) 5.6 1.2 4.7 to 8.6 
Glucose (mmol/l) 5.0 0.6 4.2 to 6.8 
Total Cholesterol (mmol/l) 4.7 0.7 3.9 to 6.0 
HDL (mmol/l) 1.3 0.3 0.93 to 1.84 
LDL (mmol/l) 2.8 0.7 1.9 to 4.3 
Triglycerides (mmol/l) 1.4 0.9 0.5 to 3.7 
Chol:HDL ratio 3.8 0.9 4.2 to 6.9 
 
 Power Calculations for the CREEDS Study 
Using resting energy expenditure scaled for lean mass, the mean resting energy 
expenditure was 7590 kJ/day. The root mean squared error for model 1 was 460 kJ/day, 
the root mean squared error for model 2 was also 460 kJ/day. As model fit did not 
improve significantly with model 2, model 1 was used for all power calculations. The 
95% confidence interval for the RMSE was 318 to 603 kJ/day. The sample size estimates 
are presented in Table 5.6.  
  






Difference in REE 
(%) 







5 381 82 
10 757 22 
15 1138 12 
RMSE 
460 kJ/day 
5 381 48 
10 757 14 




5 381 24 
10 757 8 
15 1138 6 
 
 Power Calculations for a Definitive Study of Predictive Energy Equations  
For the Schofield, Harris-Benedict, Mifflin St. Jeor, Oxford equations the correlation 
coefficients were 0.72, 0.62, 0.51, 0.69 respectively. The mean and standard deviations 
are presented in Table 5.4. To confirm the observed difference in calculated versus 
predicted energy expenditure a sample size of; 376, 248, 50, 194, would be required for 
each of the above equations. This is partly due to the small mean bias between the 
Schofield equation and the measured REE, which was in the order of 1-2%.  
Table 5.6: Sample size estimates for the CREEDS Study   
Multiple sample size estimates were calculated based on; the RMSE, and an anticipated 
difference of either 5%, 10%, or 15% in REE between treatment groups for the 
CREEDS study.  
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5.2.5 Discussion  
This study demonstrated differences in the performance of four commonly-used 
predictive equations in estimating REE when applied to an obese Māori and Pacific 
cohort; confirmed the poor performance of BIA for allometric scaling of REE, and 
informed sample size estimation for the CREEDS study (chapter seven) 
 Cohort Profile 
The pool of participants recruited were almost exclusively in the 30-60 yr age group. 
Three quarters of the cohort were female. By contrast, only 36% of the Schofield cohort 
were female. The updated Harris Benedict equation, Mifflin St.-Jeor and Oxford 
equations were more balanced with a female cohort of 50%, 50%, 45% respectively. All 
four predictive equations include gender status in the estimation of REE, however these 
predictions may perform differently in men than women, thus affecting the validity of 
the sample size estimate for a planned cohort study with a different gender distribution. 
The under-representation of male participants in this study highlights the challenge in 
recruiting overweight and obese male Māori & Pacific participants. 
All recruited individuals were obese, despite including overweight in the eligibility 
criteria. This may reflect bias in perceived weight, such that potential overweight 
participants may not have considered themselves eligible (434). For a definitive study to 
derive a prediction equation for REE in Māori & Pacific, it would be important to 
overcome both of these issues and recruit similar numbers of men and women, across a 
wider age and BMI range.  
 Accuracy of BIA compared to DXA 
BIA estimates of FM, FFM and percentage FM compared poorly to those produced by 
DXA. The lowest correlation was for FFM. This may reflect the susceptibility of FFM 
estimation to fluctuations in hydration. However, all participants were given the same 
instructions and encouraged to keep hydrated prior to the study visit.  
Another possible reason for the poor performance of BIA compared to DXA is the 
validity of the algorithms used by the BIA method to relate height, weight and 
bioimpedence to body composition. The conversion of bioimpedence values to body 
composition is itself a prediction equation derived from multivariate regression, with the 
same issues of validity as predictions of REE. Swinburn et al, 1999, evaluated the 
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accuracy of FM assessment by BIA compared with DXA in Māori and Pacific New 
Zealanders, and developed a new equation for estimation of FM in this population. BIA 
overestimated FM particularly at a BMI of greater the 30kg/m2 (435). These are 
consistent with our findings. It would have been useful to compare the Tanita’s inbuilt 
FM estimates with those of Swinburn’s equation. However, this equation was developed 
using a different bio-impedance analyser, and the resistance values are not the same as 
those produced by the Tanita.  
 Assessing Performance of Predictive Equations 
All predictive equations were biased, underestimating REE by between 1-5% on average. 
The confidence intervals were wide with an upper limit of 6-11% overestimation. In this 
small sample, the Schofield, followed by the Oxford equations, performed best with the 
greatest correlation to measured REE and the least bias. As the Schofield equation is used 
in New Zealand a definitive study of the validity of predictive equations in NZ 
populations must be powered to assess its effectiveness. Based on the sample data 
presented here, 376 participants would be required to confirm a difference of 1%, 
between measured and predicted REE. To derive new predictive equations, a similarly 
large sample would be required, the size depending on the complexity of the proposed 
prediction model. Rush et al, 2006, used a cohort of 140 participants to develop, and 70 
participants to validate predictive equations in an Asian Indian cohort using BIA and 
DXA (327). Their equation performed better than those developed in predominantly 
European cohorts.    
 McLay-Cooke et al, 2017, conducted a study investigating the performance of predictive 
equations in New Zealand participants of unspecified ethnicity (436). This study was 
published after completion of the PREEMPt, and so did not influence protocol 
development. The Schofield, Mifflin St. Jeor and Oxford equations were found to over-
estimate REE in individuals with a measured REE up to 7950 kJ, with underestimation 
of RMR above this level. By contrast in the PREEMPt study, we found systematic 
underestimation of resting energy expenditure. Rush et al, 2003, have previously 
demonstrated greater lean mass in Pacific individuals compared to European individuals 
at the same BMI (437). As none of the predictive equations assessed include body 
composition, it is possible that a greater degree of lean mass in our Polynesian cohort 
may have accounted for the underestimation of resting energy expenditure. Assuming a 
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sample representative of Dunedin’s ethnic distribution was recruited by McLay-Cooke 
et al, approximately 90% of the sample would be New Zealand European, 8% Māori and 
2% Pacific (438).  
 Use of BIA for Allometric Scaling of Resting Energy Expenditure 
The difference in body composition with BIA and DXA has implications for assessment 
of REE. BIA does not have the same validity that DXA does for the assessment of body 
composition. This inaccuracy is indicated by the SEE, the R2 & F statistics, and the 
significance of the estimates using BIA. The SEEs were 2-fold greater in the BIA models 
than those that used DXA estimates of lean and FM. In the BIA models the FFM estimate 
did not achieve statistical significance, despite being very strongly associated with REE 
in the DXA-based models. Notwithstanding the bias introduced by the measurement 
method, the cost of the reduced accuracy compared with DXA is significant. The sample 
size estimate to detect a 10% difference between groups in the CREEDS study is 14, 
assuming the RMSE is correct. Using BIA, 60 participants would be required to detect 
the same effect, making it less cost effective than using DXA.   
 Power Calculations for the CREEDS Study 
Multiple sample sizes were estimated based on the variance in the resting energy 
expenditure. Adaptive thermogenesis has previously been quantified in the range of 5-
10%. A sample size of 32, excluding dropouts, would provide 90% power to detect a 
difference of 7% in resting energy expenditure between intervention groups. Some 
caveats apply to this estimate. First, the PREEMPt study was a cross sectional design, 
whereas the CREEDS study was planned to be a mixed, repeated measures design. The 
repeated measures in the CREEDS study design should increase power by reducing the 
within-participant variation. Secondly, this estimate is based off the RMSE rather than 
the 95% upper confidence limit of the RMSE. Assuming the 95% upper confidence limit, 
a sample size of 32 would give >90% power to detect a difference of 10%, while a sample 
size of 58 would be required to detect a difference of 7%. The possible impact of 
menstrual cycle on resting energy expenditure was not assessed in this study. Resting 
energy expenditure is more variable in menstruating women, with an approximate two-
fold increase in variability over a month compared with men (296).  Finally, the CREEDS 
study is not restricted to Māori & Pacific ethnicities, in choosing to use only this 




Based on this pilot sample of 20 obese Māori and Pacific participants, a sample size of 
32 was chosen for the CREEDS study. It was determined that for reasons of validity and 
efficiency, DXA rather than BIA would be the most appropriate body composition 
assessment method.  An estimate sample size of approximately 376 participants would 
be required to confirm the bias in the estimate of REE produced by the currently used 
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6.1 Published Abstract 
Aims: To establish whether the risk of hypoglycaemia is greater with two days’ 
consecutive compared with non-consecutive very low-calorie diet in individuals with 
type 2 diabetes (Type 2 DM).    
Methods: This was an un-blinded randomized parallel group interventional trial of 
intermittent fasting in obese adult participants with Type 2 DM treated with dietary 
modification and/or any combination of hypoglycaemic medications in Wellington, New 
Zealand. Participants followed a 2092 – 2510 kJ diet two days per week for 12 weeks. 
Forty-one participants were randomised 1:1 to consecutive (n=19) or non-consecutive 
(n=22) day fasts, 37 (n=18 and n=19) were included in the final analysis. The primary 
outcome was difference in the rate of hypoglycaemia between treatment arms. Secondary 
outcomes included; change in diet composition, quality of life, weight, lipids, glucose, 
glycated haemoglobin and liver function tests.  
Results: The mean hypoglycaemia rate was 1.4 events over 12 weeks. Fasting (RR 2.05, 
1.16 to 3.6), but not allocation to consecutive day fasting (RR1.54, -2.87 to 6.11), 
increased hypoglycaemia risk despite medication reduction. Significant reduction in 
weight, HbA1C, fasting glucose, and improvement in quality of life occurred in both 
arms. 
Conclusions: In individuals with Type 2 DM on various hypoglycaemic medications, 
intermittent fasting with weekly supervision, hypoglycaemia education and structured 
medication reduction, is associated with increased hypoglycaemia on fasting days but a 
low overall risk of hypoglycaemia.   
Registration & Funding:   
This study was funded by a grant from the New Zealand Society for the Study of 
Diabetes. 





An unanswered question regarding altered schedules of calorie restriction, is the risk of 
hypoglycaemia during IF in patients using hypoglycaemic medication. There have been 
four studies to date of IF in participants with T2DM and in only two of these were 
participants taking medication with the potential to cause hypoglycaemia during the 
intervention period (290, 291, 439, 440). 
The popular IF diet was chosen as a model for schedule restriction for this study. This 
involved a very low-calorie diet (VLCD), 2092 kJ fast in women and 2510 kJ in men, for 
two days per week, with ad libitum intake on the other five days. The significant 
difference in energy intake between the fasting and non-fasting days creates an obvious 
risk for hypoglycaemia on fasting days in people with T2DM taking insulin or oral agents 
which promote endogenous insulin release.  The best approach to medication adjustment 
for fasting days in those with T2DM undertaking IF, and the risk of hypoglycaemia for 
an approach of consecutive or non-consecutive fasting are unknown.  
This study aimed to test the hypothesis that during a 5:2 IF diet with medication 
adjustment, non-consecutive day caloric restriction reduces the overall risk of 
hypoglycaemia, compared to consecutive days of calorie restriction.  
The intermittent fasting hypoglycaemia (IF-Hypo) study was published in Diabetic 
Medicine  (fig 6.1) (441). The accepted manuscript has been reproduced for use in this 
chapter, consistent with Diabetic Medicine’s copyright transfer agreement (442). It has 
been modified to ensure consistency with the format of this thesis. The introduction 
presented here differs from that of the article to avoid repetition of information presented 
earlier in the thesis. However, the abstract, methods, results, discussion and conclusion 
are the same.   
6.3 Methods 
6.3.1 Participants 
Participants older than 18 years with T2DM and an HbA1C 50-85 mmol/mol (6.7 to 
9.9%) with a body mass index 30 - 45 kg/m2 were recruited from secondary care diabetes 
clinics, local community networks, and primary care practices. Exclusion criteria were: 
weight change of >5 kg in the preceding three months, a diagnosis of an eating disorder, 
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pregnant or planning pregnancy, blood pressure > 180/100 mmHg despite medical 
therapy, or previous bariatric surgery. Each participant gave written informed consent. 
The study was approved by the New Zealand Health and Disability Ethics Committee 
(14/NTB/33/AM03), was performed in accordance with the Declaration of Helsinki, and 
the Australia New Zealand Clinical Trial Registry number was: 
ACTRN12614000402640. 
6.3.2 Study Visits & Randomisation 
All participants attended the Centre for Endocrine, Diabetes & Obesity Research; 
Wellington Hospital, New Zealand on three occasions over 12 weeks; at baseline, six 
weeks and 12 weeks. At baseline participants were randomised, by a computer based 
process, in a 1:1 ratio to either consecutive or non-consecutive days of fasting two days 
per week. Participants were free to choose which day of the week to fast, this could vary 
from week to week to allow flexibility and improve adherence.  
Treatment allocations were printed and placed in sequentially numbered sealed 
envelopes by a member of the research team prior to enrolment of the first participant in 
the study. The allocation was blinded from the staff member conducting enrolment until 
un-blinding at the first study visit.    
6.3.3 Dietary Intervention & Medication Adjustment 
Participants were given nine days of written sample recipes. These were developed by a 
research dietician and structured as two small snacks and one light meal amounting to 
between 2092 and 2510 kJ per day. Each participant was provided with written and verbal 
information about symptoms, management and common causes of hypoglycaemia. The 
importance of capillary glucose monitoring and hypoglycaemia prevention was 
emphasized. Hypoglycaemic medication was adjusted as follows: Sulfonylureas and 
NPH Insulin was reduced by 50% on fasting days. Humalog; Novorapid & Apidra was 
reduced by 70% on fasting days; Mixed Insulins were reduced by 25% on the night before 
a fast and 50% on the day of a fast, Lantus was reduced by 50% on the morning of a 
fasting day and/or by 50% on the evening before a fasting day. The dose of metformin 
or other medication not resulting in hypoglycaemia was unchanged.  
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6.3.4 Hypoglycaemic Events 
The primary outcome was the total number of hypoglycaemic events during 12-weeks 
observation. Participants were contacted weekly by phone or email during the study.  
Days of the week spent fasting, change in medication, the date, time, circumstances, 
severity, and capillary blood glucose concentration of any hypoglycaemic events were 
recorded. Severe hypoglycaemia was defined according to the American Diabetes 
Association guidelines as an event requiring assistance of another person to actively 
administer carbohydrate, glucagon, or other resuscitative actions (443). If a 
hypoglycaemia event was avoidable, e.g. due to a missed meal, appropriate advice was 
given to prevent a further occurrence and hypoglycaemic medications were not adjusted. 
If there was no clear cause, or if hypoglycaemia events were recurrent despite appropriate 
advice, the participants’ medication was reduced further.  
6.3.5 Anthropometry, Dietary Composition, Quality of Life, Continuous 
Glucose Monitoring 
Anthropometric measurements & food intake were assessed at all visits and included; 
height, weight, waist circumference, body fat composition by tetra-polar bioimpedence 
analysis (TBF-300, Tanita) and blood pressure (Flexiport, Welch Allyn). Participants 
completed a four day food diary to record calorie intake at baseline, six & 12 weeks 
(444). Baseline diaries contained non-fasting entries only. At six and 12 weeks, each day 
of the food diary was coded fasting or non-fasting. Quality of life and biochemical 
assessments were conducted at baseline and 12 weeks.  
The Audit of Diabetes-Dependent Quality of Life 19 (ADDQOL) Questionnaire was 
used for quality of life measurement at baseline and 12 weeks (445, 446). The ADDQOL 
contains an overall quality of life assessment score ranked between +3 (excellent) to -3 
(extremely bad); and a measure of the impact of diabetes on quality of life in general. It 
also measures the impact in 19 different domains. For each domain participants are asked 
to rate how their life would be if they did not have diabetes. The impact scales for each 
domain range from “very much better” (-3) to “worse” (+1) and are multiplied by an 
importance score from 0 to +3 which reflects the importance of that domain to the 
participant. Lower scores reflect poorer quality of life. A mean weighted impact score is 
calculated as a summary score across all domains.  
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Continuous glucose monitoring (Guardian REAL CGMS devices, Medtronic) was 
performed between week six and week 12. The target monitoring period was four days 
including at least one fasting and one non-fasting day.  
6.3.6 Glycated haemoglobin, fasting lipids, thyroid stimulating hormone, free 
thyroxine, liver function, renal function, and fasting glucose  
Fasting venous blood was collected and analysed for; lipids, glucose, liver function & 
renal function (Cobas c-501, Roche); free thyroid hormone and thyroid stimulating 
hormone (FT4, TSH, Cobas e601, Roche); full blood count (XS-1000i, Sysmex); and 
glycated haemoglobin (HbA1C, D-10, Biorad).  
6.3.7 Statistical Analysis 
The relative rate of hypoglycaemia events was estimated using a generalized linear mixed 
model. Co-variates in the model were: baseline insulin use, baseline sulfonylurea use and 
randomised dietary intervention, all as dichotomous variables. Repeated measures on the 
same participants were accounted for by incorporating them as random effects. A Poisson 
distribution for count data was used with the logarithm of the number of days’ fasting as 
the offset variable. Anthropometric & biochemical outcomes were assessed using a 
general linear mixed model that incorporated participants as random effects and 
treatment group and timepoint (baseline, 12 weeks) as fixed effects (Table 2). Quality of 
life data were analysed using two-way ANCOVA incorporating treatment group as a 
predictor variable and baseline scores as a covariate in the model. For glucose profiles 
on fasting and non-fasting days, only recordings that covered >85% of day and contained 
a minimum of three calibrations per day were used. SAS version 9.4 was used. 
6.3.8 Sample size 
The sample size was estimated by simulation from random Poisson variables. Past 
research suggested a hypoglycaemia rate of 4.4 per 12 weeks (447). We felt that detecting 
an increased rate of hypoglycaemia of 2.2 per 12 weeks is clinically meaningful. By 
simulation a sample size of 18 in each group; 36 in total, has 80% power with a two-




Baseline demographic data and medication use are shown in table 6.1.  The flow of 




n = 19 
Consecutive 
n = 18 
 Mean (Min to Max) 
Age (yr) 58 (42 to 74) 62 (44 to 77) 
 n (%) 
Women  8 (42) 7 (39) 
Maori 2 (10) 1 (5) 
NZ European 13 (68) 12 (67) 
Insulin Use 9 (47) 12 (67) 
Sulfonylurea Use 11 (58) 10 (57) 
Metformin Use 18 (95) 15 (83) 






Overall there were 53 hypoglycaemic events during 84 days of observation affecting 15 
participants. Twenty-two participants (59%) had no hypoglycaemic events. Twenty-three 
hypoglycaemic events occurred over 851 fasting days, a crude rate of 1 event per 37 days 
of fasting, and 30 over 2257 non-fasting days, a crude rate of 1 event per 75 participant 
days of non-fasting. Thirty-five hypoglycaemic events occurred in 7 of eighteen 
participants in the consecutive fasting group with 1,512 participant days of observation 
for a crude rate of 1 event per 43 days. Twenty events occurred in eight of 19 participants 
in the non-consecutive fasting group with 1,596 participant days of observation for a 
crude rate of 1 events per 80 days. There were no reported severe hypoglycaemic events.  
 The risk of having a hypoglycaemic event was two-fold greater with fasting, relative rate 
(95% CI): 2.05 (1.16 to 3.6), p=0.013. The risk of having a hypoglycaemic event was not 
different between treatment arms 1.54 (-2.87 to 6.11), p = 0.51. Although incorporated 
Fig 6.2: Patient flow diagram 
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as co-variates, we did not a detect a significant effect of baseline sulfonylurea use -1.59 
(-9.20 to 3.28), p = 0.56 or baseline insulin use: 2.16 (-2.64 to 3.29) p=0.141 and the risk 
of hypoglycaemia. Over 12 weeks, further medication adjustments were required in 
response to hypoglycaemia in 9/37 (24%). Of these, seven had their medications adjusted 
in the first two weeks, one at three weeks and one at five weeks. Six of these participants 
required one medication adjustment, two participants required two medication 
adjustments and one participant required three medication adjustments. The three 
participants that dropped out or were lost to follow up had no reported hypoglycaemia 
prior to drop out. 
6.4.2 Continuous Glucose Monitor  
In twenty-seven participants, a glucose monitoring sensor was used during the study 
resulting in 786 non-fasting and 425 fasting readings. There were seven hypoglycaemic 
events in five participants while wearing the monitor. Two occurred on fasting days and 
five occurred on non-fasting days. Mean (SD) subcutaneous glucose reading on fasting 
days was 8.34 (2.18) mmol/L and on non-fasting days was 8.93 (2.59) mmol/L. 
6.4.3 Diet Composition 
Baseline, six-week and 12-week food diaries were completed by 33 (89%), 25 (68%) and 
33 (89%) of participants respectively. The mean (SD) total energy intake was 3430 
(1129) kJ on fasting days and 7472 (2418) kJ on non-fasting days. There was a sustained 
reduction in total calorie intake after six and 12 weeks compared to baseline (fig 6.3). 
There was no significant difference in proportional macronutrient composition between 
fasting and non-fasting days at any timepoint. After six and 12 weeks, self-reported 










Change from Baseline to 12 Weeks, 
between group difference. 











(n = 18) 
  
Weight (kg) 109.8 (20.3) 108.7 (20.4) 106.2 (20.1) 105.6 (19.9) -0.8 (-13.8, 12.0) 0.89 
BMI (kg/m2) 36.8 (5.2) 36.6 (5.3) 36.0 (5.2) 36.1 (5.5) 0.6 (-3.0, 4.2) 0.75 
Body fat (%) 41.2 (6.7) 38.6 (7.2) 40.3 (7.0) 37.5 (8.1) -1.5 (-6.2, 3.2) 0.53 
Waist circumference (cm) 122.5 (13.6) 120.4 (17.0) 119.1(14.2) 118.8 (16.6) -0.4 (-10.2, 9.4) 0.93 
HbA1C (mmol/mol) 66 (7) 68 (10) 59 (8) 62 (10) 2.1 (-3.3, 7.6) 0.44 
HbA1C (%) 8.2 (1.3) 8.4(1.8) 7.5(1.5) 7.8(1.8) 0.2 (-0.3, 0.7) 0.77 
Fasting blood glucose 
(mmol/L) 
9.0 (0.5) 8.2 (2.8) 7.9 (0.4) 6.9 (2.1) -0.8 (-2.0, 0.3) 0.17 
TSH (mU/L) 1.6 (0.8) 2.1 (1.9) 1.8 (0.9) 2.0 (1.2) 0.3 (-0.4, 1.0) 0.81 
Total cholesterol (mmol/L) 4.2 (1.0) 3.9 (0.8) 3.8 (0.8) 4.0 (1.0) -0.1 (-0.6, 0.5) 0.81 
HDL-cholesterol (mmol/L) 1.1 (0.2) 1.0 (0.2) 1.1 (0.2) 1.1 (0.2) -0.1 (-0.2, 0.1) 0.26 








Change from Baseline to 12 Weeks, 
between group difference. 











(n = 18) 
  
LDL-cholesterol (mmol/L) 2.1 (0.8) 2.1 (0.8) 2.0 (0.7) 2.25 (0.81) 0.1 (-0.4, 0.6) 0.70 
Cholesterol:HDL ratio 3.8 (1.0) 3.9 (0.9) 3.5 (0.9) 3.9 (1.0) 0.1(-0.5, 0.7) 0.78 
Triglycerides (mmol/L) 1.8 (0.6) 1.8 (0.7) 1.7 (0.4) 1.7 (0.8) 0.0(-0.4, 0.4) 0.99 
Creatinine (umol/L) 79 (20) 100 (44) 82 (20) 93 (35) 16 (-3,35) 0.11 
Estimated GFR 
(ml.min-1.1.73m2-1) 
74 (17) 59 (20) 73 (17) 63 (20) -9(-21, 1) 0.11 
Systolic blood pressure 
(mmHg) 
133 (15) 132 (12) 129 (12) 129 (16) -1(-8, 7) 0.84 
Diastolic blood pressure 
(mmHg) 





6.4.4 Anthropometry & biochemistry 
There were no statistically significant differences between consecutive or non-
consecutive arms in secondary outcomes (table 6.2). Weight, waist circumference, FM, 
HbA1C & fasting glucose improved from baseline to 12 weeks. Reductions in alanine 
transaminase, alkaline phosphatase & aspartate transaminase achieved statistical 
significance but were small and not considered clinically significant. In 6/37 (16%) 
HbA1C rose between 1 and 4 mmol/mol. 
6.4.5 Quality of Life 
Treatment group had no significant impact on any quality of life or diabetes impact score 
in any domain. However, in all participants there was a small but statistically significant 
improvement in the global quality of life rating between baseline and week 12 (0.66, 95% 
CI [0.48, 0.85] p = 0.020). The effect was an improvement of 0.66 on a scale where the 
Fig 6.3: Mean daily calorie intake (kJ) at all time points. 
Self-reported energy intake was consistently lower at 6 and 12 weeks compared to 
baseline in both treatment arms. There was a trend toward lower energy intake in 




maximum achievable difference is 6.0.  This was offset by a small, statistically significant 
increase in the global impact of diabetes on quality of life between baseline and week 12 
(0.70, 95% CI [0.34,1.04] p <0.001). The effect was an increase in the negative impact 
of diabetes on quality of life of 0.70 units, on a scale where 4 units’ difference is the 
maximum. There was no significant change in the impact of diabetes on any of the 19 
specific domains or the average weighted score based on these domains.  
6.5 Discussion  
In this study, we found that despite hypoglycaemic education, a proactive standardized 
medication reduction and weekly contact, IF was associated with a two-fold increase in 
hypoglycaemia on fasting days. However, the overall risk of hypoglycaemia on both 
fasting and non-fasting days was lower than expected, there were no episodes of severe 
hypoglycaemia and most participants did not experience hypoglycaemia. These 
observations suggest that the risk of hypoglycaemia appears to be more dependent on 
individual characteristics than on the pattern of fasting. Continuous glucose monitor 
recordings supported the reported absence of severe hypoglycaemia and the relatively 
low reported rate of hypoglycaemia. 
This is one of few studies examining the risk of hypoglycaemia in people with T2DM 
following an intermittent calorie restriction(290, 440). Ash et al studied 51 overweight 
or obese men with T2DM on oral hypoglycaemia medication randomised to intermittent 
energy restriction, pre-portioned meals or self-selected meals. The intermittent energy 
restriction was four consecutive days of a 4184 kJ liquid meal for 12 weeks. While a 
comparable reduction in HbA1C was observed, medication adjustment or hypoglycaemic 
events were not reported(290). More recently Carter et al. studied a medication reduction 
protocol based on baseline HbA1C. This was altered during the study period due to 
excess hypoglycaemia in those taking sulfonylureas. The reported hypoglycaemia rate 
occurring in insulin users was 4.3 +/- 3.8 events over the 12-week study period(440). 
This compares with an overall crude rate of 1.4+/- 2.1 events (n=37) in our study over 
the same period despite a greater proportion of insulin & sulfonylurea users at baseline 
(56%) with only two participants not on hypoglycaemic medication. This rate is 
substantially lower compared to recent published rates of hypoglycaemia in comparable 
populations (447-449). This is most likely explained by the combination of 
hypoglycaemic education, a proactive reduction in hypoglycaemic medication, and 
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weekly contact to discuss hypoglycaemia. Most importantly HbA1C did not deteriorate 
because of medication reduction at baseline.  
Consistent with other studies of IF there was a clinically relevant reduction in weight, 
HbA1C and fasting glucose despite the relatively mild dietary intervention and short 
duration of the study.  
We observed a difference in adherence to the target calorie intake at six weeks and 12 
weeks, this may be due to the difference in response rate, as a larger proportion of 
participants failed to return the six-week dietary record.  
We found that participant’s perceptions of the negative impact of diabetes on their quality 
of life increased slightly during the study. This may have resulted from the dietary 
constraints, requirement for regular testing and the emphasis on body shape and weight 
during a period of calorie restriction. Despite this there was a small improvement in their 
global quality of life rating. 
6.5.1 Limitations 
Our primary outcome was reliant on self-reported hypoglycaemia during weekly contact. 
While spontaneously self-reported hypoglycaemia rates are low in individuals with 
T2DM (448), self-reported hypoglycaemia in response to questionnaires is widely used 
to measure of the true burden of hypoglycaemia in population studies(448, 449). In 
retrospect, it would have been helpful to have collected data on rates of hypoglycaemia 
prior to the commencement of the intervention.  
 Generalized linear mixed models for count measures are prone to bias depending on the 
estimation methods used and the specified distribution of the outcome variable, in this 
case hypoglycaemia (450). To test for this, we ran the procedure in both R (399) & SAS 
(SAS Institute, USA) and found no difference in the estimates. For our analysis, we 
categorised insulin use as a dichotomous variable which may have obscured a dose 
related increase in hypoglycaemia (448, 449).  
The lower than anticipated hypoglycaemia rate meant we were underpowered to detect a 
difference in hypoglycaemia between arms. However, as we were looking for a clinically 
relevant increase in hypoglycaemia compared with published averages, the finding of a 
lower than anticipated hypoglycaemia event rate in both arms is meaningful. 
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Systematic underreporting of food intake in self-reported food diaries is well recognised 
(444). In this study, there may have been greater risk of underreporting on fasting days. 
However, the within-participant comparison between fasting and non-fasting days may 
have attenuated any one individual’s tendency to under-report their intake. Systematic 
underreporting would not be expected to differ between consecutive and non-consecutive 
arms.  
6.6 Conclusion  
The principle finding of this study was that IF was associated with a lower than expected 
overall risk of hypoglycaemia when combined with weekly supervision, hypoglycaemia 
education, & medication reduction at baseline. Although fasting days were associated 
with a two-fold increase in rate of hypoglycaemia, whether the two days were 
consecutive or non-consecutive did not have a significant effect.  The intervention did 
result in weight loss, reduced HbA1c and a small improvement in quality of life.  Our 
study protocol can be adopted for the longer-term studies that will be required to assess 
the tolerability and sustained efficacy of an intermittent fast.  
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  The CREEDS Study 
 
7.1 Introduction 
As described in chapter one, dietary energy restriction is the mainstay of treatment for 
obesity and the resultant weight loss is the only proven way to induce remission of 
T2DM. Unfortunately, durable weight loss is challenging to maintain and is accompanied 
by a maladaptive reduction in REE. Adaptive thermogenesis lowers the daily calorie 
intake required to maintain weight loss during dietary restriction and is thought to be a 
product of incompletely understood energy homeostatic control mechanisms.   
The Changes in Resting Energy Expenditure with Different Schedules of calorie 
restriction (CREEDS) study aimed to investigate whether the magnitude of adaptive 
thermogenesis is attenuated with intermittent fasting (IF) compared with continuous 
daily restriction (CDR). Interrupting calorie restriction with periods of isocaloric intake, 
may reveal the time-scale over which adaptive thermogenesis is regulated. The CREEDS 
study was also designed with a clinical dietary intervention in mind. In effect, we wanted 
to see not just if adaptive thermogenesis could be mitigated, but also whether the impact 
of an altered schedule of calorie restriction would inform the implementation of a diet 
that is both feasible and acceptable in the wider population.  
The indirect calorimetry and DXA techniques used in the assessment of adaptive 
thermogenesis were of known precision and validity following the testing outlined in 
chapters two, three and four. In addition, the power calculations for the study were drawn 
from studies of a local overweight and obese population sample using these same 
techniques to maximise validity for the study as outlined in chapter five.  Whether IF 
provides additional glycaemic benefits over and above CDR was of interest in designing 
the CREEDS study. However, in view of the increased rate of hypoglycaemia on fasting 
days, outlined in chapter six, it was decided to exclude individuals with T2DM on 
hypoglycaemic medications. 
Therefore, the aim of the CREEDS study was to compare changes in energy expenditure 




7.2 The CREEDS Study 
7.3 Study Population 
Participants were recruited from advertisements in general diabetes and endocrine 
clinics, local GP practices, the regional hospital and university staff mailing lists, 
advertisements disseminated via regional community noticeboards. 
Inclusion criteria were   
• BMI ≥ 30 kg/m2 
• Male  
• Aged 18-65 years 
Exclusion criteria were:   
• Weight change > 5 kg over the previous three months  
• Current medical illness or medications that may, influence REE.  
• Current smoker 
• Weight > 220kg, the maximum weight limit on the DXA machine.  
• A history of disordered eating.  
• History of T2DM requiring treatment other than metformin or diet OR poorly 
controlled T2DM with a HbA1C >64mmol/mol (8.0%) OR a fasting plasma 
glucose > 10 mmol/l.  
Male participants were chosen to avoid variation in REE due to changes in the 
menstrual cycle observed in women (296), particularly given the three-week interval 
between study visits (section 7.5.3). Poorly-controlled T2DM has been associated 
with an elevation in the REE, and was therefore also an exclusion (451). Individuals 
with T2DM on hypoglycaemic medication were excluded due to the increased risk 




The CREEDS study was a six-week non-blinded randomised parallel group, dietary 
intervention study of IF compared to CDR. 
1. The primary outcome was the change in REE over six weeks comparing 
participants undergoing daily calorie restriction versus an intermittent calorie 
restriction, providing the same net energy deficit per week. 
The secondary outcomes were:  
1.  Adherence to the prescribed calorie restriction. 
2. Change in macronutrient composition of the diet. 
3. Change in weight, FM, FFM, waist and hip circumference with CDR compared 
to IF.  
4. Changes in fasting glucose, HbA1C, total cholesterol, triglycerides, high-density 
lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol.  
5. Changes in REE on fasting compared with non-fasting days. 
6. Changes in eating behaviour.  
7. Changes in physical activity levels. 
8. Change in thyroid function, leptin, total ghrelin, active ghrelin and adiponectin 
between the IF group and the CDR group. * 
*Analysis of thyroid function, fasting glucose, adiponectin, leptin and ghrelin is planned. 
These will be included in the CREEDS manuscript but are outside the scope of this thesis.  
7.5 Methods 
7.5.1 Diet Intervention 
Participants in the CDR group were prescribed 80% of estimated total daily calorie 
requirements every day. Participants in the IF group were prescribed 25% of estimated 
total daily calorie intake on two non-consecutive days per week and 100% of estimated 
daily requirements on the other five days. Thus, both groups were required to calorie 
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count daily throughout the study. Diet prescriptions were calculated by combining REE 
assessed by indirect calorimetry, Physical activity energy expenditure assessed by IPAQ 
and by assuming DIT accounted for 10% of TEE. Physical activity estimates were 
obtained from the IPAQ using the method outlined in chapter two, section 2.3.3.4.2. Diet 
prescriptions were calculated for all participants at each study visit. The diet duration was 
six weeks. 
 Diet Education 
Dietary education was provided during a one-hour individual education session with the 
lead researcher and research dietitian during the first study visit. The first half of the 
session was spent discussing accurate food diary completion, usual diet and food 
preferences, and the components of a healthy diet as outlined by the New Zealand 
Ministry of Health (428). The second half was spent discussing calorie counting, portion 
size estimation, converting between kilocalories and kilojoules, label reading, 
demonstrating smart-phone apps and websites to assist with calorie counting, and 
reviewing the written resources.  
A guide to calorie counting was prepared for the CREEDS study (appendix D). Briefly, 
this included; tips for sticking to a low-calorie diet, a two-page quick reference guide 
containing calorie counts for common food and drink items, sample meal-plans for 
fasting day intakes in the IF group and recipe cards for low calorie meals. The guide also 
contained; a list of recipe websites that provide calorie counts, links to online-calorie 
counters, the names of android and iOS compatible calorie counting apps and calorie 
counting or IF recipe books.  The Easy Diet Diary (Xyris software) app for iphone and 
the Calorie King website (www.calorieking.com.au) were recommended for calorie 
counting, as they are based on the food composition databases of the Food Standards 
Authority Australia New Zealand.  
 Four-day food records 
Participants completed four-day food records prior to their first study visit and during the 
first, third, and sixth weeks of the diet intervention. Template food records were provided 
in hardcopy and softcopy format (see appendix A). The baseline food record was used to 
educate participants about completing food diaries accurately, to provide an indication 
of their diet habits and food preferences, and to help with tailoring the dietary education 
and advice on adhering to a low-calorie diet. They were not used in the study analysis.  
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The remaining food records were used to assess adherence to the diet prescription and 
assess macronutrient composition of the diet at week one, week three and week six.  
Several participants indicated a preference for using spreadsheets or apps to log their 
food intake. Any method that facilitated accurate food records recording was encouraged. 
Irrespective of the method of recording food intake, participants were asked: to complete 
at least four days of food records at each time-point; to record all items consumed 
including beverages; to complete records at least once daily; to record the day and the 
time-point of all food records; and, in the IF group, to note if it was a fasting or a non-
fasting day. All records were checked and any omissions discussed during the next study 
visit or by telephone contact, whichever occurred first.  Food records were analysed using 
Food Works 9 (Xyris software), diet analysis software.  
 Weekly telephone contact 
Between visits to the study centre, participants were contacted weekly by telephone. 
Using a standard list of questions, each participant was asked about: any barriers to 
adherence; the number of days successful calorie restriction that week; whether they had 
any question about calorie counting or the diet prescription; whether there had been any 
change in medications or their health; and whether they had completed and returned their 
food record, if applicable.  
7.5.2 Randomisation 
Participants were randomly allocated 1:1 to CDR or IF. Randomisation was performed 
using a web-based application (www.RANDOM.org, Randomness and Integrity Services 
Ltd.). Randomised allocations were concealed in sequentially numbered envelopes. 
Investigators were blinded to the allocations until the participant’s first visit.   
7.5.3 Study Visits 
The study visit structure is presented in Table 7.1. Participants attended the centre three 
times over six weeks. Visits were scheduled between 0700 – 11:00 in the morning. The 
IF group attended for a fourth visit to measure REE on a fasting day to compare fasting 













Eligibility screen ✓    
Consent ✓    
Randomisation ✓    
Phlebotomy ✓  ✓  
Anthropometry ✓ ✓ ✓  
DXA ✓ ✓ ✓  
Physical Activity 
Assessment 
✓ ✓ ✓  
Indirect calorimetry ✓ ✓ ✓  
Structured Diet 
Education 
✓    
Diet Prescription ✓ ✓ ✓ ✓ 
Eating Behaviour 
Questionnaire 
✓  ✓  
Food Record review ✓ ✓ ✓ ✓ 
 
Table 7.1: Schedule of procedures for the CREEDS Study  
Visits two and three were scheduled within 21 days +/- 3 days from the previous visit. 




7.5.4 Body composition and Energy Expenditure 
Body composition and energy expenditure were measured by standard anthropometry, 
DXA and indirect calorimetry as outlined in chapter two, section 2.4.  
7.5.5 Biochemical Tests 
HbA1C and lipids, were collected and analysed using a point of care device as outlined 
in chapter two, section 2.4.5.   
7.5.6 The International Physical Activity Questionnaire  
The long-form IPAQ was used to assess physical activity at every study visit (section 
2.3.3.4.2) (359). The same interviewer carried out all IPAQ interviews during the study. 
Physical activity related energy expenditure was expressed as a percentage of total daily 
estimated energy expenditure to account for differences in body weight 
7.5.7 The Adult Eating Behaviour Questionnaire 
The adult eating behaviour questionnaire (AEBQ) is a 35 item-instrument that evaluates 
participants appetitive eating behaviours (452). Items are presented as a series of 
statements and participants are asked to select from five possible responses; “strongly 
disagree”, “disagree”, “neither agree nor disagree”, “agree”, “strongly agree. Each item 
belongs to one of seven appetitive behaviour domains or an eighth domain that represents 
hunger. The seven domains are; enjoyment of food, emotional over-eating, emotional 
under-eating, food fussiness, food responsiveness, slowness in eating and satiety 
responsiveness. Participants self-administered the AEBQ at baseline and six weeks. 
Answers for questions within each domain were averaged.  
7.5.8 Data Management 
All study data were recorded in REDCAP, a secure online data management tool hosted 
at the University of Otago Wellington (453). A tailored REDCAP database was 
developed for the CREEDS Study. To minimise data entry error and to ensure no data 
were omitted, validation rules were created for each field. This involved specifying the 
number of decimal points, format and expected range for all measured variables, 
highlighting essential missing values, automating calculation of fields such as BMI and 
age, and auto-completing fields in one instrument with data entered in another to reduce 
errors from entry of duplicate values. Where appropriate drop-down menus or radio-
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buttons were used to avoid data entry errors. Data were entered contemporaneously at 
each visit by the research team. 
7.5.9 Statistical Analysis 
Statistical analysis was performed in R (399). For the primary endpoint a general linear 
mixed model was used, incorporating individuals as random effects and treatment, 
timepoint, FFM and FM as fixed effects. Timepoint by treatment was included as an 
interaction term. The restricted estimates of maximum likelihood method was used as it 
is associated with less bias for smaller samples.  For secondary outcomes, changes from 
baseline to six weeks were evaluated using ANCOVA incorporating baseline values as a 
covariate and treatment as a fixed effect. Comparison of macronutrient composition and 
physical activity between groups was conducted using student t-tests at each time point, 
with Bonferroni correction for multiple comparisons. Differences indirect calorimetry 
recordings following a fast-day compared with a non-fasting day were assessed with a 
paired student’s t-test.  As outlined in chapter five (section 5.2.5.5), a sample size of 32, 
excluding dropouts, was estimated to provide 90% power to detect a difference of 7% in 
REE between intervention arms. 
7.5.10 Ethics Approval, Maori Consultation and Funding 
Consultation with Maori was conducted during protocol development with Wellington 
Regional Hospital’s Research Advisory Group – Māori. Ethics approval was obtained 
from the Northern A, Health, Disability and Ethics Committee, ref. 16/NTA/208. A 
grant-in-aid for this study was received from the Maurice and Phyllis Paykel Trust, 
registered charity number CC27541. All study visits were conducted at the Centre for 
Translational Physiology, University of Otago Wellington. 
7.6 Results 
7.6.1 Participant Recruitment and Retention 
A flow chart for participant recruitment is presented in Fig. 7.1. Fifty-two individuals 
expressed an interest in the study and thirty-six were eligible for inclusion. Sixteen 
participants were not eligible for inclusion; twelve had a BMI < 30kg/m2; one had a 
diagnosis of obstructive sleep apnoea; one had a mitochondrial disorder; one had T2DM 
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requiring oral hypoglycaemic medications, and one was enrolled in a pharmacological 
weight loss study.  
 
 
7.6.2 Baseline Characteristics 
Of the 34 included participants 26 identified as New Zealand European, seven New 
Zealand Māori, two European, one Asian and one Australian. Three participants 
identified with more than one ethnic group. The median age was 50 with an interquartile 
range of 41 to 57 years.  Baseline anthropometric, biochemical and body composition 
data are presented in Table 7.2.     









Change from Baseline 









(n = 16) 
F-value p-value 
Weight (kg) 111 (23) 107 (18) 107(24) 101 (18) 2.9 0.099 
BMI (kg/m2) 35 (5) 34 (5) 34(5) 33(6) 2.7 0.11 
Waist circumference (cm) 114 (14) 112 (11) 109 (15) 109 (12) 0.47 0.50 
Hip Circumference (cm) 116 (9) 114 (11) 114(10) 112(13) 0.40 0.53 
Fat Free Mass (kg) 71 (10) 67 (6) 69(10) 64(6) <0.01 0.989 
Fat Mass (kg) 39 (13) 39 (12) 37 (14) 35 (12) 4.8 0.04 
Body fat (%) 34 (5) 35 (5) 34 (5) 34 (5) 2.8 0.11 









Change from Baseline 








(n = 16) 
F-value p-value 
Systolic blood pressure 
(mmHg) 
121 (12) 125 (10) 116(7) 113(9) 1.25 0.27 
Diastolic blood pressure 
(mmHg) 
78(8) 82(11) 80(5) 77(10) 2.0 0.17 
HbA1C (mmol/mol) 38 (8) 39(8) 35(7) 35(4) 2.1 0.16 
HbA1C (%) 5.6 (0.7) 5.7 (0.7) 5.6 (0.7) 5.7 (0.7) 2.1 0.16 
Total cholesterol (mmol/l) 5.1 (1.5) 4.6 (1.4) 4.6 (1.4) 4.6 (0.5) 0.30 0.59 
LDL-cholesterol (mmol/l) 2.8 (1.1) 3.32 (1.0) 2.8 (1.0) 2.8 (0.5) 0.39 0.54 








Change from Baseline 








(n = 16) 
F-value p-value 
Cholesterol:HDL ratio 4.6 (1.5) 5.0 (1.5) 4.2 (1.2) 4.5 (1.0) 0.28 0.60 




7.6.3 Adaptive Thermogenesis 
The general linear mixed models are presented in Table 7.3. Model one contained the 
time by treatment interaction. This was not significant and thus dropped for model two. 
There was minimal loss of fit (Table 7.3) with removal of the interaction terms. Subjects, 
incorporated as random effects, had a SD of 760 kJ/24 hours in REE and a residual of 
335 kJ/24 hours indicating significant between subject variation not accounted for by 
fixed effects in model one. Thus, subjects were retained as a random effect for model 
two. Plots of the standardized residuals for both models are presented in Fig. 7.2 
 
  
Model 1 Model 2 










SEE t-value p-value 
Model 1  Intercept 492 274 1.8 0.078 
 Fat Free Mass 14.7 4.5 3.2 0.002 
 Fat Mass 14.0 3.1 4.6 <0.001 
 IF -25.1 70.4 -0.4 0.723 
 Visit 2 -67.7 30.2 -2.24 0.0293 
 Visit 3 -8.6 31.5 -0.27 0.785 
 IF:Visit 2 30.5 41.9 0.73 0.470 
 IF:Visit 3 -12.5 43.2 -0.29 0.774 
Model 2 Intercept 487 272 1.8 0.077 
 Fat free mass 15.2 4.5 3.4 0.001 
 Fat Mass 13.2 3.0 4.4 <0.0001 
 IF -27.2 66 -0.4 0.684 
 Visit 2 -53.0 21.7 -2.4 0.0179 
 Visit 3 -13.4 26.5 -0.5 0.616 




7.6.4 Adherence to Dietary Prescription 
Food diaries were completed and returned by 91%, 84% and 63% of participants at weeks 
one, three and six respectively. Across all timepoints the average return was 77% in the 
CDR group and 81% in the IF group. A total of 323 days of food diary entries were 
collected and analysed, 168 in the IF group and 155 in the CDR group.  In the CDR 
group, the average recorded energy intake as a proportion of estimated requirements was 
68% across the whole study period, compared with a diet prescription of 80%. In the IF 
group, non-fasting day energy intake was 74% of requirements rather than 100%, and 
fasting day intake was 30% rather than the prescribed 25% requirements. Averaged over 
the week, the mean proportionate energy intake in the IF group was 61% compared with 
the 80% prescribed. Food record returns and energy intake at each timepoint are 
presented in table 7.4. 
 
 













CDR 100 62 (24) 75 75 (23) 56 67 (23) 
IFAVG 81 58 (23) 94 60 (28) 69 62 (32) 
IFF 81 30 (8) 94 32 (17) 69 29 (8) 
IFNF 81 69 (17) 94 75 (22) 69 79 (27) 
Table 7.4: Food Diary Returns and Energy Intake as a Proportion of Estimated 
Requirements  
IF group non-fasting day (IFNF); IF group fasting day (IFF); IF group average weekly 
intake (IFAVG). All IF recordings contained both fasting and non-fasting day entries. The 
target calorie intake for CDR and IFAVG was 80%.  
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7.6.5 Difference in Macronutrient Composition at 1, 3 and 6 weeks 
The proportion of daily energy intake consumed as fat was lower in the IF group at week 
one, 22% (SD: 7%), compared with the CDR group 28% (SD: 4%). This difference in 
macronutrient intake was driven by fasting day fat intake of 19% (SD: 7%) of total 
energy, with no significant difference between the IF non-fasting macronutrient intake, 
25% (SD:5%) of total energy, compared to the CDR group, 28% (SD:4%) of total energy 
intake. Macronutrient intakes were not different between groups at any other timepoint 
(table 7.5). However, there was a trend toward lower fat and higher protein intake in the 
IF group compared with the CDR group at all timepoints, particularly on fasting days.  
Protein fell below the recommended intake of 20% only in the CDR group, at week three 
only.  
7.6.6 Intra-recording variability in REE, VO2, VCO2, RQ.  
As a marker of the quality of calorimetry recordings, the intra-recording variability was 
calculated, for REE, VO2, VCO2 and RQ. The SD expressed as a percentage of the mean 
was averaged across all recordings as a marker of variability, as outlined in chapter four, 
section 4.4.2.2. The mean SDs for REE, VO2, VCO2 and RQ respectively were; 5.6%, 





 CDR IFNF t p-value IFF t p-value IFAVG t p-value 
Week 1 
Protein (%) 20 20 0.07 0.941 23 -1.3 0.227 22 -0.8 0.433 
Fat (%) 28 25 1.4 0.183 19 3.5 0.004 22  3.0 0.004 
Carbohydrate (%) 42 45 -1.1 0.273 47 -1.3 0.232 46 -1.5 0.152 
Week 3 
Protein (%) 18 21 -1.2 0.250 28 -2.4 0.032 24 -2.4 0.022 
Fat (%) 28 27 0.8 0.450 24 1.6 0.120 25 1.4 0.165 
Carbohydrate (%) 43 43 0.1 0.953 38 1.2 0.248 43 0.967 0.340 
Week 6 
Protein (%) 20 21 -0.2 0.836 24 -1.3 0.206 22 -1.0 0.333 
Fat (%) 32 25 2.1 0.053 23 2.3 0.031 24 2.5 0.024 
Carbohydrate (%) 38 44 1.8 0.07 42 -1.0 0.333 43 -1.6 0.120 
The IF group diet composition is presented by non-fasting day (IFNF), fasting day (IFF) and average intake (IFAVG).  
 
Table 7.5: Difference in macronutrient composition at one, three and six weeks. 
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7.6.7 Changes in Weight and Body Composition 
Changes in weight and body composition at visit one, two and three are presented in table 
7.6.  
 Weight Change 
At week three participants in the CDR and IF groups, participants lost 2.5 kg (SD:1.6 kg) 
and 4.1 kg (SD:1.8 kg), respectively. This was 2.3% (SD:1.4%) and 3.8% (SD:1.8%) of 
the baseline weight. 
By week six participants in the CDR group lost 4.4kg (SD: 2.5kg) and in the IF group 
5.9kg (SD:2.2kg). This represented 4.2% (SD: 2.2%) and 5.6% (SD: 2.0%) of baseline 
weight respectively.  
 Body Composition Change 
At three weeks in the CDR group FFM loss was 0.9 kg (SD: 2.1 kg), and FM loss was 
1.0 kg (SD:2.8 kg), a change of 1.4% (SD: 3.0%) and 2.7% (SD: 6.8%), respectively. In 
the IF group FFM loss was 2.4kg (SD: 1.8kg) and the FM loss was 2.4 kg (SD: 1.8kg), a 
change of 2.3% (SD: 2.5%) and 6.3% (SD: 4.5%), respectively.  
At six weeks in the CDR arm FFM loss was 2.3 kg (SD: 1.8kg) and FM loss was 1.8 kg 
(SD: 2.4), representing a change of 3.3% (SD: 2.7%) and 5.1% (SD:5.4%) respectively. 
In the IF arm, FFM fell by 2.4 kg (SD:0.89 kg); and FM by 3.6 kg (SD: 2.0 kg) reflected 
a change of 3.6% (SD:1.5%) and 9.4% (SD:5.3%), respectively.   
There was a significant effect of treatment on FM loss (β: - 1.73kg; 95% CI: -3.4 to – 




 Week 3 Week 6 
kg (SD) % (SD) kg (SD) % (SD) 
Weight CDR 2.5 (1.6) 2.3 (1.4) 4.4 (2.5) 4.2 (2.2) 
IF 4.1 (1.8) 3.8 (1.8) 5.9 (2.2) 5.6 (2.0) 
Fat Free Mass CDR 0.9 (2.1) 1.4 (3.0) 2.3 (1.8) 3.3 (2.7) 
IF 2.4 (1.8) 2.3 (2.5) 2.4 (0.89) 3.6 (1.5) 
Fat Mass CDR 1.0 (2.8) 2.7 (6.8) 1.8 (2.4) 5.1 (5.4) 
IF 2.4 (1.8) 6.3 (4.5) 3.6 (2.0) 9.4 (5.3) 
 
7.6.8 Change in Cardiovascular Risk Factors 
 Lipids 
Changes in lipids are presented in Table 7.2. There was no statistically significant effect 
of the diet intervention on lipid profile 
 HbA1C 
HbA1C rose by 0.02 mmol/mol (SD: 0.11 mmol/mol) in the CDR group and decreased 
by 0.03 mmol/mol (SD: 0.18 mmol/mol) in the IF group.  
There was no statistically or clinically significant effects of the diet intervention on 
HbA1c or lipid profile (Table 7.2).  
Table 7.6: Weight, fat free mass and fat mass loss relative to baseline.  
212 
 
 Blood Pressure 
There was no significant effect of IF, compared with CDR on the change in either systolic 
or diastolic blood pressure (Table 7.2).  
7.6.9  Changes in REE measured following a Fasting versus Non- Fasting 
Days  
In the IF group, 15 of 16 participants completed the fourth study visit. Unfortunately, two 
participants did not observe fasting day calorie intake during the day prior to this visit 
and these were excluded from the analysis. REE following a non-fasting day (M: 7954 
kJ/24hr; SD: 1234 kJ/24hr) was not significantly different from that following a fasting 
day (M:8096 kJ/24hr; SD:1360 kJ/24hr): (M: 67 kJ/24hrs; 95%CI: -201 to 343 
kJ/24hours; t: 0.55; p = 0.59). Given the small sample size (n=13) and minimal observed 
difference between groups, a post hoc sensitivity analysis was conducted in G*Power 
(433). With a difference in REE of 1.6% between consecutive measurements, such as we 
observed, the power was estimated to be ~20%, indicating an unacceptably high risk of 
type II error. However, when a 5% difference was chosen as the minimal clinically 
relevant difference between REE measurements, there was >80% power to detect a 
change of this magnitude.  
7.6.10 Changes in Adult Eating Behaviour Questionnaire 
The effect of treatment group on each of the seven eating behaviour domains is presented 
in table 7.7. Possible domain scores vary on a five-point scale from -2, strongly disagree 
to +2, strongly agree, and reflect agreement with statements relating to the eating 
behaviour domain. There was no significant effect of diet intervention on eating 
behaviour. Changes in eating behaviour changed little over the six-week diet intervention 
period.  
7.6.11 Changes in Physical Activity Levels 
At baseline there was no difference between physical activity energy expenditure in the 
CDR group (M: 7%, SD: 7%) and the IF group (M:3%, SD: 5%). This was also evident 
at visit two, CDR (M:6%, SD:6%), IF (M:4%, SD:7%) (t = 1.0, p = 0.316); and visit 









Change from Baseline 









(n = 16) 
F-value p-value 
Enjoyment of Food 1.5 (0.5) 1.3 (0.6) 1.4 (0.4) 1.3 (0.5) 0.5 0.49 
Emotional Over-Eating 0.1 (1.1) -0.3 (0.9) 0.2 (1.3) -0.2 (1.1) 0.1 0.83 
Emotional Under-Eating -0.8 (0.5) -0.8 (0.6) -1.0 (0.6) -0.8(0.7) 0.5 0.49 
Food Fussiness -1.2 (0.6) -0.9 (0.6) -1.2 (0.6) -1.1 (0.7) 0.0 0.98 
Food Responsiveness 0.2 (0.6) 0.2 (0.6) -0.2 (0.4) 0.0 (0.6) 0.4 0.52 
Slowness in Eating -0.8 (0.9) -0.4 (0.9) -0.8 (0.9) -0.7 (0.7) 0.1 0.77 
Hunger -0.3 (0.7) -0.3 (0.6) -0.2 (0.8) -0.2 (0.6) 0.1 0.82 
Satiety Responsiveness -1.2 (0.5) -0.9 (0.6) -0.9 (0.6) -0.9 (0.7) 0.8 0.39 




The CREEDS study, was designed to investigate the hypothesis that IF would reduce 
adaptive thermogenesis during weight loss, compared with a conventional continuous 
energy restricted dieting schedule, CDR. We found no significant effect of IF on adaptive 
thermogenesis. IF was associated with preferential FM loss, but no difference in 
cardiovascular risk factors after six weeks.  Fat mass loss, and dietary fat intake at week 
one was greater with IF. No other differences were found in cardiovascular risk factors, 
adult eating behaviour, or physical activity levels between groups.  
7.7.1 Adaptive thermogenesis  
Adaptive thermogenesis was assessed using a general linear mixed model. The advantage 
of such a model is that it incorporates body composition changes and repeated measures 
of REE while enabling between group comparisons. In the context of this model adaptive 
thermogenesis is interpreted as the change in REE beyond that which is predicted by 
changes in body composition.  
Visit two, occurring at three weeks was a significant predictor of REE after accounting 
for body composition change with estimated adaptive thermogenesis of -222 kJ/24 hrs 
(95%CI: -402 to -42 kJ/24 hours). While statistically significant this is a very small effect, 
accounting for <5% of mean REE observed at visit one. By visit three, the estimate of 
adaptive thermogenesis was a reduction in REE of – 54 kJ/ 24 hours. 
The detection of adaptive thermogenesis is challenging and may be influenced by; the 
method used for allometric scaling, the assessment of body composition with weight loss, 
the magnitude of adaptive thermogenesis and the accuracy of REE measurements. These 
factors are discussed below. The achievement of weight loss, another determinant of 
adaptive thermogenesis, and an important outcome, independent of adaptive 
thermogenesis, is discussed separately in section 7.7.2. 
 Allometric Scaling of REE using Fat Free Mass and Fat Mass 
As expected, FFM and FM were significant predictors of REE. The estimates for both 
FFM and FM were 63 kJ/kg (95%CI: 26 to 100 kJ/kg) and 54 kJ/kg (95% CI: 29 to 80 
kJ/kg) respectively, with a regression intercept of 2059 kJ/day. While this differs slightly 
from the PREEMPt study estimates of 100 kJ/kg (95%CI: 75 to 121 kJ/kg) and -5 kJ/kg 
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(95%CI: -16 to 5) for FM and FFM, the 95% confidence intervals for the FFM estimates 
from both the CREEDS study and the PREEMPt study overlap. The effect of FM on REE 
is smaller than for FFM and may not have been detected in the smaller PREEMPt sample.   
Lazzer et al, 2010, in a study of 7,368 obese Italian adults, used regression to model the 
relationship between FFM, FM and REE (351). They produced estimates for FFM of 50 
kJ/kg and FM of 41 kJ/kg, with an intercept of 3,270 kJ/day. Thus, the FFM and FM 
estimates produced in the CREEDS study, while not identical, are in keeping with 
expected values for an obese cohort. This provides an additional measure of assurance 
regarding the validity of the DXA and indirect calorimetry methods used during the 
study.  
 Errors in Body Composition Assessment with Weight Loss 
As outlined in chapter two, section 2.3.1.2, the accuracy of body composition analysis 
may be compromised during weight loss. Muller et al, 2012, suggest that balance 
methods should be used to assess the composition of weight loss as they are more 
accurate, particularly for smaller degrees of weight loss (337). 
Should balance methods to measure body composition have been used for the 
CREEDS study? 
There are several problems with using balance methods to assess body composition as it 
might apply to the CREEDS study, notwithstanding the challenges of using balance 
methods outlined previously. First, Yang et al, 1977, who performed one of the earliest 
analyses of various types of balance methods in the assessment of body composition 
during weight loss identified that the changes in ratio of water and nitrogen loss violate 
assumptions of balance methods, and suggested that they not be used during a period of 
dynamic weight change (335).  
Secondly, the validity of balance methods is assumed in the studies of Muller and Jebb, 
rather than compared to a truly valid reference method.  This is perhaps because no such 
method has been developed for assessing body composition during weight loss (334, 
337). It is unlikely that balance methods are entirely unbiased or without random error. 
It follows that comparison of other body composition assessment methods will 
undoubtedly appear worse when balance methods are assumed as a reference criterion.  
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Thirdly, the studies of Jebb and Muller assessed FM change only, not whole-body 
composition. For the CREEDS study a measure of whole body composition is required 
to scale REE. Muller et al suggest using a combination of balance methods and an 
alternate body composition method to circumvent this issue, but this would mean waiting 
for weight stabilisation to measure both REE and body composition. As the presumed 
biological basis for adaptive thermogenesis is conservation of energy during a period of 
weight loss, what is required is a method of measuring body composition that is valid in 
this dynamic phase.   
Fourth, the rapid weight loss induced in these studies, approximately three kilograms in 
one week, is likely to produce a greater flux in water, protein and electrolytes than the 
weight loss observed in the CREEDS study in which a mean of three kilograms was lost 
over three weeks.  Finally, though Muller and others’ data indicate that the standard error 
of the measurements using balance methods is less than in-vivo methods, the sample 
sizes for these studies are very small with six participants in two studies(334, 335) and 
10 participants in a third(337), which limit the generalizability of their findings.   
Assessment of Body Composition During Weight Loss in the CREEDS Study 
In the CREEDS study, a total of 96 DXA scans were conducted over nine months and 
the single operator precision was evaluated using the DXA scanner at our test lab as 
discussed in chapter two, section 2.4.2.2. For reasons of cost, time and manpower this 
would not have been possible with balance methods. This does leave the question of the 
validity of DXA measurements during weight loss. As discussed in section 2.3.1.2, the 
validity of DXA is compromised during weight loss. However, it is not clear precisely 
how significant an impact this might have on the estimate of adaptive thermogenesis at 
visit two and visit three. The least significant change for obese participants assessed by 
the DXA operator and machine used for the CREEDS study was 1.27% for FFM and 
2.19% FM during weight stability. By comparison, the smallest observed changes in the 
CREEDS study were 1.4% for FFM and 2.7% for FM, both in the CDR arm. Therefore, 
if dynamic weight change resulted in a modest additional loss of precision it may not 
have compromised the accuracy of the weight loss detected. However, an increase in the 
LSC of 25% or more would certainly have had an impact on the accuracy of the detected 
body composition change.  
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The additional loss of precision accompanying weight loss may have compromised the 
body composition assessment at visit two. However, it is less likely that it had an impact 
at visit three given the minimum FM and FFM changes were approximately three-fold 
greater than the LSC values for the method established during weight stability. The 
ANCOVA for the effect of treatment on body composition incorporated baseline and 
visit three values only, not visit two. However, the primary outcome analysis did 
incorporate repeated measures at baseline, visit two and three, and so may have been 
affected by the presumed loss of precision with dynamic weight change.  
Using a mixed design, the analysis of adaptive thermogenesis allowed for estimates in 
the relationship between FFM and FM and REE, across visits, while assessing the 
treatment effect between groups.  While this approach doesn’t solve the question of 
whether the reduction in REE at visit two was due to adaptive thermogenesis or errors in 
body composition assessment with weight loss, it allows us to answer the question of 
whether IF had any bearing on this observed effect.  As weight loss was similar in both 
groups and occurred at a similar rate, it is expected that any error in body composition 
assessment during weight loss would have been similar between groups, and any 
difference between groups would have been due to adaptive thermogenesis.  
 The Magnitude of Adaptive Thermogenesis 
Assuming the reduction in REE compared to that expected for the change in body 
composition was due to adaptive thermogenesis and not the assessment of body 
composition, how do these findings compare with other similar studies of adaptive 
thermogenesis? Liebel et al¸1995, reported a 10-15% percent reduction in REE with 
controlled underfeeding to 90% of initial body weight over six to 14 weeks, in 17 
participants in an inpatient setting (117). As outlined in chapter one, Prentice et al, 2014, 
estimated adaptive thermogenesis of 5-25% in response to ‘slimming diets’(103). 
Though only one study directly compared a VLCD with less severe forms of dietary 
energy restriction, the authors noted greater adaptive thermogenesis, measured REE less 
than 15% predicted, in studies with a daily energy intake of under 3000 kJ compared to 
adaptive thermogenesis less than 5% REE in studies with a prescribed energy intake of 
under 5000kJ.   
Several studies have reported changes in adaptive thermogenesis comparable to those 
seen in the CREEDS study with comparable weight loss.  In the CALERIE-2 study, a 
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25% restricted low-calorie diet compared to a non-dieting control resulted in a significant 
377 kJ/24 hr reduction in REE by six months (454). In the MATADOR study, 
participants were randomised to either low-calorie diet alternating with isocaloric intake 
in eight two-week blocks or matched continuous calorie restriction. By four weeks, the 
drop in REE below predicted, i.e. adaptive thermogenesis, was ~ 105 kJ in the continuous 
group and ~ 209 kJ in the IF group (Fig 3, Panel C and D), this was even less by eight 
weeks. Adaptive thermogenesis was not statistically significant at either timepoint (295). 
The rate of weight loss for this study, 7-10 kg over 16 weeks, compared to the CREEDS 
study with weight loss of 4.5-6 kg over six weeks.  In the Biosphere 2 study, normal and 
overweight participants were underfed 10% of their habitual intake and achieved a weight 
loss of 9.1 kg over two years (455). By this time there was no significant adaptive 
thermogenesis detected, with a mean reduction in SEE of -573 kJ(SD: 1276 kJ), the study 
sample was comprised of eight individuals, which may account for these results. Camps 
et al, 2013 , detected a difference of 4% in predicted versus measured REE after an 
average weight loss of 9.6kg (SD 4.1 kg) achieved with a VLCD over eight weeks in 91 
individuals (456). 
In practical terms these are small differences, between 3 – 5% of daily REE, though this 
may be sufficient during gradual sustained weight loss, to have a significant clinical 
impact on weight loss over months.   
 The Quality of Indirect Calorimetry Recordings 
As discussed in chapter four, the assessment of human indirect calorimetry recording 
quality can be challenging as there is no reference criterion against which to evaluate the 
method (section 4.4.2.1). Haughen et al, 2003, have previously used an intra-recording 
variability of 15% as an indicator of quality of REE recordings (420). An acceptable 
threshold of 10% was suggested based on the low intra recording variability observed 
during the second test-retest reliability study. In the CREEDS study the mean intra-
recording variability for REE was well below this threshold, at 5.6%.  
 IF Does Not Attenuate Adaptive Thermogenesis 
In the final model, IF was associated with a mean reduction in REE of 113 kJ/day 
(95%CI: -674 to + 745 kJ/day) compared to CDR and was thus not clinically significant. 
The CREEDS study is the only study of adaptive thermogenesis using this schedule of 
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IF. As outlined in chapter one, there have been several studies of various intermittent 
schedules of fasting versus CDR however only one study prior to the CREEDS study IF 
vs CDR using calorie matched controls with calorie prescriptions based on individually 
calculated energy requirements.  
The MATADOR study was published in February 2018, after completion of the 
CREEDS study. It was a 16-week RCT of CDR versus IF in obese men. The IF group 
was structured as two weeks of energy balance alternating with two weeks of calorie 
restriction.  The net energy intake in both groups was 67% as compared with 79% in the 
CREEDS study. Body composition analysis was performed by air displacement 
plethysmography and REE by indirect calorimetry. Diet prescriptions were based on 
REE multiplied by physical activity level, as in the CREEDS study. The authors found 
that IF was associated with a 377kJ reduction compared to the continuous restriction 
group. They concluded that IF attenuated the reduction in REE seen with fasting and 
suggested,  
“… these findings provide preliminary support for the model as a superior 
alternative to continuous ER” 
 
The MATADOR study addresses many of the limitations with studies of IF vs CDR to 
date (chapter one, section 1.6.3.4.7) however there are some significant remaining 
limitations. First, though participants were randomised to the treatment group, allometric 
scaling was done separately for each group at baseline or using an equation developed in 
a separate population of obese men. There was not a substantial difference between these 
two methods. However, using separate regression equations for the randomised groups 
at baseline risked introducing significant bias as the method used for calculating 
predicted REE, and thus adaptive thermogenesis, was different before the intervention 
even began. The use of a regression equation developed in a separate population also 
raises legitimate concerns regarding the validity of the estimates, as outlined in chapter 
five.  
Secondly, the authors performed repeated measures at four, eight, twelve and sixteen 
weeks. The difference in adaptive thermogenesis was only significant at 16 weeks. Prior 
to this it appeared that IF produced greater adaptive thermogenesis (non-significant), a 
trend which was reversed between week 12 and 16 weeks. As the superiority of IF in 
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attenuating adaptive thermogenesis was offered as an explanation for superior weight 
loss, one would expect that the attenuation of adaptive thermogenesis ought to have been 
present throughout the study, not simply at the final timepoint.  
Thirdly, IF participants were issued scales and contacted during the weight maintenance 
periods by phone. They were advised to alter their diet if they were losing or gaining 
weight consistently for three days. While energy requirements do vary during a diet 
intervention study, the primary outcome for the MATADOR study was weight loss. A 
procedure that directly interfered with weight loss or gain depending on the response of 
the individual during the intervention was another source of significant bias.  
Finally, there was no measurement of adherence to diet prescription performed in the 
MATADOR study, despite participants completing diet records.   
Thus, based on the findings of both the MATADOR study and the CREEDS there does 
not appear to be compelling evidence of a significant effect of IF on adaptive 
thermogenesis.  
7.7.2 Significant Weight Loss Was Achieved with IF and CDR.  
Weight loss in both groups of the study was approximately 5% over the six weeks 
intervention period. Based on self-reported dietary intake, participants in both groups 
under-ate relative to the diet prescription, however they remained well matched in terms 
of net calorie intake with a mean 7% deficit in the IF group compared with the CDR 
group.  
Thomas et al, 2011, have developed a tool that enables prediction of expected weight 
loss  during diet intervention studies (457). The model predicts REE based on age, gender 
and anthropometry; assumes mild to moderate physical activity; contains an estimate of 
DIT, and incorporates a parameter, α, to model adaptive thermogenesis. The model was 
developed from obese North American participants. The weight loss predicted by this 
model for each participant was computed and compared to the observed weight loss in 
the CREEDS study. Assuming adherence to a 79% calorie restriction, the mean weight 
loss predicted for the entire study cohort was 5.76kg (SD: 1.37kg). In the event, the 
observed weight loss was 5.27 kg (SD: 2.4kg), only 0.5kg less (t = 1.12, p = 0.27).  
Bearing in mind the reported energy intake was not 79% but 65% on average across the 
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entire cohort, this suggests that underreporting of intake probably did occur, but that 
participant energy intake was close to the prescribed target of 79%.   
7.7.3 Preferential Fat Mass Loss was Observed with Intermittent Fasting 
Of the secondary outcomes assessed during the CREEDS study, the preferential FM loss 
with IF was the chief significant finding. While the CREEDS study was not powered to 
detect differences in FM, the two-fold greater FM loss in the IF group compared to the 
CDR group, is an interesting one. Baseline FM and weight were similar between groups 
(table 7.2).  
The challenges in assessment of body composition during weight loss are obviously 
relevant to a correct interpretation of the preferential FM loss with IF.  However, only 
the difference between visit three and visit one was used to assess body composition 
change, and the difference in FM loss between groups relative was sufficiently large to 
make it unlikely, albeit not impossible, that the observed difference was attributable to 
measurement error alone. 
How can this observed preferential loss of FM with IF be explained?  Differences in body 
composition during weight loss may be related to the extent of weight loss, the 
macronutrient content of the diet, the degree of physical activity or the schedule of energy 
restriction.    
 Did the Rate of Weight Loss Affect Fat Mass Loss? 
Heymsfield et al, 2012, have described phases of weight loss during a calorie restricted 
diet associated with different body composition loss (458). The early phase of weight 
loss is associated with greater loss from the FFM compartment compare, between 6-24 
weeks of a hypocaloric diet, there appears to be a greater contribution of FM to the weight 
lost. It is possible that the IF group, having lost more weight at week three and week six, 
were losing more FM than the CDR group because of this effect. However, the weight 
loss difference was 0.5 kg between groups and seems insufficient to explain a 1.8kg 
difference in FM loss, particularly as the difference in FM loss with the IF group was 
evident by week three (table 7.6).   
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 Did Macronutrient Composition of the Diet Affect Body Composition?  
The POUNDS LOST Study assessed four calorie restricted diets of different 
macronutrient composition on changes in body composition with weight loss by six 
months and two years in 424 overweight or obese men and women (459). The diets were 
low fat/average-protein, low-fat/high-protein, high-fat/average protein and high-fat/high-
protein. There was no effect of diet on FM loss found. By contrast Clifton et al, 2014, 
performed recent systematic review and meta-analysis on the effect of low-
carbohydrate/high protein diets on body composition change (460). No fixed protein or 
carbohydrate thresholds were set as inclusion criteria, the protein content needed to be 
higher, and the carbohydrate lower than the control group. Studies were a minimum one 
year in duration. The high protein/low carbohydrate diet was associated with an 
additional reduction of 0.44 kg in FM compared with the control group. This dropped to 
0.3kg if the difference in protein was <5% by the end of the intervention. In the CREEDS 
study, the only significant difference in macronutrient composition was a higher fat 
intake at week one in the CDR arm. Therefore, it is not likely that macronutrient intake 
accounted for the preferential FM reduction seen during the study.  
 Did Changes in Physical Activity Affect Body Composition? 
Physical activity reported in the study was very low as a proportion of total daily energy 
expenditure. In the CREEDS study, two participants at visit one, three participants at visit 
two and no participants at visit three had a daily physical activity energy expenditure 
greater than 2000 kJ/day. More importantly, there were no significant differences in 
physical activity between groups to explain the difference in body composition.  
 Does the Intermittent Fasting Schedule Affect Body Composition? 
As outlined in chapter one (section 1.6.3.4.7.7) body composition changes have been 
assessed during several intermittent schedules of fasting. In the MATADOR study, the 
IF group lost an extra 2.7 kg FM compared with the CDR group.  The weight difference 
between groups was 3.5 kg in that study, and the proportion of weight lost as fat was 
>80% in both groups. The excess weight loss alone may account for the extra FM lost in 
the IF group. As percentage FM lost was not reported, this cannot be ruled out. By 
contrast in the CREEDS study the weight loss difference was only 0.5kg greater in the 
IF group, while the difference in FM loss was 1.8 kg between groups.  Nonetheless given 
the similarity of the MATADOR study population, the diet prescription and the body 
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composition outcomes, it does raise the possibility of the schedule of fasting having an 
effect on change in body composition.   
Harvie et al, 2011, using a similar schedule of intermittent energy restriction as the 
CREEDS study found no difference in the change in body composition between groups 
(289). The diet prescription in this study was 25% on fasting days and ad-libitum 
otherwise. Thus, the relative calorie deficit between groups may have been less than in 
the CREEDS study. Furthermore, the body composition method used was BIA which 
may underestimate changes in FM with weight loss in obese individuals (461).  
In a second study by Harvie et al, 2013, IF combined with carbohydrate restriction was 
associated with a reduction in FM, also assessed by BIA. This was not observed when IF 
was combined with protein and fat restriction or in the calorie-matched CDR control 
(287). This suggests that macronutrient intake rather than the fasting schedule may have 
had a bearing on composition of weight loss. However, as outlined above, the observed 
differences in macronutrient composition between groups in the CREEDS study were 
small and not sustained throughout the six-week intervention.   
Arguin et al, 2012, detected a reduction in FFM, assessed by DXA, in obese women 
undergoing IF compared with CDR. In this study IF consisted of five-week blocks of 
weight loss, alternating with five weeks of weight stabilization. The calorie prescription 
in this study was adjusted according to weight loss. Thus, both groups were not calorie 
matched which may have confounded these findings (294). Arguin and Harvie’s studies 
were conducted in women only, thus there may be a gender-specific of IF on body 
composition.  
Though a secondary outcome, the preferential loss of FM in the IF arm may represent an 
ancillary benefit with this type of fasting. However, the finding does need to be confirmed 
in a longer-term study, designed and powered to assess body composition change as the 
primary outcome. An examination of the gender specific effects of IF on body 
composition would be of great interest in such a study.  
7.7.4 A Fast Day Prior to Indirect Calorimetry does not Affect REE 
To establish if the preceding days energy intake would affect the indirect calorimetry 
precision for the IF arm, we studied participants on consecutive days. The mean 
difference between measurements was almost negligible at 67 kJ/day. Not only does this 
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alleviate any concerns about the impact of the intervention on precision, it reproduced 
the high level of precision that was demonstrated in the second test retest reliability study 
(chapter four). This finding will be of use when planning future studies of energy 
expenditure during IF.   
7.8 Conclusion 
In conclusion, we conducted a randomised controlled trial of IF, consisting of a five-day 
isocaloric and two-day hypocaloric diet compared with seven days of continuous 
restriction, with matched total energy prescription between groups. While other authors 
have investigating this schedule of IF previously, this is the first study that has looked at 
adaptive thermogenesis using this schedule. Using this schedule, IF does not appear to 
attenuate adaptive thermogenesis compared with CDR after three or six weeks. We had 
good adherence, high participant retention rates and significant weight loss. The 
magnitude of adaptive thermogenesis observed was smaller than expected in this study 
and this may have reduced our ability to detect a difference in the mitigation of adaptive 
thermogenesis between groups.  Fasting the day before an indirect calorimetry recording 
was found not to affect REE measurements.  IF was associated with preferential FM 
reduction after six weeks.  This observation warrants confirmation with an appropriately 
powered larger study including women and over a longer period.  
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  Discussion 
8.1 Evolution of the Work Presented  
The principle area of interest of our research group is in the association between obesity 
and T2DM. This thesis was conceived to further understand the mechanisms that mediate 
the disruption of glucose metabolism in obesity and how these can be reversed with 
weight loss.  
Bariatric surgery is one model for understanding these mechanisms and has been studied 
for over 25 years as a model for weight loss and improvement in glycaemia. This 
literature has been very fruitful, contributing to a greater understanding of gut peptide 
physiology, intestinal microbiota, bile acid metabolism and diabetes pathophysiology. 
However, most studies investigating the mechanisms of diabetes remission in the 
bariatric literature do not control for calorie restriction.  
Dietary calorie restriction offers another model for the study of mechanism of diabetes 
remission, however prescribed weight loss in diet intervention studies does not always 
result in the expected weight loss. Upon reviewing the reasons for this, it became clear 
that the occurrence of adaptive thermogenesis during weight loss was a contributing 
factor to this failure to lose weight and is incompletely understood. This led to the 
hypothesis that adaptive thermogenesis may be triggered by the degree or pattern of 
energy restriction and that altering the schedule of intake may mitigate adaptive 
thermogenesis. The intermittent fasting schedule was appealing both as a research tool, 
to investigate the regulation of metabolism and energy expenditure, and potentially as a 
diet intervention.  However, there were only a handful of studies in humans and many of 
these had limitations, particularly with the prescription of dietary energy. The Changes 
in Resting Energy Expenditure with Different Schedules of calorie restriction (CREEDS) 
study was planned to address these limitations.  To conduct such a study, reference 
methods for measurement of body composition and energy expenditure are required.  Our 
research group was instrumental in the collaborative effort to fund and install an indirect 
calorimeter and DXA scanner, which coincided with the conception of this thesis. Before 
the CREEDS study could be conducted, several methodological issues with these tools 
and protocols needed to be addressed. This then became an integral component of the 
methodological development of this thesis.  
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8.2 Overview of the Thesis 
The principal aim of this thesis was to evaluate the effect of intermittent fasting on 
adaptive thermogenesis during weight loss.  To achieve this, I required the ability to 
accurately and precisely measure energy expenditure and body composition.  First, I 
developed and tested the validity of the indirect calorimetry protocols as described in 
chapter three. In chapter four I assessed the test-retest reliability of the indirect 
calorimeter and DXA protocols in human subjects. In chapter five I investigated the 
relationship between body composition and REE in an obese cohort using the methods 
that I had validated in chapter two. This allowed me to plan the sample size for the 
CREEDS study and provided preliminary data on the validity of the assumptions of 
commonly used predictive energy equations. To determine if intermittent fasting could 
be studied safely and accurately in individuals with T2DM, it was necessary to assess the 
risk of hypoglycaemia with intermittent fasting in individuals taking oral hypoglycaemic 
medications, as described in chapter six. Chapter seven describes the final CREEDS 
study, that investigated the effects of intermittent fasting compared with continuous daily 
restriction on adaptive thermogenesis.  
This provided the framework for the studies that form this thesis.  The first test-retest 
reliability recordings of the new indirect calorimetry system exhibited an intra-recording 
variability in REE of 20.1%. This was clearly unacceptable and raised concerns about 
the validity of the indirect calorimetry recordings.  
Because of the first test-retest reliability study, the indirect calorimetry measurement 
protocols were refined. Between the first test-retest reliability study and the later accurate 
nitrogen validation studies lay a steep learning curve. This was particularly true in the 
absence of on-site expertise or a user manual for the Promethion. I needed to become 
familiar with all aspects of the indirect calorimetry technique to identify sources of error. 
Much of the technical knowledge in chapters two and three, and the appendix were 
acquired during this period of protocol refinement.  
Prior to testing the new protocols in human participants, in-silico studies with nitrogen 
dilution and ethanol combustion were performed. It was unclear to me which method 
would be superior in the assessment of validity, so I performed both. The consistency of 
the ethanol burn was inferior to that of the nitrogen validation study and the large water 
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vapour production meant the ethanol burn was less physiological as an assessment of 
validity than the nitrogen dilution method. The nitrogen dilution results (section 3.3.5) 
demonstrated a mean O2 recovery of 101%, with a high degree of consistency between 
dilution trials (Table 3.1). These results indicated that I could proceed to indirect 
calorimetry measurements in human participants, confident in the quality of my indirect 
calorimetry methods.  
When I assessed the precision of indirect calorimetry in the second test-retest reliability 
studies it was similar to that of the first test-retest reliability study, but the quality of the 
measurements was superior, as indicated by an intra recording variability of 5.8%, 
compared to >20% in the first study. The intra class correlation coefficient was 
established as 0.98 and the least significant change in resting energy expenditure was 
established as 561 kJ (section 4.3.4) in the second test re-test reliability. This value for 
the least significant change was rather high, considering the precision represented by the 
intra class correlation coefficient measure and the precision of approximately 99%, from 
the nitrogen dilution study, and was due to the variance in resting energy expenditure in 
the cohort used to generate the least significant change value. The intra class correlation 
coefficient value, which is a ratio of within subject variation to within subject variance 
plus error, was a more useful marker in extrapolating the precision observed in the second 
test retest reliability study to the CREEDS study, as it is not population dependent. This 
was considered more than satisfactory as an indicator of the precision of the indirect 
calorimetry with the newer protocol. 
To generate sample size estimates for the CREEDS study using allometrically scaled 
resting energy expenditure, the Prediction of Resting Energy Expenditure in Māori and 
Pacific (PREEMPt) study (chapter five) was conducted. Based on the variance in resting 
energy expenditure observed in this study, a sample size of 32 was determined 
appropriate to detect a between group difference of 7% in the intermittent fasting group 
versus the continuous daily restriction group of the CREEDS study. There were some 
important differences in the populations studied for the PREEMPt and CREEDS studies. 
First, in the PREEMPt study the baseline REE was 7586 kJ/day, compared with 8437 
kJ/day in the CREEDS study. This was due to a lower mean weight in the PREEMPt 
study, 101 kg, compared to 109 kg in the CREEDS study. Body composition was also 
different, the mean FM percentage in the PREEMPt study was higher at 40% compared 
with 35% in the CREEDS study. The difference in body composition between studies 
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was likely due to selection of men only for the CREEDS study but should not have 
affected the ability to detect a difference in adaptive thermogenesis in the CREEDS 
study.  
Having formed the research question and determined the sample size required for the 
CREEDS study I also considered whether I would include participants with established 
T2DM on medication.  The IF-Hypo study was conducted to determine the risk of 
hypoglycaemia with intermittent fasting in those with T2DM on hypoglycaemic 
medication, which was unknown up to that point.  The IF-Hypo study demonstrated a 
small increased risk of hypoglycaemia despite a carefully constructed and tested protocol 
for medication adjustment. As the primary research question in CREEDS was not 
specifically about glucose metabolism, but rather adaptive thermogenesis, we therefore 
adopted a conservative approach in excluding participants on hypoglycaemic 
medications from the CREEDS study.  
The final CREEDS study did not demonstrate a difference in adaptive thermogenesis 
during weight loss with intermittent fasting compared to continuous daily restriction but 
did identify a preferential reduction in FM of 3.6 kg in the intermittent fasting group 
compared to 1.8 kg in the continuous daily restriction group.   
8.3 Strengths  
A large component of this thesis was the development and assessment of indirect 
calorimetry methods of a high standard. We have demonstrated a high degree of precision 
and validity in our recordings and have developed a robust method for conducting 
indirect calorimetry at our centre. Knowing the accuracy and precision for both our DXA 
and indirect calorimetry methods, reassured us during the interpretation of the CREEDS 
study that the lower than anticipated adaptive thermogenesis was not due to measurement 
error.   
A second strength of the work in this thesis was the use of local population variance in 
REE to predict sample size estimates for the CREEDS study.  To the best of my 
knowledge, none of the previous studies of adaptive thermogenesis discussed in this 
thesis have performed sample size estimation based on allometric scaling of REE in a 
pilot sample.  
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An important strength of this thesis was the acknowledgment of uncertainty with 
allometric scaling of REE in both the PREEMPt and CREEDS study. Allometric scaling 
is superior to any alternative methods of normalising REE. However, it does come at a 
cost. The use of a regression model which incorporates FM or FFM will account for 60-
70% of the variance in REE at best. The regression model used in the CREEDS study 
accounted for 66% of the variance in REE. The unexplained variance contributes to 
uncertainty in the estimate of the relationship between REE and body composition. This 
uncertainty must temper the interpretation of the presence and magnitude of adaptive 
thermogenesis.   
This uncertainty in allometric scaling by regression has two implications. First, were an 
allometric scaling model to explain more of the variance in REE, e.g. by identifying 
additional covariates, or refining body composition analysis, it would greatly improve 
the ability to detect adaptive thermogenesis. The second implication is that calculation of 
adaptive thermogenesis is most valid when the error in the estimates of allometrically 
scaled REE are incorporated in the statistical assessment. These variances are 
incorporated in a linear mixed model such as that in the CREEDS study and were 
reflected in my sample size estimates produced by the PREEMPt study, when I 
incorporated the 95% confidence intervals of the root mean square error in the sample 
size calculations.  Catenacci et al, 2003, used a similar statistical approach in a study of 
alternate day fasting versus continuous daily restriction. However, it is more common to 
find adaptive thermogenesis calculated by subtracting measured values of REE from 
predicted values of REE.  This concept is illustrated in fig. 8.1 using data from the 
CREEDS study. The FM and FFM estimates obtained from regression of the entire cohort 
at baseline were compared to the CDR arm. The 95% confidence intervals for the 
estimates were calculated using the RMSE of the regression equation and plotted.  
Were the regression model only used without any consideration of the error in the model, 
it would be easy to conclude that there was indeed adaptive thermogenesis identified. 
Examining the 95% confidence limits, this assertion needs to be seriously questioned. In 
the analysis that was conducted for the CREEDS study the linear mixed model controlled 
for inter-individual variations in REE, and individual estimates incorporated three 
measurements per participant in the model. This would have reduced the variance in the 
model, as shown by the statistically significant finding of adaptive thermogenesis at visit 







Fig 8.1 Estimating Adaptive Thermogenesis using Baseline Regression Values 
 
8.4 Limitations  
While the nitrogen dilution quality control testing that was completed as part of this thesis 
is a strength of our current calorimetry setup, it does not incorporate CO2 gas flows or a 
fluctuating REE simulation such as that seen in human recordings. Ideally a second 
method such as doubly labelled water could be used to cross validate the indirect 
calorimetry measurements in obese subject recordings. Unfortunately, doubly labelled 
water isn’t currently available at our centre.  
Lines in red represent the 95% confidence intervals for the predicted REE.  
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A second limitation of this work was the small degree of adaptive thermogenesis seen in 
the CREEDS study. This was below the 7% estimate that was used to power the study. 
One of the challenges with planning studies of adaptive thermogenesis is the wide range 
of published findings on the magnitude of the effect of adaptive thermogenesis. In 
planning the CREEDS study a trade-off between the power of the study and the cost, and 
thus feasibility of the study needed to be achieved. Dulloo et al., 2013, have summarised 
the challenges of measuring adaptive thermogenesis and suggest that it may be a 
theoretical rather than a measurable entity, a question that remains controversial (462). 
Many of the challenges with measuring adaptive thermogenesis raised in Dulloo’s paper 
such as the use of statistical models that incorporated inter-individual variability, and 
ensuring high levels of methodological precision and validity with body composition and 
calorimetry methods, were addressed in preparation for the CREEDS study. For the 
CREEDS study itself, we opted for conservative inclusion criteria such as male gender, 
the exclusion of individuals on hypoglycaemic medications, frequent contact, one to one 
diet education, and regular REE measurements to maximise our ability to detect adaptive 
thermogenesis. This approach appeared to pay off with good weight loss observed and 
excellent participant retention. A study of this intensity would not have been possible in 
the time available with the large cohort required to detect a difference of 2-3% in adaptive 
thermogenesis.  
While the CREEDS study answered the question of whether there is likely to be an 
important impact of intermittent fasting on adaptive thermogenesis during weight loss in 
an outpatient setting, it revealed less about the time scale of regulation of adaptive 
thermogenesis or the effect of intermittent fasting on components of energy expenditure 
other than REE. While analysis of ghrelin, adiponectin, leptin, and thyroid hormones 
from the CREEDS study is planned, a more detailed study of intermittent fasting in an 
inpatient setting may provide different insights into the effects of intermittent fasting on 
metabolism. Such a study could include objectively measured dietary intake with whole 
room calorimetry, and examine change in diet induced thermogenesis, physical activity 
related energy expenditure and sleeping energy expenditure and may determine whether 
there are differences in intermittent fasting compared with conventional dietary 
restriction. This work would be challenging to accomplish due to; inter-individual 
variability in energy expenditure, increasing the sample size requirements; the 
requirements to be admitted for a week or more until weight loss is achieved. 
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8.5 Future Work 
The work in this thesis has laid the groundwork for future studies of dietary energy 
balance and metabolism. During the PhD a total of 224 indirect calorimetry recordings 
were conducted, 164 of these had paired body composition scans. The foundation of a 
body composition and REE data archive would be a useful resource to advance the 
investigation of the relationship between body composition and energy expenditure and 
to develop predictions of resting energy expenditure in New Zealand populations and in 
Pacific and Māori ethnic groups, in particular.  
Adaptive thermogenesis could be assessed using different schedules than the ones 
examined in this thesis. For example, rather than varying the energy intake over the week, 
it could be varied over a day with altered meal allocation, that vary on circadian time 
scales. Expression of circadian regulators, discussed briefly in (section 1.6.3.4.2), are 
entrained in mice. It would be of interest to see if genes involved in intermediary 
metabolism can be similarly entrained in humans to circadian variations in energy intake. 
It would also be of interest to see if adaptive thermogenesis during weight loss was 
altered by conditions of thyroid under- or over-activity.  
The gas validation method should be extended to a dual gas analysis, by incorporating 
CO2 using a high precision gas mixer. An additional extension of the gas validation 
method would be to programme variable flows, not simply constant flow rates, to emulate 
the variation in REE that is seen in human participants to assess if this affects the validity 
of the recording. This application is possible with modification of our current software 
and to my knowledge has never previously been done.   
There is the opportunity to analyse REE without relying exclusively on a mean REE 
value during a recording. One approach to this is to analyse REE measurements using 
deconvolution, the decomposition of waveforms into component frequencies. Changes 
in these components during exposure to different environmental conditions, in different 
disease states, or in response to different medications, may help to reveal the time scale 
over which REE is regulated. While deconvolution methods have been used in other 
fields they have not been applied in this way to canopy hood indirect calorimetry. 
Component frequencies common to individuals, in response to environmental stimuli, 
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medications or disease states, may offer insights into the regulation of basal metabolism 
that would otherwise be missed if the mean REE alone were used.  
Using our current body composition and calorimetry methods we could examine the 
effect of weight loss on improvements in glycaemia with bariatric surgery compared to 
a calorie matched very low-calorie diet intervention. An accurately matched calorie 
prescription could be achieved using serial measures of resting energy expenditure in the 
bariatric cohort in the immediate post-operative period. Measurements of calorie 
requirements prior to the 14th post-operative day are not available in the published 
literature. A study of this type would clarify the relative contribution of a hypocaloric 
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Glossary of Terms 
Accelerometry: The measurement of movement. In energy balance studies this often 
involves measurement of limb movement to estimate physical activity related energy 
expenditure. 
Ad libitum intake: Unrestricted Dietary energy intake 
Adaptive thermogenesis: the reduction in REE, beyond that which is expected for the 
change in body composition, occurring during a period of dietary energy restriction 
Adipokine: Hormones secreted by adipose tissue 
Allometry: The study of the relationship between body size and other physiological 
measures. 
Anorexigenic: Producing a decrease in appetite. 
Arcuate nucleus: A nucleus of the hypothalamus that contains POMC and AgRP/NPY 
neurones involved in the regulates of appetite. 
Autocrine: Relating to a cell-produced substance that has an effect on the cell by which 
it is secreted. 
Bariatric surgery: Surgeries with the primary intention of promoting weight loss. 
Endocrine: Relating to or denoting glands which secrete hormones or other products 
directly into the blood. 
Energy homeostasis: The biological processes that match dietary energy intake to 
energy expenditure. 
Epigenetics: the study of heritable changes in gene expression that are not due to changes 
in DNA sequence 
First-phase insulin response: The early insulin response to a glucose load, occurring 
within minutes of nutrient ingestion. 
Glycated haemoglobin: A form of haemoglobin that is used a marker of glycaemia. 
Gut microbiome: The bacterial composition of the gut 
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Histones: Proteins that influence a genes folding structure 
Lipolysis: The breakdown of fats and other lipids by hydrolysis to release fatty acids 
Locus (pl. loci): the position of a gene or mutation on a chromosome. 
Macro: A single instruction given to a computer that produces a set of instructions for 
the computer to perform a particular piece of work 
Metabolic equivalent: the energy cost of physical activity expressed as a ratio to a 
standard energy expenditure of 4.184 kJ per kilo of body weight per hour of activity 
performed 
Non-exercise activity thermogenesis: the energy expenditure of all occupation, leisure, 
sitting, standing and ambulation 
Obese: A body mass index 30kg/ m2 and above 
Orexigenic: Producing an increase in appetite 
Overweight: A body mass index of between 25 kg/m2 and 30kg/ m2. 
Paracrine: Relating to or denoting a hormone which has effect only near the gland 
secreting it. 
Resting Energy Expenditure: The the amount of energy used by an organism at rest 
while in a state of complete muscular relaxation and awake 
Satiety: The feeling of fullness after eating 
Sensor drift: The tendency of a gas sensor, when exposed to a stable gas concentration 
starts to “drift” off the true value with prolonged exposure. 
The mesolimbic pathway: Part of the limbic system involved in the hedonic response 
to food. 




Appendix A: Table of RCT’s of Intermittent Fasting in Animals 
A.1 Table of RCT’s of Intermittent Fasting in Animals 
Author Year Animal Model 
Age at start 
of 
Intervention 















3 months 18 weeks 
NF: Nocturnal AL Feeding  
NF-HF: NF + 61% fat chow 
AL: AL, unrestricted 
AL-HF: AL + 61% fat chow 
Calorie content not given 
Absolute quantity 
the same in NF & AL 
groups. 
When normalised for 















4 weeks of 
TRF 
All Chow animals feed 58 kcals on 
feeding days.  
All vegetal animals fed 0.42kcals/g 
body weight 
Time restricted feeding(TRF):  
Fasting 1700-0800 each day. 
Vegetal Diet Control: Veg-CR 
Vegetal Diet TRF: Veg-TRF 
Non-Diabetic Chow: Chow-CR 
Non-Diabetic Chow TRF: Chow-
TRF 
Diabetic Chow: DM-Chow-CR 























Vegetal group based 
on weight of rats. 
The chow group 





Author Year Animal Model 
Age at start 
of 
Intervention 















3 wks AL 
 +16 weeks 
Intervention 
ADF: AL/Complete Fast 







restriction & AL 
intake 







2 months 12 weeks 





Not given N/A 
Pedersen et 
al(270) 
1999 BB Rats 3 weeks 26 weeks 
AL Control 
IF-1: Complete Fast 1 day 
weekly/AL 6 days 





Not given N/A 
Anson et 
al(271) 
2003 C57BL/6 Mice 9 weeks 29 weeks 
AL:Ad libitum 
ADF:Complete fast/AL 
CDR: 60% AL Animal Intake 
PF: Food allottment matched to 
ADF 
Exact figures not 
given:  
ADF=AL=PF 
CDR = 60% AL 
Not given Not given 
CR: Based on AL 
groups intake 







4 weeks 32 weeks 
AL:Ad libitum 
ADF:Complete fast/AL 
CDR: 60% AL Animal Intake 


















Author Year Animal Model 
Age at start 
of 
Intervention 











2016 C57BL/6 Mice 7 weeks 4 weeks 
8 weeks AL high fat diet phase + 
4 weeks 
HF-AL: High Fat Ad Libitum: HF-AL 
LF-AL: Low Fat Ad Libitum: LF-AL 
HF-ADF: AL High Fat/Fast 
LF-ADF: AL Low Fat/Fast 
Cumulative food 
intake (kcals) 
HF-AL: 700  
LF-AL: 600   
HF-ADF: 600  
LF-ADF: 550 
HF-AL: 8 
LF-AL: 8   
HF-ADF: 8  
LF-ADF: 8 







Wild Type Mice 
(wt) 
12 weeks 12 weeks 
ADF: AL/Complete Fast 





Exact figures not 
given: Approx 16-
24 for each 
group. 






3 weeks 10 weeks 
All were fed high fat diet 
AL: Ad libitum 
CDR: 90% of AL intake 
ADF: AL/Complete Fast 
Daily Calorie Intake 
on Feeding Days 
(Relative to AL) 
AL: 4.8g (100%) 
CDR: 4.3g (90%) 










8 weeks 3 weeks 
AL:Ad Libitum 
ADF:Ad libitum/Complete Fast 
Cumulative intake 
relative to AL:  
AL: 100% 
ADF 80% 
Gorging pattern in 
ADF mice noted on 
fast days. Not 
ADF: 12 
AL: 12 
Not given N/A 
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Author Year Animal Model 
Age at start 
of 
Intervention 

















7 weeks 4 weeks 
1-week AL prior to randomization 
CDR-25%: 75% AL intake 
ADF-75%: 25% AL Intake/AL 
ADF-85%: 15% AL Intake/AL 
ADF-100%: Complete Fast/AL 
AL: Ad libitum 














assumption that AL 
consumption at 




2015 C57BL/6J 9 weeks 39 weeks 
AL: Ad libitum 
CR-30%: 30% Calorie Restricted 
MF-AL: 25% Fat Ad Libitum 
IF: 40% Cal Res. 1 week/MF-AL 1 
week 
Presented as 
proportion of AL 
Control* 
Relative proportions 
only verified at 











Calorie restriction as 
a proportion of the 
ad-libitum group 
intake calculated 




Author Year Animal Model 
Age at start 
of 
Intervention 














7 week 4 weeks 
AL: Ad libitum 
CR-5%-DF: 95% AL.Daily Feed. 
CR-5%-PF: 95% AL.Continuous.   
CR-5%-ADF: 95% AL.3x per wk   
CR-33%-DF: 67% AL.Daily Feed. 
CR-33%-PF: 67% AL.Continuous.   
CR-33%-ADF: 67% AL. 3x per wk   
 
AL: 22g week 




CR-5%-PF: 6   
CR-5%-ADF: 6   
CR-33%-DF: 6 
CR-33%-PF: 6   
CR-33%-ADF: 6   
 








7 weeks 43 weeks 
AL: Ad libitum 
CR-25%: 75% AL intake 
IF: 2 week 50%AL/100%AL 















A.2 Table of RCT’s of Intermittent Fasting in Animals (ctd.) 













Fatty Acid Oxidation   
Fatty Acid Synthesis   
 adipocyte hypertrophy 
altered expression of circadian regulator genes 
hepatic intracellular lipids 
 mitochondria  
 hepatic Steatosis 
rhythmic UCP-1 expression in BAT 
Inflammtory markers 
NF gained 5g-7g  
AL gained 9g - 22g 





Glucometer from tail 
blood 
Fasting and after 
intraperitoneal 
glucose infusion 




















between Veg & Chow 
diets 
No difference by 
diabetes status 
Weight loss with  
Veg-CR: + 18.8g 
(17.2%), n =4 
































2006 ADF:  Ciradian Activity 
Weight gain 
approximately 20% 
(no figures given),  
both arms 






2005 Cardiac Damage with coronary artery ligation. 
IF: 49 g weight gain 
AL:125g weight gain 
N/A N/A N/A No 
Pedersen et 
al(270) 
1999 No difference in the degree of insulitis 




ADF: + 245g 
N/A 
Diabetes Diagnosed 





















IGF-1: No difference 
Neuronal survival in response to chemical 
injection: ADF & PF >AL 
Beta-hydroxybutyrate:  
Increaed with ADF > PF 
AL: +17g 







ADF vs PF:  







CR > IF & AL 











Response to IPGTT: 
 IF > CR > AL 
Fasting glucose:  


























Lower in all groups compared to HF-AL. 
Ghrelin: 
Unaffected 
Neurotransmitter concentrations:  
Norepinephrine concentration ADF-diets: 
Greater concentrations in the antero-medial 
hypothalamus compared with AL controls 
ADF-LF: Greater concentration in the in the 
posterior hypothalamus. 
Dopamine Concentration: 
IMF-LFD > other arms 
NPY&POMC mRNA expression: 
NPY  expression greater with ADF. 
POMC lower in all groups compared to HF-AL 
AgRP: No difference 
GHSR expression greater with ADF 
Exact figures not 
given. Approximate 
figures.  
Absolute Wt Change  
(%):  
HF-AL: +2.5g (~7%) 
LF-AL: -2g (~5%) 
HF-ADF: -2g (~5%) 
LF-ADF: -2g (~6%) 
MRI. 2g 




























IMF-LF was lower 
than HF-AL, but 


































ADF made no 
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AL-wt: + 7g 
AL-tg + 8g 
ADF had less 
fat than AL 
















 AUC glucose 
following IPGTT 
 AAC glucose 
following ITT 
 insulin stimulated 










Beta agonist stimulated lipolysis:  
NEFA, TG, Glycerol 
Analysis of Hepatic Lipid Droplet Proteins 
Liver & Skeletal Muscle TG content:  
ADF  muscle DAG & TG content,  
Increases muscle FA oxidation 
AL: +36 




Lean Mass  
AL: +15g /+ 
15g 







Insulin tolerance test 
Fasting insulin 
higher in CR but not 
AL compared with 
ADF 
No difference in 
IVTT or OGTT 
between groups 

















Spontaneous Physical Activity: 
No difference during light phase; 
During dark phase, fasting ADF mice moved less. 
Higher Temp & VO2 in ADF mice on feeding 
days (unsurprising - TEF). 
Effect of IP Leptin on Food Intake: 
Decreased intake in ADF mice but not AL mice 
Effect of intra-abdominal leptin on 
hypothalamic signalling: 
Increased 
Skeletal muscle mitochondria: 
No change in mass or function 
Hypothalamic Neurotransmitter mRNA 
 ADF: AGRP & NPY feeding & fasting.  
                 Orexin,  fasting days only. 
 ADF: TRH, fasting days only 
Unchanged: CRH, POMC, Melanin 
Concentrating. 
Daily fluctuation in overall weight and liver mass: 
The store depletion is unlikely to be siimilar to that 
of human subjects over a similar time course. 
ADF: +22.5g 
AL: + 50.3g 
Not Assessed Not Assessed Not Assessed 




Higher VO2 on 
Fed days in 
ADF rats 
Higher RER in 
ADF rats on 
fasting days 






TG-Synthesis assessed by Deuterium: 
Unaffected in ScAT and VAT 
Net Lipolysis & Lipogenesis: 
ScAT not VAT: Denovo lipogenesis greater in all 
arms compared with AL. 
No significant 
difference in weight 
between any groups 
excepts CR-25% and 
AL.  
ScAT higher 
and VAT lower 
in all groups 
c.f. AL. 
Weighed 
Not Assessed Not Assessed No 
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No difference in lipolysis. 
No difference in lipogenic or lipolytic gene 
expression 
Plasma Adiponectin:  
Higher in all groups compared to AL 
Plasma Leptin: No difference between arms  
Reproductive Cycle assessmnet by vaginal 
cytology: 
CR stopped cycling 
ADF or AL did not 
Absolute wt gain (% 
baseline ) 
AL: +1.9g (10% ) 























ALT: Lowest in IF group 
AST:Lowest in IF group 
Liver Histology: 
Cirrhosis in MF-AL & AL groups 
Hepatic TG deposition: 
Lower in IF  & CR groups. 
Genes assoc with Liver Droplet 
formation: 




AL: + 14g (63.6%) 
CR-30: -2g (9%) 
MF-AL: +20g 
(91%)  




No difference with IF 
group in fasting 
plasma insulin 
Lower peak glucose  














Lowest in INT group. 




Estrus Cycle: Not examined for IF 
Cell Proliferationt: 
Reduced epithelial, T-Cell & Epidermal 
proliferation in CR-5%-ADF compared 
with AL intake 
Exact figures not 
given:  
No SEM or SD's given 
Approximate Intake 
(g):  
AL: +2g (11%) 
CR-5%-DF: -3.5g 
(20%)  
CR-5%-PF: 1.5g (9%)  
CR-5%-ADF: 
0.5g(3%)   
CR-33%-DF: -3 (15%) 
CR-33%-PF: -2.5g 
(13%)   
CR-33%-ADF: -1g 
(6%) 
Not assessed Not assessed Not  assessed Not assessed 
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Appendix C: Promethion Signal Processing Algorithm Used to 
Calculate REE from Indirect Calorimetry  
Macros, sets of instructions that allowed batch processing and automation of most of the 
data processing, were provided with the Promethion and executed in Expedata (Sable 
Systems, USA). These macros were Promethion-specific but their validity for our unique 
calorimetry setup was unknown at the outset. I adjusted the code for these macros in 
Expedata so that they occurred in a stepwise, graphically illustrated fashion. This allowed 
me to visually inspect every step of the data processing and to identify if an error in the 
data was amplified by application of the standard macro. This stepwise macro was used 
during the data processing of studies where; the raw data differed from expected absolute 
values, showed a larger than expected variability, when sensors from different channels 
differed significantly or when unexpected outputs were produced by the automated data 
processing.  
Correction of Temporal Lag 
The measurement of excurrent O2 and CO2, is assumed to occur simultaneously. In our 
setup, the O2 and CO2 analysers are placed in series in each channel and there is a 
temporal lag between the recordings of these gases. There is also a temporal lag when a 
channel switches from measuring excurrent to incurrent gas flows. The issue of temporal 
lag is a common one in signal processing and is easily corrected by shifting the data 
samples backward with respect to time. A different correction is applied to the O2 and 
CO2 channels to temporally align these sensors. The switch from excurrent to incurrent 
air is “marked” in the raw data and the adequacy of the temporal lag correction is possible 
to check by visual inspection of the data to see that the change in gas values align with 
the channel switch as expected.  
Smoothing Barometric Pressure 
 Smoothing is another signal transformation that reduces noise in signal processing.   This 
can be achieved by several statistical techniques (Wood GA, 1982). Nearest neighbour 
smoothing is a form of smoothing that bases an estimation, y, of a given sample point x, 
on the average of a pre-specified set of “nearest neighbour values” i.e. the set of values 
adjacent to the point in question. This is repeated for every point on the line. For example, 
we use the 599 samples on either side of any given sample to smooth the samples. 
280 
 
Barometric pressure is slow to change, and thus smoothing over a ten- minute interval 
reduces noise that would otherwise introduce inaccuracies in the correction for 
barometric pressure.  
Correction of O2, CO2 and Flow Rate for WVP and Barometric Pressure  
The barometric pressure of the measured gas mixture is inversely proportional to the 
volume of the gases in that mixture, as mentioned in section 2.1.1.  To adjust for this, the 
following equation can be used: 
Equation C.1:   𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑂2  =  
Measured 𝑂2 ∗ 101.325
(Measured 𝐵𝑃)
 
Thus, when barometric pressure is lower than the standard pressure of 101.325 kPA of 
oxygen the gases are multiplied by a factor <1 and their STP value is, appropriately, less 
than the measured value at a lower barometric pressure. The converse is also true.  
When water vapour increases in a mixed volume of gases it reduces the partial pressure 
of that gas, as the calorimetry equation assumes dry air at CTP, the effect of water vapour 
pressure on the “dilution” of CO2 and O2 must be corrected for. This is done by modifying 
the above equation as follows:  
Equation C.2:   𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑂2   =
 Measured 𝑂2 ∗ 101.325
(Measured 𝐵𝑃 − Measured 𝑊𝑉𝑃)
 
It is this equation that is employed in our standard macro, a similar equation is used for 
CO2 correction. Thus, at a fixed atmospheric pressure, water vapour pressure diminishes 
the denominator, thus increasing the factor by which the O2 or CO2 is corrected. Simply 
put, the higher the WVP, the greater the correction factor applied. This is analogous to 
mathematically ‘drying’ the measured air in addition to adjusting for barometric pressure 
in one step.  
A related correction must be applied to flow-rate estimation. Barometric pressure alters 
gas volumes traversing a flow sensor per unit time, i.e. flow rate, in the same way that it 
affects gas volumes. By contrast WVP “inflates”, rather than dilutes, the flow rate 
compared to dry air at STP. It does this because it represents an additional volume of gas 
passing along the flow sensor. The equation to correct this produces a correction factor 
less than one, for any WVP > 0 kPa, by which the flow rate is multiplied. As with the 
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previous equation this adjustment can be performed simultaneously with an adjustment 
for barometric pressure:  
Equation C.3:   Corrected 𝐹𝑅 =  
𝐹𝑅 ∗ (Measured 𝐵𝑃 – Measured 𝑊𝑉𝑃)
Measured 𝐵𝑃
 
Calculating FiO2 and FiCO2.  
The Promethion baselining process for any given channel results in a timestamped mix 
of excurrent and incurrent samples. To calculate VCO2 and VO2 the FeO2 and FeCO2 
values for the measurement period need to be “separated” from the FiCO2 and FiO2 
vectors. The O2 value of atmospheric air should be 0.2094. The most level consecutive 
baseline samples in the oxygen channels are adjusted to this level, if they are not already 
there, and all other samples are adjusted by the same degree. This correction calibrates 
all oxygen samples. It does rely on accurate WVP calibration, which is why this is 
performed daily. The FiO2 values at STP can now be treated as a constant, 0.2094, and 
the decrement from this value to the measured FeO2 is the delta O2. 
Generation of the FiCO2 vector involves linear interpolation, this technique creates a line 
based on a set of data points. Once again, the most level set of data-points in the 
baselining segments in each channel are used. This involves the assumption that CO2 
change slowly in the atmosphere surrounding the hood calorimeter and that for any given 
channel the atmospheric CO2 does not change when it is not being monitored. In practice, 
the amount of time that the baseline is not being monitored by either channel is 360 
seconds out of 1800 seconds, consisting of 3 intervals of 120 seconds each. The 
baselining frequency was deliberately set to minimise these unmonitored intervals while 
maximising the number of baselining instances and maintaining compatibility with our 
macro. Non-contiguous baseline segments of CO2 are thus replaced by a single line of 
data points that can be treated as the FiCO2, this is done for both channels. FiCO2 and 
FiO2 are used to calculate VCO2 and VO2 for incorporation in the Weir equation 
(equation 2.4, section 2.2.4.1). 
Calculation of the delta CO2 and delta O2 
Having determined the FiCO2, FiO2, FeO2, FeCO2 at each sampling point, the CO2 
production and O2 depletion can be calculated. These correspond to the (FeCO2-FiCO2) 
term and the (FiO2-FeO2) term in the VCO2 and VO2 equations (equation 2.1 and 2.2, 
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section 2.2.4.1) and are termed delta CO2 and delta O2 respectively. All samples in each 
O2 channel are subtracted from 0.2094 – the FiO2 at STP. This produces two delta O2 
vectors of 1800 samples each specifying the reduction in O2 from baseline at each time 
point. Similarly, each CO2 channel is subtracted from a level section of the corresponding 
baseline CO2 value to produce two delta CO2 vectors.  
The delta vectors are used to calculate VO2 and VCO2 using; flow rate, and a correction 
for the effect of changing CO2 on O2 and vice versa.  
Merging FiCO2, O2, CO2 Channels 
Having generated values for FiO2, FiCO2, delta CO2 and delta O2 for both channel one 
and channel two, these paired vectors must now be combined. At this point, the FiO2 
vector is considered a constant value 0.2094 and there are two FiCO2 vectors that 
represent incurrent CO2 values across all 1800 timepoints. These two vectors are 
combined by averaging them to create a single FiCO2 vector.  
Once calculated, within each delta CO2 channel and each delta O2 channel are excurrent 
segments containing the delta values interspersed with baseline samples containing the 
incurrent values (fig 2.3). For each gas, each channel baselining timing is offset with 
respect to the other channel so that when one channel is measuring baseline samples, the 
opposite channel is measuring excurrent air. In contrast to the baselining measurements, 
which miss 360 samples during the usual setup, the excurrent air samples are 
continuously acquired by one or the other channel. For each channel, its baseline readings 
are replaced using a merging function that copies the alternate channels excurrent 
readings across. This is done for WVP, CO2 and O2 channels. Once this is done, both 
vectors for each gas are combined and then divided by two to produce a single averaged 
reading for each of WVP, CO2 and O2.   
Calculating VO2, VCO2, RQ and REE 
Finally, the combined, baseline-free delta CO2 and O2 vectors are incorporated in 
equation 1 and equation 2, (section 2.2.4.1) to calculate VO2 and VCO2 respectively: 










VCO2 and VO2 are then incorporated in the equation 4 to calculate REE: 




Appendix D: Guide to Calorie Counting Used for the CREEDS Study 
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